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FRAMEWORK FOR ANALYSIS 
This section provides the conceptual framework for understanding the analytic approach 
in the next six sections.  As discussed in Section 3, the Continuity Assessment Record and 
Evaluation (CARE) tool was designed to build on the current scientific knowledge base for case-
mix measurement, including the approaches already used in the Medicare program’s prospective 
payment systems (PPSs).  All four post-acute care (PAC) PPSs use a case-mix measurement 
approach that measures patient complexity in terms of medical conditions and treatment 
procedures; three of the PPS (inpatient rehabilitation facilities [IRFs], skilled nursing facilities 
[SNFs], and home health agencies [HHAs]) also measure functional status and cognitive status to 
assess the patient’s complexity at admission and to varying degrees during the treatment period. 
This framework builds on the existing approaches for defining patient complexity to 
explain variation in costliness and outcomes.  Much of the literature in this area has focused on 
medical, functional, and cognitive status as key drivers explaining resource use and outcomes 
(Campbell, Seymour, and Primrose, 2004), and these are the primary drivers in the Medicare 
PAC payment systems.  This section of the report discusses the analytic framework used and the 
analytic variables constructed from the CARE items to control for patient complexity in 
examining discharge destinations and predicting routine/therapy resources intensity, functional 
change, and hospital readmission outcomes. 
5.1 Development of a Case-Mix Classification Framework 
One approach to thinking about patient clinical complexity is to examine patient severity 
within theoretically important subdomains and subsequently evaluate how these subdomains 
interact to create a complete picture of a patient.  Building on the current case-mix measurement 
approaches for patients treated in PAC, we examined three domains of patient acuity:  medical, 
functional, and cognitive status.  Each of these components of health status is important for 
defining case-mix criteria and may affect the patient outcomes independently or by interacting 
with other patient characteristics.  As the developers of the early Diagnostic Related Groups 
(DRG) system noted, a case-mix system should include “all available patient characteristics 
which … would be expected to consistently affect resource intensity” (3M, v.21).   
Our approach assumes that each of these three domains may potentially predict resource 
needs and outcomes because they define severity of illness, difficulty of treatment, type of 
intervention needed, and the expected volume and types of routine or therapy resource intensity.  
This framework was used to guide the selection of patient acuity measures in the following 
sections of the report to test the extent to which each domain is important in each setting and to 
identify the best measures of each concept in terms of their potential contribution to explaining 
resource intensity and treatment outcomes.  Figure 5-1 shows the classification schema 
underlying our approach, which is described below. 
Each of these three domains is currently represented in at least one of the four post-acute 
care (PAC) payment systems as factors that predict variation in resource intensity.  Medicare 




CARE case-mix classification schema 
 
*A modified MS-DRG/MDC system was used in the analysis (e.g., the neurologic major diagnostic category (MDC 
01) is subdivided into neurologic, stroke (MS-DRGs:  020, 021,022,061-066), neurologic, surgical (MS-DRGs:  
024-042), neurologic, medical (MS-DRGs:  052 -060, 067-103).  Similarly, the HCC classification was modified 
slightly for use in this project. 
** The motor scale combines the self-care and mobility scales that are listed separately in this section as well.  
NOTE: Where the complete list of factors under each category is not presented in this chart, this is indicated by the 
notation: ‘+ …’ . 
factors in their populations.  For example, the LTCHs’ PPS uses Medical Severity-Diagnostic 
Related Groups (MS-DRG) to classify patients based on medical complexity.  The MS-DRG 
system uses ICD-9 codes to define the primary condition, whether they were medical or surgical 
in nature, and assign a severity of illness level based on complicating comorbidities, because all 
those factors affect the relative complexity or costliness of patients at that level of illness.  
Although cognitive status may be impaired, it is generally assumed to affect the costliness of 
nursing care in each diagnostic group in a consistent manner and is not measured separately.   
Within the MS-DRG system, the effect of a limited number of the cognitive conditions 
has been recognized as varying within a case-mix group.  These specific conditions are indicated 
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 as a complicating condition by including an ICD-9 code for the condition in the severity 
adjustment (e.g., Alzheimer’s Dementia w/Behavioral Disturbance as a complicating severity 
factor within a DRG).  Functional status is not used in classifying LTCH patient complexity for 
the purposes of payment, although many LTCHs provide specialized therapy services in addition 
to the medical treatments, and these effects may be variable within MS-DRG groups.  This 
suggests separate recognition of function may be valuable for improving the predictive power of 
LTCH case-mix classification systems. 
The IRF payment policies use medical, functional, and for some cases, cognitive factors 
to classify a patient’s complexity.  The primary reason for treatment is defined by 
diagnosis/impairment codes that specify the medical condition.  In this system, the primary 
reason for treatment is used to classify the case, and the comorbidities are used to adjust 
payments.  In addition to medical status, functional status and, for some cases, cognitive status 
are also used to assign patients to case-mix groups in the IRF PPS.  
Similarly, SNF payment policies also use medical, functional, and cognitive factors in the 
resource utilization groups (RUGs) case-mix system.  The primary reason for treatment is less 
important than the total constellation of medical factors in this setting.  SNF medical conditions 
are identified by an indicator of whether a patient has certain medical conditions currently 
affecting treatment without distinguishing between primary and secondary diagnoses.  Medical 
complexity is further refined by information on the presence of other medical factors such as 
pressure ulcers and the need for ventilators.  Functional status also is reflected in the case-mix 
group assignment in SNFs and is based on hours of therapy provided.  In addition, cognitive 
status is taken into account in the SNF system.   
HHA policies also use medical, functional, and cognitive factors in their case-mix 
system.  HHAs must report both primary reason and comorbid conditions using ICD-9 codes.  
HHA case-mix adjustment includes large groupings of medical conditions, some based on the 
primary diagnosis only, while others are based on all diagnoses listed.  Like the SNF policies, 
medical conditions are further identified by additional complications such as pressure ulcers and 
other factors.  Both HHA and SNF coding systems may use a procedure (or a V code) as the 
primary reason for admission.  Like the SNF PPS, the HH PPS includes a measure based on the 
therapy services provided in their calculation of therapy payment rates. 
5.1.1 Medical Complexity 
Defining medical complexity in a consistent manner is key to understanding the extent to 
which severity drives resource use.  First, as shown in Figure 5-1, the medical complexity 
domain includes patient conditions, both primary and comorbid, in addition to such factors as 
skin integrity, physiologic factors, major treatments, and measures of patient frailty.  Medical 
complexity is relevant to all patients receiving Medicare services.  For all the domains, including 
medical complexity, the impact of the individual components within each domain is tested rather 
than creating a composite measure of medical complexity.  
As described above, each of the current PPSs have their own approach for including 
diagnoses or conditions.  For example, some PPSs require identification of the primary diagnosis 
along with the comorbid or complicating conditions, while others do not distinguish between 
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primary and secondary conditions in defining the patient’s medical complexity.  A more 
complete discussion of how diagnosis information is used to derive a measure of “primary reason 
for treatment” is discussed in the next section. 
A major area of concern with developing a measure of primary reason for treatment is 
deciding to what extent this measure should be defined by diagnoses in the initiating hospital or 
by diagnoses at the PAC setting.  Medical condition will be related to the types of services that a 
patient will need in PAC, in addition to prognosis and severity.  Defining the patient’s condition 
is more complex in PAC than in hospital admissions.  To understand the severity of the PAC 
case, certain pre-PAC admission medical factors must be considered, including whether the 
patient was admitted directly to PAC from a hospital and, if so, whether they had surgery in the 
hospital.  The majority of cases treated in PAC sites initiated their episode with a prior hospital 
admission, although the reason for the hospital admission is not necessarily the same as the 
reason for PAC admission.  Classification of PAC patients by medical condition should take into 
account both the reason for PAC admission and for the preceding hospitalization if the PAC 
episode initiated with a hospital stay.  The medical condition listed as the reason for PAC 
services will frequently be closely related to the reason for the preceding hospitalization, but it 
may also be the case that a procedure code in the preceding hospital stay condition may be very 
important for identifying the type of precipitating medical condition. 
Comorbidities in the PAC admission are also complex to define.  Comorbidities 
important to PAC services are very frequently chronic illnesses that potentially affect the 
treatment needs in both the hospital and PAC setting.  Other complicating conditions that 
occurred in the hospital, such as pressure ulcers, also have a high likelihood of being present in 
the PAC setting because the two services are usually sequential with very few, if any, 
intervening days between discharge from the hospital and admission to the PAC setting (Gage, 
Morley, Smith, et al., 2009). 
Another aspect of medical complexity is whether the patient is receiving major treatments 
such as dialysis or ventilator use.  Although receipt of major treatments may be highly correlated 
with severity and increased costs, some treatments, such as indwelling catheter use, are not ideal 
measures of medical complexity because they are resource based and potentially “gameable” and 
may increase in frequency in response to financial incentives.  Less discretionary services, such 
as hemodialysis, are less likely to be initiated by the provider without indisputable need. A 
preferred measure is of the patient’s condition that requires the resource, rather than the resource 
itself.  As discussed in Section 3 describing the CARE tool, the major treatments targeted for 
collection were ones that are less discretionary in nature.  Including nondiscretionary treatments 
that require more intensive nursing or physician care can still be helpful in understanding 
expected resource variation.  Some of these are currently reflected in the MS-DRG system or 
RUGs system, although the items are collected in different ways.  The IRF PPS incorporates 
these types of factors in the payment tier adjustment. 
Physiologic or other biologic factors such as HbA1c levels and other laboratory values  
can be valuable in understanding severity of illness.  Their inclusion in payment models would 
be less likely to create incentives for providers to provide unnecessary services, though it should 
be noted that including some physiologic factors could encourage unnecessary invasive or 
expensive testing.  Physiologic factors were also included to see if resource measures included in 
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the form of major treatments could be replaced with certain physiologic measures of severity, an 
approach that is less gameable and preferable for payment policies. 
Another potentially important component of the medical domain is integumentary status.  
Skin integrity conditions are used in most of the PPSs, although how the concept is measured in 
each system varies.  Presence of skin ulcers and wounds can complicate treatment, affecting 
staffing needs, resource use, and patient outcomes in any setting. 
5.1.2 Functional Status and Impairments 
The second domain in this classification schema (Figure 5-1) is function, which was 
broken into two components: functional status and impairments.  Separating the function domain 
from the medical domain, which may specify a physical rehabilitation condition as the primary 
diagnosis, allows one to measure the severity of functional limitations and how their 
improvement is related to treatment.  Goals of treatment in PAC frequently include improvement 
in functional status (e.g., providing physical and occupational therapy to a patient to regain 
mobility or independence in activities of daily living so a patient can return to their prior living 
situation).  Functional status and impairments at admission can directly drive resource utilization, 
patient length of stay, and discharge destination and also can affect patient risk for adverse 
outcomes, such as pressure ulcers.  Functional improvement will be complicated by medical 
conditions and by premorbid functional status. 
Impairments can be a key aspect of a patient’s functional ability.  Multiple types of 
impairments were assessed in the CARE tool, as described in Section 3, and include impairments 
in bowel and bladder management, swallowing, expression, sight and vision, ability to bear 
weight, grip strength, endurance, and respiratory status.  Physical impairments reflect a reduction 
in one’s ability in physical functioning, but are not direct measures of functional abilities.  
However, the presence of these impairments will affect the level of staff intensity required to 
care for a patient and can also affect patient outcomes.   
Functional status scales were developed to measure level of independence across three 
subcomponents:  self-care, mobility, and instrumental activities of daily living (IADLs).  Each of 
these scales was tested in the analyses detailed in the subsequent sections to see if they had 
separate, independent effects on discharge destination, outcomes, or resource utilization.  
Additional analyses were conducted with these separate subscales on subsets of patients based on 
primary diagnosis.  These models tested whether the effect of function on patient outcomes 
differed depending on the patient’s primary condition (i.e., a patient with a lower limb 
amputation may have no deficits in self-care, while their mobility may be highly impaired).  
Measuring these components separately will allow these sorts of differences to be addressed in 
measuring resource use and outcomes, particularly for different patient populations.  These 
subscales were found to be highly correlated when used to predict resource utilization and 
readmission, so a fourth scale was also tested—the motor scale, which combines the self-care 
and mobility scales into a single scale.  The IADL scale was not included in final models because 
the scale largely only differentiated among patients in HHAs who were able to perform the more 
difficult CARE items that comprise the IADL scale.  The development of the functional scales is 
described in greater detail later in this section. 
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5.1.3 Cognitive Status 
Last, cognitive factors may play a complicating role in predicting resource intensity or 
outcomes because they reflect understanding, memory, or other problems that may impede 
medical or functional treatments related to the patient’s ability to understand the directions being 
given.  Additionally, patients who may be verbally or physically abusive to self or others may 
require additional staffing.  For example, an inpatient who is pulling his or her IV lines will need 
more monitoring than a patient who is not.  Similarly, a brain injury patient may need additional 
monitoring because his/her cognitive deficits may lead to concerns for safety and thus greater 
need for staff supervision.  Mood disorders (e.g., depression) are also important measures of 
cognitive ability.  Patient mood may play a role particularly in the case of patients needing 
therapy because depression can complicate treatment by affecting patient motivation and ability 
to participate in treatment.  These types of issues underscore the need for a conceptual 
framework that is comprehensive, using standardized items that can be measured across settings 
and patient populations, but does not require all CARE items for every patient. 
Cognitive status items are already included in the IRF and SNF PPSs.  Cognitive factors 
may be less relevant for setting payment for HHA patients, but it may be a consideration in 
admitting patients to home health care or explaining variation in the outcomes achieved within 
home care; patients with cognitive deficits may be less likely to be admitted to home health care 
because of increased potential for harm.   
5.2 Defining More Complex Concepts:  An Operational Approach 
As mentioned above, several of these concepts are more complex to operationalize.  This 
section discusses our approach in more detail for defining patients’ medical conditions, both 
primary medical condition and comorbidities, in addition to our approach for measuring patient 
functional status. 
5.2.1 Medical Conditions 
Primary Reason for Treatment.  We considered multiple approaches for defining the 
primary reason for treatment.  Typically, in each setting, the reason for treatment is based on four 
factors: 1) the reason for requiring treatment during this spell of illness, in particular, diagnoses 
related to their immediate prior service use or reason for prior hospital stay, 2) the type of 
chronic condition underlying the acute event, 3) the reason for admission to a specific care 
setting, and 4) any complicating or comorbid conditions that need to be monitored or treated 
while treating the primary condition.  For the purposes of this analysis, we created a primary 
reason for treatment, which classified patients into one mutually exclusive category based on the 
diagnosis at the preceding hospital stay or, if no hospital stay occurred within the appropriate 
observation window, based on diagnosis in the PAC setting.  If the primary reason for admission 
to the PAC setting is a different type of condition than the reason for the index hospitalization, 
this is taken into account through inclusion of the PAC diagnosis in the calculation of 
comorbidities.  All secondary conditions on the prior acute and current PAC claim are 
considered candidates to be assessed as active comorbidities.  The specific measurement of 
comorbidities is discussed in greater detail later in this section.   
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One issue in identifying why a person is being treated is that the current PPSs use 
different methodologies to define a medical condition.  Although ICD-9 codes are useful for 
specifying the exact problem for the purposes of treatment, they are too small a unit for 
constructing payment groups.  Our objective in formulating the primary diagnostic aggregation 
we propose below is to develop exhaustive sets of related conditions appropriate for 
understanding patients with similar resource utilizations and courses of illness in PAC settings.   
We propose to build on the existing science in the medical communities and use the 
existing logic structures for aggregating ICD-9 codes.  To do so, we suggest that because the 
treatment of ICD-9 codes in payment systems have been developed and modified over the years 
by physician experts focusing on aggregating ICD-9 codes into similar, related condition groups 
we should build on that expertise.  The intention is to reflect back toward the acute DRG 
diagnostic classification while building on and incorporating diagnostic elements from the legacy 
SNF, IRF, HHA, and LTCH classifications.  For all settings, one important observation is in 
considering the level of aggregation of diagnoses or level of specificity that is needed to define 
the concept of primary condition to identify groups that are relatively homogenous in terms of 
resource use.  
Our approach built on the current systems for addressing diagnoses in the five settings.  
Acute hospitals and LTCHs use ICD-9 codes that are aggregated into MS-DRGs.  The MS-DRG 
system uses the ICD-9 as a building block to specify groups of diagnoses associated with 
surgical or medical treatments.  A worthwhile feature of this system is that the DRG-based 
system identifies whether the reason for treatments began with a surgery.  At the same time, 
although the level of specificity present in the MS-DRG system is appropriate for the settings for 
which it was created, it may be overspecific for identifying the types of case in PAC settings.  
In every system, the manner in which diagnosis is incorporated in the payment system 
influences both what is coded and how it is coded.  The IRF system uses ICD-9 codes grouped 
into categories designated as impairment group codes.  An important feature of how diagnosis is 
examined in IRFs is that it includes information identifying the primary reason for treatment as 
the underlying or etiologic condition precipitating this episode of care.   
SNF PPSs and home health PPSs use condition indicators that were considered to be the 
appropriate level of aggregation of clinical conditions for these populations because many factors 
in addition to the medical diagnosis affect use and outcomes in these two groups.  The home 
health PPS condition indicators, assessed at admission, are derived from ICD-9 codes, although 
they may reflect codes that are not used in the other settings such as V-codes.  The SNF PPSs, to 
the extent they use condition information, base it on condition flags on the MDS, which are more 
aggregated than individual ICD-9 codes.  In addition, ICD-9 codes are reported on the SNF 
claim, but because payment is not based on this information, it may not necessarily be completed 
by a professional coder.   
Taking these issues into account, we present the following approach for classifying the 
type of medical conditions being treated.  We are using a standard building block to unify 
classification across settings and encourage greater service equity and coordination.  The MS-
DRG represents the building block from which primary medical, surgicals or rehabilitative 
diagnoses are aggregated into groupings of clinically related diagnoses. 
7 
 
We proposed a combination of medical condition information obtained from the prior 
hospital claim and from the current PAC claim to define the primary reason for treatment.  First, 
we considered prior hospitalization discharge diagnoses for every PAC admission and the 
diagnoses on the PAC claim corresponding to the CARE assessment.  The prior hospitalization 
reason is important in understanding the medical complexity of the PAC patient and allows 
identification of patients whose reason for hospitalization was surgical or medical.  In particular, 
using the prior acute hospitalization allows identification of patients with recent acute events, 
such as stroke and acute myocardial infarction (AMI) that may be important factors.  It also 
allows identification of patients who have had recent orthopedic procedures, such as joint 
replacement, that are particularly relevant to subsequent need and intensity of PAC services but 
that may be difficult to identify on PAC claims because of current coding practices.  And further, 
it provides a standard approach to coding that reduces the difficulties in using PAC claims data 
for these purposes.  In creating the variable primary reason for treatment, we used the hospital 
diagnosis to classify the patient for patients with an acute stay within 100 days prior to their 
CARE stay.  For patients that did not have an acute stay within 100 days, we used the medical 
diagnoses from the PAC claim. 
Regardless of whether the major reason for PAC treatment came from the prior acute 
discharge diagnosis or the PAC claim, we used the same strategy for aggregating diagnoses into 
meaningful groups to allow prediction of our dependent variables.  With the input of our clinical 
experts, we evaluated the current classification strategies for grouping medical conditions 
including the Major Diagnostic Categories (MDCs), which classify diagnoses by major body 
systems, and the MS-DRGs, which allow for more granular differentiation of patients within 
each MDC.  A third system we considered was the hierarchical condition categories (HCCs), 
which was particularly useful for classifying PAC patients’ diagnoses because the HCCs are not 
dependent on surgical or procedure codes to group patients.  Our objective was to create a set of 
categories that were clinically meaningful in PAC settings that group patients of similar severity 
and resource needs, while taking into account sample size issues and current coding practices. 
These considerations lead to using the set of conditions groupings in Table 5-1 to 
identify the underlying reason for treatment in each setting.  The classification system is 
primarily based on grouping ICD-9s into MDCs but uses the information from the MS-DRG and 
the specific ICD-9s to further specify cases if warranted.  Reasons to subdivide MDCs include 
the need to distinguish between cases with medical or surgical diagnoses in the prior acute 
hospital stay.  Some MDCs were reclassified based on whether a condition was major or minor.  
Comorbidity severity indicators generated by the MS-DRG grouper were not used because we 
are using the more specific CARE items and comorbidities from the PAC setting to define 
medical severity.   
For MDCs that are not prevalent in the PAC population (e.g., 02 = diseases and disorders 
of the eye), we combined MDCs into two larger categories of “other medical” and “other 
surgical.”  Other types of cases that are highly prevalent in the PAC populations, such as stroke 
or chronic obstructive pulmonary disease (COPD), were broken out within their MDC.  In 
Table 5-1, the first column shows the variable name or condition category name used in our 
models, the second column shows the MDC, and the third column shows the MS-DRGs included 
in that category.  For example, we subdivided the Neurologic MDC (01) into three groups:  
stroke, “surgical,” and other “medical.”  The respiratory-diagnosis-related groupings include 
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MDC (04) and the Pre-MDC category of tracheostomy.  These conditions are divided into four 
groups:  ventilator, surgical, COPD, and nonventilator, non-COPD medical categories.  COPD is 
its own category (“Respiratory, COPD”) because of its high prevalence in PAC.  We also 
included a separate category for Pre-MDC MS-DRGs for ventilator and tracheostomy 
(“Respiratory, Ventilator, and Tracheostomy”) because of their distinctness as a cost group.  
Cardiovascular conditions were subdivided by whether they were vascular or cardiac, surgical, or 
medical and included a more common, nonspecific “general” category composed of diagnoses 
such as atherosclerosis, hypertension, and chest pain.  Orthopedic diagnoses were split into 
minor and major surgery, spinal, and minor and major medical categories.  For infections, in 
addition to splitting out medical and surgical diagnoses, septicemia diagnoses have their own 
category.  Major organ transplants were grouped together in a “Transplant” category, while 
gastrointestinal (GI) and hepatobiliary MDCs (06 and 07) were aggregated into larger categories 
that cut across the two MDCs, resulting in major and minor surgical, and major and minor 
medical groupings. 
Active Comorbid Conditions.  For each model, we tested whether there were key 
comorbid conditions active in the current PAC stay that affected the predicted outcomes.  To 
identify these active comorbid conditions, we used the secondary diagnoses from the prior acute 
claim and all diagnoses from the PAC claims.  These diagnoses were grouped using HCC logic 
that had been designed to predict program costs for beneficiaries enrolled in the capitated 
Medicare Advantage (MA) plans.  The grouper was used to predict readmissions and mortality 
for quality measures as well.  For these analyses, we used the diagnoses on the concurrent 
claims.  The HCC methodology in the MA program uses the retrospective methodology to 
predict cost in the upcoming year based on diagnoses in the prior year.  Both retrospective and 
concurrent HCCS have been used in this study and in prior work as a proxy for complexity and 
as a predictor of service utilization.   
Comorbidity indicators were coded based on the diagnoses on the claim associated with 
either the prior acute stay or the stay for which the CARE data were collected.  They were 
classified based on aggregations of HCCs that were slightly recategorized for the purposes of this 
analysis.  The objective of the HCC recategorization, as with the primary reason for treatment, 
was to identify clinically meaningful groupings of related diagnoses predictive of our dependent 
variables and to optimize groupings to fit PAC populations, while taking into account small 
sample sizes.  Given small cell sizes related to specific conditions in our sample, it was necessary 
in some cases to group conditions into larger categories.  We aggregated clinically similar HCCs 
and focused particularly on grouping markers of more severe patients where possible.   
Table 5-2 shows the final set of comorbidity groupings tested in our models in the first 
column and their component HCC categories in the second column.  For example, the “cellulitis” 
grouping combines HCC 120 Major Eye Infections and HCC 164 Cellulitis, local skin infection.  
In some cases the HCCs, such as depression, were already being captured by items on the CARE 
tool; therefore, we did not include them separately as comorbidities in our models.  We also 
excluded very prevalent, nonspecific HCCs such as Rehabilitation (HCC194).  We hypothesized 
that with larger sample sizes more refined categories could be built on these HCCs that would 
allow one to break out the more severe categories into their own categories or to combine these 
markers with other CARE items to identify types of patients with constellations of related 
characteristics that have similar resource needs and outcomes. 
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In addition to the reconfigured HCC groupings, we created a single comorbidity index for 
the resource intensity index analysis sample (Sections 9 through 11) that was based on the more 
specific HCCs but was not identical to the current system.  The estimated model used 87 HCC 
groups as predictors.  The weights used were based on the version of the HCC model developed 
for predicting costs in the same year and based on secondary diagnoses reported in the acute 
hospital claim.  The nondiagnosis component of the HCC score was not used in the creation of 
the comorbidity index.  Instead, age, gender, and Medicaid status were examined separately.  
The calculation of the comorbidity index is additive.  If any diagnoses were reported that were in 
a model HCC group, the total index for that beneficiary was incremented by the coefficient of 
that group.  An index was created by dividing all the cost estimates by mean costs, resulting in 
the national average Medicare beneficiary having a comorbidity index of 1.0. 
5.2.2 Functional Measures 
Unlike medical conditions, such as pressure ulcers, functional status is difficult to directly 
observe in a consistent manner.  As a result, functional status has been traditionally measured 
using a combination of several items to measure the concepts of self-care or mobility.  When 
multiple items are used, it is important they are tested to determine whether they are all working 
together to measure the same concept, that is, does each item contribute meaningfully to 
document the concept of self-care or mobility.  The following analysis suggests they do. 
Within the CARE tool, function is represented through a series of items assessed using a 
6-point rating scale that captures the concept of need for assistance, from independence to 
dependence where dependence is based on how much help a patient needs to complete everyday 
activities.  This is consistent with existing Centers for Medicare & Medicaid Services (CMS) 
measures of function that capture a similar concept.  The rating scale used in the CARE items 
describes how much help from a caregiver must be available for this person to complete 
everyday activities.  This type of scale is a measure of how much skilled care needs to be 
available while a person is in PAC and should also be strongly related to support needs at the 
discharge location.  
The current IRF payment system uses a single motor function scale that primarily 
measures physical disabilities.  For example, the motor score in the FIM®-based IRF 
characterizes a patient’s functioning on 12 physical activities, which was developed and verified 
by applying Rasch and classic analytic approaches (Stineman, 1996).  This parallel use of both 
classical psychometric analyses along with Rasch techniques is being used increasingly in scale 
construction and measurement today (Jette, 2008) and is reflected in our current work on the 
CARE tool. 
Within the CARE tool, functional status is conceptualized in three domains: self-care, 
mobility, and IADLs.  The items chosen for collection were taken to create a tool with sufficient 
range of functional status to measure both very disabled and quite able individuals, capture 
change from admission to discharge, and at the same time not be overly burdensome to clinicians 
to complete.   
Our approach is to maximize both discrimination and predictive power by dividing the 
single motor scale into two parts, mobility and self-care, using the CARE instrument items.  The 
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two-subscale approach is consistent with the current literature, which suggests that the use of two 
scales will improve differentiation among patients with different types of impairments.  Mobility 
and self-care scales have been used in prior work published by Haley, Jette, Coster and 
colleagues (2002) and also has clinical plausibility.  Although not currently included in the IRF 
classification, mobility and self-care subscales have also been identified within the FIM® motor 
scale, which is a multilayered scale.  Specifically, these form finer dimensions that are nested 
within its broader motor score (Stineman, 1997).  The decision to use one layer over another 
depends on the question being asked.  If the intent is to approximate total disability in one large 
metric, then more aggregated scales are appropriate, but details about the disability are obscured.  
Different types of conditions have particular effects on body functions, resulting in distinct 
patterns of disability.  Self-care skills primarily depend on use of the arms and hands, while 
mobility depends mostly on general balance and use of the legs.  Therefore, the functional ability 
for different conditions could be better captured by either the mobility or the self-care subscale, 
which might not be adequately measured by the combined motor scale. 
In thinking about how to combine the patient’s performance on individual items into a 
scale capturing the overall concept of functional ability, several issues must be addressed.  One 
issue is the missing data due to issues such as environmental constraints or safety concerns.  An 
approach where not all patients are administered the same items would pose a challenge to 
traditional psychometric approaches based on total scores.  If a patient is not scored on an item, 
his/her total score must, by definition, be different and not comparable to others who were scored 
on more items.  A Rasch-based approach, however, does not suffer the same problem because 
under this probabilistic model, all available data can be used to estimate a person’s ability.  This 
is a major advantage in such situations as the PAC-PRD where patients are changing in 
functional status over time such that certain items that are not relevant or not assessed at 
admission due to medical contraindications can be assessed at discharge.   
This work uses Rasch measurement models to allow us to build a scale that uses the 
appropriate items for each person without using all items in the domain.  Below we outline the 
basic description of the Rasch measurement approach and how it enables person-ability estimates 
to be obtained without requiring that everyone take all the same items.  We also explain the basic 
analysis of the function items to examine whether they work as intended.   
In creating the final item sets for the scales and in creating the Rasch scales, we examined 
the following analytic questions: 
• Does the 6-point rating scale that captures need for assistance operate as 
intended? Does the pattern of responses to the rating scale steps (from dependent to 
independent) operate as is required by the model (e.g., monotonic progression of step 
thresholds, adequate use of each step)? 
• Do the items form two unidimensional hierarchies of function:  self-care and 
mobility?  Do the core and supplemental items for the two scales cohere (e.g., have 
appropriate item fit statistics)?  Factor analysis was used to confirm that these are 
indeed separate constructs.  
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• How well do the items measure the patients? How well do they examine the extent 
to which items sufficiently cover the range of patients measured both at admission 
and discharge, examine the extent to which patients are effectively measured (ceiling 
and floor effects) in each setting, examine the extent to which patient response 
patterns fit the assumptions of the measurement model, and examine the extent to 
which the addition of supplemental items improves measurement of range of patient 
function? 
5.2.3 Basic Principles of Item Response Theory (IRT) Models 
The Rasch model, a variant of IRT, calculates functional status measures (e.g., self-care 
measure, mobility measure, motor measure) for each patient regardless of the specific items that 
are reported.  Using this technology enables comparisons from admission to discharge and 
between settings so that it is not necessary that the same function items be used in each setting or 
at each time point, only that the items capture the same construct.  This crosswalk effect enables 
items to be appropriately targeted to the client needs in a given setting while maintaining the 
ability to compare across settings.  The Rasch model is a probabilistic model that uses available 
data to estimate both item difficulty and person ability on the same dimension (Wright and 
Stone, 1979).   
Most implementations of the Rasch model are robust to missing data (Linacre, 2006).  In 
other words, it is not required that all patients take all items if the items are all in the same frame 
of reference.  It can be useful to think of the analogy of a ruler.  To measure a 10-inch object on a 
ruler, it is not necessary that the markings at 2, 3, or 4, inches be available, just that there are 
sufficient markings around the 10-inch level for accurately measuring the object.  Similarly, 
when measuring a 2-inch object, markings around 9, 10, and 11 inches are not needed.  The same 
is true for measuring the functional status of patients precisely.  It is not necessary that a patient 
who can sit on the side of the bed with assistance be administered items about walking long 
distances or for a patient who can walk long distances to be scored on if they can sit up in bed. 
Rasch began with the idea that any person’s score (observation) on a test could be 
expressed as a ratio of probabilities.  That is, the probability that the person succeeds on the item 
against the probability that he/she fails the item is p/(1 − p).  This relationship can take values 
between 0 and infinity (∞) and thus has a nonlinear relationship with the continuous underlying 
variable being measured.  Taking the log of this relationship, log(p/(1 − p)), creates values that 
go from −∞ to +∞, forming a linear relationship with the underlying variable.  A unique feature 
of this model for determining the difference between the ability of two different people or items 
was that the item parameter could be removed from the equation.  That is, the difference between 
two persons could be estimated without needing information about the difficulty of the items 
they took. 
A person’s ability is determined by the observed responses and by the ratio between the 
ability parameters of the two people; it is not influenced by which items are used.  Exactly the 
same relationship can be shown for estimating item difficulty (i.e., they can be determined from 
observed responses and the ratio of the difficulty parameters of the items); they are not 
influenced by which people took the items.  In recent years, IRT has become increasingly used in 
both test equating and item banking procedures.  In item banking, items from multiple tests are 
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“combined” to form a single test, in which items are ordered from least to most challenging.  
Item banks are used because the combined set of items usually covers a greater range of the 
ability being measured than any of the individual tests alone, and because the bank can be used 
in computer adaptive testing where only that subset of the items in a bank most relevant to a 
person’s level of ability is administered.   
A. Does the 6-point rating scale of need for assistance operate as intended? 
The first step is to establish that the 6 steps of the CARE rating scale are operating as 
intended both overall and for individual items.  The probability that a person will be scored on a 
particular rating scale step varies depending on the functional ability of the person.  That is, very 
able people will be more likely to be scored as 5s and 6s than as 1s and 2s.  Looking empirically 
at these distributions, we should see the transitions from one step to the next (called thresholds) 
proceed monotonically and distinctly across the range of person abilities.  Put another way, there 
should always be some point along the range at which each rating-scale step is more probable 
than another step.  When a rating-scale step is not more probable at any point, it suggests that 
raters are not able to use that step to consistently distinguish patient ability at that level.  
Generally this lack of ability to distinguish between levels of ability introduces noise to the 
measurement model, and the approach is to combine ratings in one or two of the adjacent 
categories, effectively reducing the number of rating-scale steps.  The test of the success of this 
approach is that reducing the number of rating-scale steps does not reduce the meaningfulness of 
other indicators of test precision such as separation and person reliability. 
B. Do the items form two unidimensional hierarchies of function: self-care and mobility? 
The next step is to look at overall performance of the items.  This occurred in several 
steps.  First, we examined the extent to which the items worked together to define a coherent 
construct.  This was conducted separately for the self-care and mobility items.  We examined the 
separation and person reliability statistics as indicators of measurement precision.  Person 
reliability can be interpreted as analogous to Cronbach’s alpha in traditional psychometric 
theory.  Item fit statistics were examined as an indication of how well all items work together to 
describe the overall construct (self-care or mobility).  Fit statistics are a type of chi-square 
statistic—the acceptable range is generally .6 to 1.4 although .8 to 1.2 is preferred.  If the item 
values are above this range, it reflects that person response patterns are erratic, generally 
suggesting the item is not measuring the same construct as other items.   
Second, principal component analysis was used to examine how well items form a single 
construct (self-care or mobility).  In addition, we combined self-care and mobility items into a 
scale and examined overall precision of the scales and item.  Rasch-residual-based Principal 
Components Analysis (PCAR) differs from traditional PCA in that with PCAR the components 
contrast opposing factors, rather than loadings on one factor.  It should be noted that the purpose 
of PCAR is not to generate common factors as in traditional PCA but to explain variance in the 
residuals. 
C. How well do the items measure the patients? 
In this step we examined how well the items selected measure the persons in the data set 
for both self-care and mobility items.  We examined the extent to which person response patterns 
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fit the assumptions of the measurement model using the same range of infit statistics identified 
above.  We examined the extent to which persons are effectively measured (ceiling and floor 
effects) in each setting overall and for admission and discharge time points.  Finally, we 
examined the extent to which the addition of supplemental items improves measurement of range 
of patient function.  This is used as an indication of the increase in precision gained for the 
additional response burden of these items.   
As a result of this analysis, a stable set of core items was identified that maintain general 
stability from admission to discharge and between settings.  Overall, the mobility and self-care 
items were well targeted to the range of patient ability sampled within this PAC population.  
Four sets of function measures were included:  self-care, mobility, IADL, and a motor scale that 
combines elements of the self-care and mobility scales.  The variables were based on the CARE 
tool function items on the admission and discharge assessment forms.  These items were used to 
construct Rasch function scales that are continuous, calibrated to a range from 0 to 100, and 
include the following: 
• Self-care scale:  constructed based on independence ratings in eight items, including 
eating, oral hygiene, toilet hygiene, dressing (upper and lower body), putting on and 
removing footwear, washing upper body, and showering/bathing self 
• Mobility scale:  constructed based on independence ratings on 13 items, including 
lying to sitting on side of bed; sit to stand; chair or bed-to-chair transfer; toilet 
transfer; car transfer; rolling left and right; sit to lying; picking up objects; taking one 
step or over a curb, up and down 4 exterior steps, and up and down 12 interior steps; 
walking 10 feet on uneven surfaces; and walking 50 feet with 2 turns 
• IADL scale: constructed based on performance on 10 items: telephone answering, 
telephone-placing call, medication management (oral medications, inhalant/mist 
medications, injectible medications), making a light meal, wiping down surfaces, 
light shopping, laundry, and using public transportation 
• Motor scale:  constructed based on all items in the self-care and mobility scales 
The Rasch measurement approach is important when building scales from ordinal level 
data as in the function rating scales.  Although Rasch is not as transparent as the additive scoring 
method, it imposes the interval structure necessary for defensible quantitative analysis and 
modeling.  Ordinal-level data are not appropriately analyzed using an additive sum score because 
they do not provide measures of equal units.  The amount of ability needed to score 5 ‘Set-up 
Assistance’ on eating is much less than the ability needed to score 5 on lower body dressing.  
The Rasch Measurement Model takes these differences into account when determining an 
individual’s ability level where a simple summed score does not.  The resulting person-ability 
estimates, although on a logit scale (i.e., the natural log-odds of success on the items chosen), 
can be used just as a sum of scores would be in quantitative analyses or modeling.  Tables 5-3, 
5-4, and 5-5 show the relationship between the summed raw scores and the Rasch measures.  To 
calculate the summed raw score, we added the numeric score reported for the patient.  When a 
letter was recorded, we recoded those that were missing for M (medical reasons), S (safety 
concerns), or A (attempted but not completed) to Dependent (1), and those that were P (patient 
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refused), N (not applicable), and E (environmental constraints) to missing.  In the summed 
scores, the presence of a missing is equivalent to adding 0 for that measure to the scale.   
Table 5-3 shows the data for the motor scale used in the resource intensity sections 
(Sections 9, 10, and 11) and Tables 5-4 and 5-5 are the self-care and mobility tables, 
respectively.  Table 5-3 shows that the combined motor scale (mobility and self-care) ranges 
from a raw score of 25 on all 21 items associated with the motor score to a raw score of 147.  
Each raw score measure does not exactly match up with a single unique Rasch score value.  
Instead, the Rasch score considers that the responses to specific questions such as dependence on 
more basic tasks may indicate a higher level of disability than dependency on a more difficult-to-
perform task.  A raw mobility score of 90, for example, corresponds, on average, to a Rasch 
mobility score of 50.4 with a standard error of 1.7.   
Table 5-4 shows the estimated relationship between the summed raw scores and Rasch 
measures for the self-care scale.  The summed raw score for self-care ranges from 8 to 48, which 
corresponds to the corresponding Rasch measure values using a scale that was set to range from 
0 to 100.  The table shows the Rasch measures ranging from 7.64 to 85.57 due to the use 
of anchored item and rating scale values.  The mean self-care Rasch measure for all patients was 
46.4 units (see column 2), which is roughly equivalent to a total raw score of 29 (column 1) 
(when there are not missing data).   
Table 5-5 shows the estimated relationship between the summed raw scores and Rasch 
measures for the mobility scale.  For mobility, the summed raw scores range from 17 to 99.  The 
mean admission Rasch measure for all patients was 45.1, which is approximately equivalent to a 
summed raw score of 45.   
Tables 5-6 and 5-7 show the distribution of the self-care, mobility, motor, and IADL 
scales by provider type at admission (Table 5-6) and discharge (Table 5-7) for the initial sample 
of CARE assessments with valid responses at admission and discharge.  The first column shows 
the mean score, the second the standard deviation, and the remaining columns the 5th, 10th, 25th, 
median, 75th, 90th, and 95th percentiles.  LTCH patients, not surprisingly, had the lowest 
function scores across all the scales at both admission and discharge and across the distributions.  
LTCH patients have scores clustered at the low end of all of the scales, with similar scores at the 
5th and 10th percentiles.  HHA patients had the highest scores across the scales at both 
admission and discharge.  IRF and SNF scores tended to be similar at admission and discharge 
on all scores and across the distributions.  IRF patients have the smallest standard deviation in 
their scores at admission and discharge across all of the scales except IADLs at admission.  Note 
that the sample sizes are lower for the IADL scales across all settings, given the difficulty in 
ascertaining scores for these items as described above.   
As discussed in Section 3.6, all three measures demonstrated good reliability as measures 
of function.  However, mobility and self-care measures are frequently highly correlated as shown 
in earlier work (Stineman, 1996).  Despite this potential multicollinearity, the three measures 
were used separately in the analysis because they measure different aspects in different 
populations.  Using the two subscales of mobility and self-care is consistent with the current 
literature, which suggests that using two subscales will improve differentiation among patients 
15 
 
with different types of impairments.  Mobility and self-care scales have been used in prior work 
published by Haley, Jette, Coster, and colleagues (2002). 
Figure 5-2 illustrates the density of observations of self-care Rasch scores with the 
mobility Rasch scores for the four settings using a “sunflower” plot.  The sample shown in these 
figures corresponds to the sample used in the later sections on resource intensity.  These plots 
show high correlation between the self-care and mobility Rasch measures, suggesting that the 
combined motor function measure may be a sufficient statistic for the information measured by 
the separate self-care and mobility measures depending on the analytic goal.  As expected, the 
distribution of patients’ functional status measures varied across the settings.  HHA had the 
highest functioning patients, on average, but also had some lower functioning patients.  IRF 
patients were predominantly in the middle of the chart, with about half in the lower quadrant and 
the other half in the middle upper quadrant but closer to the middle, indicating that these patients 
were fairly disabled.  SNF patients were distributed similarly to IRF patients but with more 
patients in the higher functioning quadrant.  LTCH patients had the lowest functional levels.  
These plots illustrate that the greatest volumes of patients in a narrow range of functional 
performance are the IRF and SNF settings.  The HHA observations were more dispersed than the 
institutional settings, which were more tightly clustered.  The second set of figures (in 
Figure 5-3) plots the IADL and motor Rasch scores for the settings.  There also appears to be a 
strong positive association between the IADL and motor scores for all four settings.  In addition, 
the discontinuities in the IADL measure distributions suggest some weaknesses with this 
measure being used in all settings.  IADLs include activities such as medication administration, 
laundry, and use of public transportation.  Accurate assessment may be challenging, because 
some activities, such as using public transportation, may not be relevant for every patient, and a 
full assessment of a patient’s ability to plan and implement the entire activity would be very time 
consuming.  Medication administration is also difficult to assess because of inpatient policies 
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NOTE:  HHA = Home Health Agency; IRF = Inpatient Rehabilitation Facility; LTCH = Long-Term Care Hospital; 
SNF = Skilled Nursing Facility; CRU = Cost and Resource Utilization. 
SOURCE:  RTI International analyses of CARE tool data for the CARE+CRU sample:  the set of CARE patients 
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NOTE:  HHA = Home Health Agency; IRF = Inpatient Rehabilitation Facility; LTCH = Long-Term Care Hospital; 
SNF = Skilled Nursing Facility; CRU = Cost and Resource Utilization. 
SOURCE:  RTI International analyses of CARE tool data for the CARE+CRU sample:  the set of CARE patients 
with matched claims and CRU data collection forms. 
5.3  Covariate Specification 
In addition to the diagnosis and function measures discussed above, a variety of other 
measures were used in the models presented in this report.  Below is a listing of the covariates 
used in our analyses, including type of setting, patient demographics and premorbid factors, 
medical complexity, prior functioning, cognitive status, function at admission, and impairments.  
Variables were selected for analysis based on prior research.  Not every variable is used in every 
model, but we include this listing here for reference for the models discussed in Sections 6 
through 11.  Below we note where items were recoded or reference categories varied by section.  
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5.3.1 Demographic Factors 
• Age at admission:  This variable was coded into four groups (younger than 65 years, 
65 to 74 years, 75 to 84 years, 85 years or older).  The reference group was 65 to 74 
years in Section 6 (discharge destination) and 85 years or older in Sections 7 through 
11 (readmissions, functional change, and resource intensity).  
• Race:  This variable was coded into two groups (Black, not Black).  The latter was 
the reference group. 
• Gender: This variable was coded into two groups (male, female).  The latter was the 
reference group. 
• Medicaid as a secondary payer at admission:  This variable identifies whether the 
beneficiary had secondary insurance coverage under either Medicaid fee-for-service 
or Medicaid managed care as specified during admission (yes/no).  The latter was the 
reference group.  Medicare managed care patients were excluded from the sample. 
5.3.2 Medical Complexity 
Medical complexity is defined with several subdomains.  Included are measures of prior 
health care use reflecting potential medical complexity of this admission, current medical 
conditions and comorbidities, major treatments, and skin integrity and wound complications. 
5.3.2.1 Prior Service Use   
Several items were used to control for prior health service use.  The exact variables 
differed by section.  Section numbers are provided after each definition to identify the sections in 
which an item was used in the analytic models. 
• Prior acute claim within past 2 months:  This variable identifies whether the 
patient was in an acute hospital in the 2 months prior to the observed PAC service 
admission.  This measure was based on Medicare claims examinations (Sections 9 
through 11). 
• Other acute claim within past 2 months:  This variable identifies whether the 
patient was in an acute hospital in addition to the hospital stay immediately prior to 
the PAC stay being studied in the 2 months prior to the start of this episode.  This 
measure was based on Medicare claims examinations (Section 6). 
• ICU length of stay:  This variable specified the length of stay in the intensive care 
unit of the acute hospital prior to CARE stay. This was modeled as GT/LT 7 days in 
Section 6 and as a continuous variable and as the square of the continuous variable in 
Sections 9 through 11. 
• Days since prior acute discharge:  This variable was used to control for variation in 
the readmission analysis attributable to the timing of the PAC CARE admission.  It is 
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defined as the number of days from the discharge date on the claim from the prior 
acute stay to the admission date on the PAC stay (Section 7). 
• Admitted from long-term nursing facility or short stay acute hospital:  This pair 
of variables identifies whether the patient was admitted from either the hospital or a 
long-term care facility immediately prior to the PAC setting (Section 8).  
• Any of the following medical service use in the last two months:  This set of 
variables identifies whether the patient used any of the following services in the 2 
months prior to this admission: LTCH, home health, outpatient services, SNF, IRF, 
short-stay acute hospital, or none.  This variable was included in the functional 
change analysis as a measure of related complexity (Section 8).   
5.3.2.2 Medical Conditions and Complications   
These items specify the reasons for the services, comorbidities, and any related 
complications such as skin integrity and major treatment needs.  
• Primary medical diagnosis groups (PMDG):  As described in the introduction to 
this section, the PMDG was obtained from the short-stay acute claim prior to the PAC 
CARE admission or from the PAC claim if there was no prior admission within 100 
days.  Two versions of this variable were used.  Both are based on a modified 
MDC/MS-DRG approach, but one approach uses 35 diagnostic groups that specify 
whether the prior acute diagnosis was medical or surgical and breaks out several 
larger subgroups, such as the stroke cases from the other neurological cases, the 
ventilator cases from other respiratory medical cases, to name a few (Sections 7 
through 11).  The second version aggregates the 35 PMDGs into 12 groups without 
specifying surgical or other subconditions (Section 6).   
• Surgical status: This indicator variable (yes/no) was defined on the basis of whether 
the prior hospital stay included a surgical MS-DRG (Section 6).   
• Comorbidities: This set of variables control for comorbidities in each setting.  
Several different approaches were used in this report.  Sections 6, 9, 10, and 11 use a 
set of comorbidity indicator variables based on the secondary hospital diagnoses and 
the PAC diagnoses on the associated claims.  ICD-9 codes were grouped into 
modified hierarchical condition categories:  Examples include liver, diabetes, other 
endometrial conditions, orthopedic, stroke, other neurological, cardiovascular, 
respiratory, cellulitis, morbid obesity, head and spine, psychiatric, renal, and urinary 
tract infections.  Sections 7 and 8 use the same approach but base these variables on 
the ICD-9 codes provided on the CARE assessment instead of claims.  Persons filling 
out the CARE assessment diagnosis section were instructed to submit the same 
information as was coded on their claims. 
• HCC comorbidity index:  In addition to the comorbidity indicators, this variable is a 
modified version of the concurrent HCC weighting method.  This measure was built 
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from the underlying HCCs and came from the type of risk models used to predict 
Medicare expenditures (Sections 9 through 11).  
• Major treatments:  Indicates whether the patient received any of a set of selected 
major treatments during the 2-day assessment period.  The specific major treatments 
included in the models varied by section.   
– Total parenteral nutrition (TPN) (Sections 6, 9 through 11) 
– Mechanical ventilation (weaning and nonweaning) at admission/during stay/at 
discharge (Sections 8 through 11) 
– Mechanical ventilation (weaning and nonweaning) at time of transfer  (Section 6) 
– Central line management (CLM) (Section 7, 9 through 11) 
– Hemodialysis (Sections 6, 8, 9 through 11)  
Other major treatments that were considered for the models but not found to be 
significant because of low prevalence in the sample include the use of a tracheostomy 
tube with suctioning, continuous cardiac monitoring, and intravenous vasoactive 
medications or anticoagulants.  
• Skin integrity:  Several skin integrity items were tested in these models.  Most of the 
sections controlled for the presence of a severe pressure ulcer as defined below.  The 
resource intensity models also controlled for a major wound item in addition to the 
severe pressure ulcer items.  The functional change model controlled for whether any 
turning surfaces were not intact in addition to the presence of a severe pressure ulcer.   
• Severe pressure ulcer: Indicates whether the patient had a severe (stage 
3/4/unstageable) pressure ulcer or a stage 2 ulcer that was known to be present for 
more than 1 month at the time of transfer from the hospital or admission to the PAC 
setting (yes/no) (Sections 6, 8, 9 through 11).  
• Presence of a major wound:  Indicates whether the patient had a major wound 
present (yes/no).  Major wounds were defined as delayed healing of surgical wounds; 
trauma-related wounds, such as burns; diabetic foot ulcers; and vascular ulcers 
(arterial or venous) (Sections 9 through 11). 
• Turning surfaces-at least one not intact:  Indicates whether the patient had at least 
one turning surface not intact.  Turning surfaces include right or left hips, back or 
buttocks, and other turning surface (yes/no) (Section 8). 
5.3.3 Cognitive Status 
• Cognitive status (Brief Interview for Mental Status [BIMS] with observational 
assessment):  Several cognitive status measures were created based on the BIMS or 
an observational assessment of cognitive status for patients for whom interviews were 
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not feasible.  Thresholds for combined BIMS score are based on standards used for 
the MDS:  cognitive status intact or borderline (13–15), moderately impaired (8–12), 
or severely impaired (≤7).  This was used in combination with the observational 
assessment when the BIMS response was missing. 
Patients assessed based on the observational assessment were classified as cognitively 
intact or borderline if they could recall all four observational items or three items 
including whether they were in a hospital, nursing home, or home.  Patients were 
classified as having moderate impairment if two items were recalled or three were 
recalled but not whether the patient was in a hospital, nursing home, or home.  
Patients were classified as severely impaired if they recalled none or only one of the 
four items, or they recalled two but not whether they were in a hospital, nursing 
home, or home (Section 7).  Sections 9 through 11 used a variant of this approach 
allowing cases previously categorized as missing to be further reassigned to severely 
impaired based on the number of items observed to be recalled, regardless of whether 
the patient knew where he/she was.  Section 8 used a dichotomous measure of 
“severely impaired/not severely impaired” based on the variable in Section 7.   
Section 6 only had a subset of the BIMS items assessed in the acute hospital 
population: month and year.  These were used in combination with the observed 
assessment to develop a three-level variable indicating whether the patient had 
difficulty knowing the month or year at the time of transfer from the hospital or 
admission to the PAC stay.  It is a composite variable based on a combination of the 
BIMS items “year” and “month,” or if not answered, staff observation of how many 
of the following items the patient knows: season, room location, staff names/faces, or 
that they are in a hospital, nursing home, or home.  The codes are:  
– Intact or borderline:  Both month and year were answered correctly (year is 
correct; month is accurate within 5 days) or observation showed at least 3 items 
were correct. 
– Severely impaired:  Missed two years or more or missed month by more than 1 
month or could not answer (and did not have a communication deficit) or were 
observed to only know one or fewer of the observation items. 
– Moderately impaired:  Not missing and not in either of the above groups. 
• Symptoms of depression:  Indicates whether the patient may have been depressed 
during the discharge assessment window.  This indicator variable is coded yes/no; the 
latter is the reference group.  Symptoms of depression was defined as having scored 
any of the following at the time of transfer (Section 6):  
– Little interest or pleasure in doing things more than half of the days in the past 2 
weeks (7 to 11 days) or nearly every day (12 to 14 days) in the last 2 weeks, or  
– Feeling down, depressed, or hopeless more than half of the days (7 to 11 days) or 
nearly every day (12 to 14 days) in the last 2 weeks, or  
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– Having an HCC comorbidity of depression on the associated acute or PAC claim.   
• Depression (feeling sad).  During the 2-day assessment period, patients are asked, 
“during the past two weeks, how often would you say, ‘I feel sad’?”  They are given 
the following five choices: never, rarely, sometimes, often, and always.  Patients are 
defined as depressed if they answer “often” or “always” (Sections 7, 8, 9 through 11). 
5.3.4  Functional Status 
• History of falls: Indicates whether the patient has had two or more falls in the past 
year or any fall with injury in the past year (yes or no/unable to assess).  The latter is 
the reference group (Section 6). 
• Self-care status:  (See Section 5.2 for a complete discussion of Rasch scale 
construction and rating levels.)  Rasch self-care scale based on independence in eight 
items, including eating, oral hygiene, toilet hygiene, dressing (upper and lower body), 
putting on and removing footwear, washing upper body, and showering/bathing self.  
Independence is based on a Rasch scale ranging from 0 units (total dependence) to 
100 units (total independence).  This item was included in its natural form and as a 
squared term because of its nonlinearity (Sections 6 and 8). 
• Mobility status:  (See Section 5.2 for a complete discussion of Rasch scale 
construction and rating levels.)  Rasch mobility scale based on independence in 13 
items including lying to sitting on side of bed; sit to stand; chair or bed-to-chair 
transfer; toilet transfer; car transfer; rolling left and right; sit to lying; picking up 
objects; taking one step or over a curb, up and down 4 exterior steps, and up and 
down 12 interior steps; walking 10 feet on uneven surfaces; and walking 50 feet with 
2 turns.  Independence is based on a Rasch scale ranging from 0 units (total 
dependence) to 100 units (total independence).  This item was included in its natural 
form and as a squared term because of its nonlinearity (Sections 6 and 8). 
• Motor status:  (See Section 5.2 for a complete discussion of Rasch scale construction 
and rating levels.)  Rasch motor scale constructed based on all items in the self-care 
and mobility scales.  This factor was used in place of the two subscales (self-care and 
mobility) in models when the two subscales were highly correlated with each other.  
This effect varies by sample characteristics; patients having both types of disability 
had highly correlated subscales.  The motor item was included in its natural form and 
as a squared term because of its nonlinearity (Sections 6, 7, 9 through 11).  
5.3.5  Functional Impairments 
• Bladder incontinence frequency: This is a three-level variable indicating level of 
incontinence.  The first two are examined in the model; the third level includes those 
who are neither continent nor incontinent.  The main comparison is on the effect of 
having greater incontinence (Section 6). 
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– 0= continent or stress incontinence 
– 1= incontinent daily or always incontinent 
– 2= no output or incontinent less than daily or not applicable due to indwelling 
catheter.   
• Bladder device: Indicates patients with an external or indwelling device or 
intermittent catheterization (yes/no) (Sections 7 and 8). 
• Bowel incontinence frequency:  A patient is defined as bowel incontinent if he or 
she is assessed as being either incontinent daily or always incontinent during the 2-
day assessment period following PAC admission (Sections 9 through 11). 
• Bowel assistance needed with device:  Indicates patients who need assistance to 
manage equipment or devices (yes/no) (Sections 6, 7, and 8).  The reference group is 
the latter.  
• Indwelling bowel catheter management system: Indicates patients with a major 
treatment equal to 1 if an indwelling bowel catheter management system is reported 
during the 2-day assessment period and equal to 0 if it is not reported (Sections 9 
through 11). 
• Swallowing NPO:  The patient had no intake by mouth (NPO) at the 2-day window 
associated with the assessment (yes/no).  The reference group is the latter (Sections 6 
through 11). 
• Swallowing-other signs of difficulty: The patient had signs or symptoms of a 
possible swallowing disorder, including coughing or choking during meals or when 
swallowing medications, or holding food in mouth/cheeks or residual food in mouth 
after meals, or loss of liquids/solids from mouth when eating or drinking (yes/no).  
The reference group is the latter (Sections 6 through 11). 
• Communication:  This concept was measured in several ways.  When measuring 
functional change, this concept included two separate items distinguishing between 
verbal communication and ability to understand.  The discharge destination models 
collapsed these two areas into one measure of communication. For the purposes of the 
analysis, if no information was available on the impairment (due to missing or unable 
to assess responses), the variable was coded as not impaired. 
• Understanding verbal content:  Indicates patients who rarely or never understand 
verbal content (yes/no).  The referent for understanding verbal content is 
“understands without cues or repetitions,” “usually understands,” or “sometimes 
understands” (Sections 7 through 8). 
• Expression of ideas and wants:  Indicates a patient who (1) rarely/never expresses 
self or speech, is very difficult to understand; (2) frequently exhibits difficulty with 
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expressing needs and ideas; (3) exhibits some difficulty with expressing needs and 
ideas (e.g., some words or finishing thoughts) or speech is not clear; or (4) expresses 
complex messages without difficulty and with speech that is clear and easy to 
understand (Sections 7 through 11). 
• Communication:  This set of indicator variables is a composite based on the 
patient’s ability to understand verbal content and express ideas and wants.  The three 
indicator variables are (Section 6): 
– Not impaired:  if both understanding and expression are coded as “4” (clear 
comprehension without cues or repetitions and expresses complex messages 
without difficulty and with speech that is clear and easy to understand) or if both 
items are coded “8” (unable to assess) or  “9” (unknown) 
– Severely impaired:  if either item is coded “1” (rarely/never understands), or 
rarely/never expresses self, or speech is very difficult to understand 
– Moderately impaired:  if either item is coded “2” (sometimes understands or 
frequently exhibits difficulty) or “3” (usually understands or exhibits some 
difficulty) 
• Ability to see in adequate light:  Indicates patients who are (1) severely impaired:  
no vision or object identification questionable; (2) mildly to moderately impaired:  
can identify objects; may see large print; (3) adequate:  sees fine detail, including 
regular print in newspapers/books; and (4) not assessed due to medical restriction 
(Section 8). 
• Ability to hear:  Indicates patients who are (1) severely impaired:  absence of useful 
hearing; (2) not severely impaired: mildly to moderately impaired, difficulty hearing 
in some environments or speaker may need to increase volume or speak distinctly; (3) 
adequate:  hears normal conversation and TV without difficulty; (4) not assessed due 
to medical restriction (Section 8). 
• Respiratory status: This set of variables in Section 6 is a composite variable based 
on the patient’s respiratory status with supplemental oxygen and without 
supplemental oxygen.  The three indicator variables are:  
– Healthy respiratory status:  Reflected patients who were only short of breath 
when climbing stairs without oxygen or never short of breath on oxygen.   
– Moderate respiratory status: Reflected patients who were without oxygen, had 
shortness of breath climbing stairs AND with oxygen were either never out of 
breath (coded “0”) or only when climbing stairs (coded “1”) or with moderate 
exertion (coded “2”).  Others in this category used no oxygen but had shortness of 
breath with moderate exertion (coded “2”) or were missing data. 
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– Severe respiratory status: Reflected patients who were not on oxygen but were 
coded “3” (shortness of breath with minimal exertion), “4” (shortness of breath at 
rest), or “5” (severely struggling to breathe at rest).  Others in this group all had 
oxygen and these included the following combinations: 
▪ with oxygen, shortness of breath on stairs (coded “1”) AND without oxygen, 
shortness of breath with minimal exertion (coded “3) or mild shortness of 
breath at rest (coded “4”), or severely struggling to breathe at rest, or 
▪ with oxygen, shortness of breath with moderate exertion (coded “2”) AND 
without oxygen, shortness of breath with minimal exertion (coded “3) or mild 
shortness of breath at rest (coded “4”), or severely struggling to breathe at 
rest, or  
▪ with oxygen, any difficulty with minimal exertion or at rest (coded as “3,” 
“4,” or “5”), regardless of rating without oxygen, or  
▪ with oxygen, coded as not assessed or not applicable but without oxygen, 
coded as any difficulty with minimal exertion or at rest (coded as “3,” “4,” or 
“5”). 
• Respiratory status–impaired:  Patients were considered impaired if they were using 
supplemental oxygen; patients with no oxygen use reported were considered impaired 
if they were short of breath or dyspneic with minimal or less exertion (yes/no).  
Patients on ventilators are included in a separate category (Sections 7 through 11).   
• Respiratory status–any impairment: Patients were considered to have any 
impairment if they answered yes to the statement “Does the patient have any 
impairments with respiratory status?” (Sections 10 and 11). 
• Sitting/mobility endurance: This variable in Section 6 is a composite of the two 
endurance impairment variables—sitting for 15 minutes with/without support and 
walk/wheel 50 feet with/without rest.  Having a code in either sitting or mobility will 
lead to an equal code for the combined variable.  This variable is coded as follows:  
– No endurance: if either mobility OR sitting endurance were coded as “0” (could 
not do) or “8” (not assessed due to medical restriction) 
– Endurance with support/rest: if mobility OR sitting endurance were coded as “1” 
could do with support/rest and neither were coded as “0” or “8” 
– Endurance without support/rest: if mobility AND sitting endurance were coded as 
“2” could do with support/rest 
• Mobility endurance:  Patients who could not walk or wheel 50 feet without rest were 
considered impaired in mobility endurance (yes/no) (Sections 7 through 8). 
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• Sitting endurance:  Patients were scored on whether they could safely sit for 15 
minutes with support, without support, or not at all.  Some models recoded this into a 
dichotomous measure: those who could not sit for 15 minutes unsupported were 
considered impaired (yes/no) (Sections 7 through 8). 
5.3.6  Premorbid Status 
• Prior function: Based on a composite of the five interview items on the patient’s 
usual ability with everyday activities prior to this current illness, exacerbation, or 
injury.  The five items include the following and each was scored on a 5-point scale:  
3) independent, 2) needed some help, 1) dependent, 8) not applicable, or 9) unknown.   
– Self-care:  Did the patient need help bathing, dressing, using the toilet, or eating? 
– Ambulation:  Did the patient need assistance with walking from room to room 
(with or without cane, crutch, walker, etc.)? 
– Stairs:  Did the patient need assistance with stairs (with or without cane, crutch, 
walker, etc.)? 
– Wheelchair:  Did the patient need assistance with moving from room to room 
using a wheelchair, scooter, or other wheeled mobility device? 
– Cognition:  Did the patient need help planning regular tasks, such as shopping or 
remembering to take medication? 
• Lived alone in community prior to admission: This indicator variable identifies 
beneficiaries who lived in the community prior to this admission AND who lived 
alone (yes).  Those who did not live in the community or who lived with others were 
the reference group (no) (Section 6).   
5.3.7 Market Supply (Section 6) 
This set of covariates identifies the market in which the data were collected.  Each market 
was selected in the initial phase as representing a high or low PAC market based on whether they 
had an IRF or LTCH available within a 2-hour radius (High PAC) or did not and were reliant on 
SNFs and IRFs for PAC services within a 2-hour radius (see Section 4).  The markets include:  
• Rochester, NY 
• Tampa/Lakeland, FL 
• Louisville, KY 
• Chicago, IL 
• Dallas, TX 
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• Lincoln/Omaha, NE 
• Seattle, WA/Portland, OR 
• San Francisco, CA 
• Columbia, MO 
• Wilmington, NC 
• Raleigh/Durham, NC 
• Supplemental Regions 1 through 4, 6, 9: These areas are aggregated because they are 
each high PAC areas and do not represent markets but instead select providers.   
The following sections use these variables in the discharge destination (Section 6), 





Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Neurologic, Stroke 01 020: Intracranial Vascular Procedures with PDX Hemorrhage with MCC 
Neurologic, Stroke 01 021: Intracranial Vascular Procedures with PDX Hemorrhage with CC 
Neurologic, Stroke 01 022: Intracranial Vascular Procedures with PDX Hemorrhage without CC/MCC 
Neurologic, Stroke 01 061: Acute Ischemic Stroke with Use of Thrombolytic Agent with MCC 
Neurologic, Stroke 01 062: Acute Ischemic Stroke with Use of Thrombolytic Agent with CC 
Neurologic, Stroke 01 063: Acute Ischemic Stroke with Use of Thrombolytic Agent without CC/MCC 
Neurologic, Stroke 01 064: Intracranial Hemorrhage or Cerebral Infarction with MCC 
Neurologic, Stroke 01 065: Intracranial Hemorrhage or Cerebral Infarction with CC 
Neurologic, Stroke 01 066: Intracranial Hemorrhage or Cerebral Infarction without CC/MCC 
Neurologic, Surgical 01 
023: Cranio with Major Dev Impl/Acute Complex Cns PDX with MCC or Chemo 
Implant 
Neurologic, Surgical 01 024: Cranio with Major Dev Impl/Acute Complex Cns PDX without MCC 
Neurologic, Surgical 01 025: Craniotomy & Endovascular Intracranial Procedures with MCC 
Neurologic, Surgical 01 026: Craniotomy & Endovascular Intracranial Procedures with CC 
Neurologic, Surgical 01 027: Craniotomy & Endovascular Intracranial Procedures without CC/MCC 
Neurologic, Surgical 01 028: Spinal Procedures with MCC 
Neurologic, Surgical 01 029: Spinal Procedures with CC or Spinal Neurostimulators 
Neurologic, Surgical 01 030: Spinal Procedures without CC/MCC 
Neurologic, Surgical 01 031: Ventricular Shunt Procedures with MCC 
Neurologic, Surgical 01 032: Ventricular Shunt Procedures with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Neurologic, Surgical 01 034: Carotid Artery Stent Procedure with MCC 
Neurologic, Surgical 01 035: Carotid Artery Stent Procedure with CC 
Neurologic, Surgical 01 036: Carotid Artery Stent Procedure without CC/MCC 
Neurologic, Surgical 01 037: Extracranial Procedures with MCC 
Neurologic, Surgical 01 038: Extracranial Procedures with CC 
Neurologic, Surgical 01 039: Extracranial Procedures without CC/MCC 
Neurologic, Surgical 01 040: Periph & Cranial Nerve & Other Nerv Syst Proc with MCC 
Neurologic, Surgical 01 041: Periph/Cranial Nerve & Other Nerv Syst Proc with CC or Periph Neurostim 
Neurologic, Surgical 01 042: Periph & Cranial Nerve & Other Nerv Syst Proc without CC/MCC 
Neurologic, Surgical 24 955: Craniotomy for Multiple Significant Trauma 
Neurologic, Medical 01 052: Spinal Disorders & Injuries with CC/MCC 
Neurologic, Medical 01 053: Spinal Disorders & Injuries without CC/MCC 
Neurologic, Medical 01 054: Nervous System Neoplasms with MCC 
Neurologic, Medical 01 055: Nervous System Neoplasms without MCC 
Neurologic, Medical 01 056: Degenerative Nervous System Disorders with MCC 
Neurologic, Medical 01 057: Degenerative Nervous System Disorders without MCC 
Neurologic, Medical 01 058: Multiple Sclerosis & Cerebellar Ataxia with MCC 
Neurologic, Medical 01 059: Multiple Sclerosis & Cerebellar Ataxia with CC 
Neurologic, Medical 01 060: Multiple Sclerosis & Cerebellar Ataxia without CC/MCC 
Neurologic, Medical 01 067: Nonspecific CVA & Precerebral Occlusion without Infarct with MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Neurologic, Medical 01 069: Transient Ischemia 
Neurologic, Medical 01 070: Nonspecific Cerebrovascular Disorders with MCC 
Neurologic, Medical 01 071: Nonspecific Cerebrovascular Disorders with CC 
Neurologic, Medical 01 072: Nonspecific Cerebrovascular Disorders without CC/MCC 
Neurologic, Medical 01 073: Cranial & Peripheral Nerve Disorders with MCC 
Neurologic, Medical 01 074: Cranial & Peripheral Nerve Disorders without MCC 
Neurologic, Medical 01 075: Viral Meningitis with CC/MCC 
Neurologic, Medical 01 077: Hypertensive Encephalopathy with MCC 
Neurologic, Medical 01 078: Hypertensive Encephalopathy with CC 
Neurologic, Medical 01 079: Hypertensive Encephalopathy without CC/MCC 
Neurologic, Medical 01 080: Nontraumatic Stupor & Coma with MCC 
Neurologic, Medical 01 081: Nontraumatic Stupor & Coma without MCC 
Neurologic, Medical 01 082: Traumatic Stupor & Coma, Coma >1 Hr with MCC 
Neurologic, Medical 01 083: Traumatic Stupor & Coma, Coma >1 Hr with CC 
Neurologic, Medical 01 084: Traumatic Stupor & Coma, Coma >1 Hr without CC/MCC 
Neurologic, Medical 01 085: Traumatic Stupor & Coma, Coma <1 Hr with MCC 
Neurologic, Medical 01 086: Traumatic Stupor & Coma, Coma <1 Hr with CC 
Neurologic, Medical 01 087: Traumatic Stupor & Coma, Coma <1 Hr without CC/MCC 
Neurologic, Medical 01 088: Concussion with MCC 
Neurologic, Medical 01 089: Concussion with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Neurologic, Medical 01 091: Other Disorders of Nervous System with MCC 
Neurologic, Medical 01 092: Other Disorders of Nervous System with CC 
Neurologic, Medical 01 093: Other Disorders of Nervous System without CC/MCC 
Neurologic, Medical 01 094: Bacterial & Tuberculous Infections of Nervous System with MCC 
Neurologic, Medical 01 095: Bacterial & Tuberculous Infections of Nervous System with CC 
Neurologic, Medical 01 096: Bacterial & Tuberculous Infections of Nervous System without CC/MCC 
Neurologic, Medical 01 097: Non-Bacterial Infect of Nervous Sys Exc Viral Meningitis with MCC 
Neurologic, Medical 01 098: Non-Bacterial Infect of Nervous Sys Exc Viral Meningitis with CC 
Neurologic, Medical 01 099: Non-Bacterial Infect of Nervous Sys Exc Viral Meningitis without CC/MCC 
Neurologic, Medical 01 100: Seizures with MCC 
Neurologic, Medical 01 101: Seizures without MCC 
Neurologic, Medical 01 102: Headaches with MCC 
Neurologic, Medical 01 103: Headaches without MCC 
Respiratory, Ventilator and 
Tracheostomy Pre 
003: Ecmo or Trach with MV 96+ Hrs or PDX Exc Face, Mouth & Neck with Maj 
O.R. 
Respiratory, Ventilator and 
Tracheostomy Pre 004: Trach with MV 96+ Hrs or PDX Exc Face, Mouth & Neck without Maj O.R. 
Respiratory, Ventilator and 
Tracheostomy Pre 011: Tracheostomy for Face, Mouth & Neck Diagnoses with MCC 
Respiratory, Ventilator and 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Respiratory, Ventilator and 
Tracheostomy Pre 013: Tracheostomy for Face, Mouth & Neck Diagnoses without CC/MCC 
Respiratory, Ventilator and 
Tracheostomy 04 207: Respiratory System Diagnosis with Ventilator Support 96+ Hours 
Respiratory, Ventilator and 
Tracheostomy 04 208: Respiratory System Diagnosis with Ventilator Support <96 Hours 
Respiratory, Surgical 04 163: Major Chest Procedures with MCC 
Respiratory, Surgical 04 164: Major Chest Procedures with CC 
Respiratory, Surgical 04 165: Major Chest Procedures without CC/MCC 
Respiratory, Surgical 04 166: Other Resp System O.R. Procedures with MCC 
Respiratory, Surgical 04 167: Other Resp System O.R. Procedures with CC 
Respiratory, Surgical 04 168: Other Resp System O.R. Procedures without CC/MCC 
Respiratory, Medical 04 175: Pulmonary Embolism with MCC 
Respiratory, Medical 04 176: Pulmonary Embolism without MCC 
Respiratory, Medical 04 177: Respiratory Infections & Inflammations with MCC 
Respiratory, Medical 04 178: Respiratory Infections & Inflammations with CC 
Respiratory, Medical 04 179: Respiratory Infections & Inflammations without CC/MCC 
Respiratory, Medical 04 180: Respiratory Neoplasms with MCC 
Respiratory, Medical 04 181: Respiratory Neoplasms with CC 
Respiratory, Medical 04 183: Major Chest Trauma with MCC 
Respiratory, Medical 04 184: Major Chest Trauma with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Respiratory, Medical 04 186: Pleural Effusion with MCC 
Respiratory, Medical 04 187: Pleural Effusion with CC 
Respiratory, Medical 04 188: Pleural Effusion without CC/MCC 
Respiratory, Medical 04 189: Pulmonary Edema & Respiratory Failure 
Respiratory, Medical 04 193: Simple Pneumonia & Pleurisy with MCC 
Respiratory, Medical 04 194: Simple Pneumonia & Pleurisy with CC 
Respiratory, Medical 04 195: Simple Pneumonia & Pleurisy without CC/MCC 
Respiratory, Medical 04 196: Interstitial Lung Disease with MCC 
Respiratory, Medical 04 197: Interstitial Lung Disease with CC 
Respiratory, Medical 04 198: Interstitial Lung Disease without CC/MCC 
Respiratory, Medical 04 199: Pneumothorax with MCC 
Respiratory, Medical 04 200: Pneumothorax with CC 
Respiratory, Medical 04 201: Pneumothorax without CC/MCC 
Respiratory, Medical 04 202: Bronchitis & Asthma with CC/MCC 
Respiratory, Medical 04 203: Bronchitis & Asthma without CC/MCC 
Respiratory, Medical 04 204: Respiratory Signs & Symptoms 
Respiratory, Medical 04 205: Other Respiratory System Diagnoses with MCC 
Respiratory, Medical 04 206: Other Respiratory System Diagnoses without MCC 
Respiratory, COPD 04 190: Chronic Obstructive Pulmonary Disease with MCC 
Respiratory, COPD 04 191: Chronic Obstructive Pulmonary Disease with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Cardiovascular, Vascular 
Surgical 05 237: Major Cardiovasc Procedures with MCC or Thoracic Aortic Aneurysm Repair 
Cardiovascular, Vascular Surgical 05 238: Major Cardiovascular Procedures without MCC 
Cardiovascular, Vascular Surgical 05 239: Amputation for Circ Sys Disorders Exc Upper Limb & Toe with MCC 
Cardiovascular, Vascular Surgical 05 240: Amputation for Circ Sys Disorders Exc Upper Limb & Toe with CC 
Cardiovascular, Vascular Surgical 05 241: Amputation for Circ Sys Disorders Exc Upper Limb & Toe without CC/MCC 
Cardiovascular, Vascular Surgical 05 252: Other Vascular Procedures with MCC 
Cardiovascular, Vascular Surgical 05 253: Other Vascular Procedures with CC 
Cardiovascular, Vascular Surgical 05 254: Other Vascular Procedures without CC/MCC 
Cardiovascular, Vascular Surgical 05 255: Upper Limb & Toe Amputation for Circ System Disorders with MCC 
Cardiovascular, Vascular Surgical 05 256: Upper Limb & Toe Amputation for Circ System Disorders with CC 
Cardiovascular, Vascular Surgical 05 263: Vein Ligation & Stripping 
Cardiovascular, Vascular Surgical 05 264: Other Circulatory System O.R. Procedures 
Cardiovascular, Cardiac 
Surgical 05 216: Cardiac Valve & Oth Maj Cardiothoracic Proc with Card Cath with MCC 
Cardiovascular, Cardiac Surgical 05 217: Cardiac Valve & Oth Maj Cardiothoracic Proc with Card Cath with CC 
Cardiovascular, Cardiac Surgical 05 218: Cardiac Valve & Oth Maj Cardiothoracic Proc with Card Cath without CC/MCC 
Cardiovascular, Cardiac Surgical 05 219: Cardiac Valve & Oth Maj Cardiothoracic Proc without Card Cath with MCC 
Cardiovascular, Cardiac Surgical 05 220: Cardiac Valve & Oth Maj Cardiothoracic Proc without Card Cath with CC 
Cardiovascular, Cardiac Surgical 05 
221: Cardiac Valve & Oth Maj Cardiothoracic Proc without Card Cath without 
CC/MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Cardiovascular, Cardiac Surgical 05 223: Cardiac Defib Implant with Cardiac Cath with Ami/Hf/Shock without MCC 
Cardiovascular, Cardiac Surgical 05 224: Cardiac Defib Implant with Cardiac Cath without Ami/Hf/Shock with MCC 
Cardiovascular, Cardiac Surgical 05 225: Cardiac Defib Implant with Cardiac Cath without Ami/Hf/Shock without MCC 
Cardiovascular, Cardiac Surgical 05 226: Cardiac Defibrillator Implant without Cardiac Cath with MCC 
Cardiovascular, Cardiac Surgical 05 227: Cardiac Defibrillator Implant without Cardiac Cath without MCC 
Cardiovascular, Cardiac Surgical 05 228: Other Cardiothoracic Procedures with MCC 
Cardiovascular, Cardiac Surgical 05 229: Other Cardiothoracic Procedures with CC 
Cardiovascular, Cardiac Surgical 05 230: Other Cardiothoracic Procedures without CC/MCC 
Cardiovascular, Cardiac Surgical 05 231: Coronary Bypass with Ptca with MCC 
Cardiovascular, Cardiac Surgical 05 232: Coronary Bypass with Ptca without MCC 
Cardiovascular, Cardiac Surgical 05 233: Coronary Bypass with Cardiac Cath with MCC 
Cardiovascular, Cardiac Surgical 05 234: Coronary Bypass with Cardiac Cath without MCC 
Cardiovascular, Cardiac Surgical 05 235: Coronary Bypass without Cardiac Cath with MCC 
Cardiovascular, Cardiac Surgical 05 236: Coronary Bypass without Cardiac Cath without MCC 
Cardiovascular, Cardiac Surgical 05 242: Permanent Cardiac Pacemaker Implant with MCC 
Cardiovascular, Cardiac Surgical 05 243: Permanent Cardiac Pacemaker Implant with CC 
Cardiovascular, Cardiac Surgical 05 244: Permanent Cardiac Pacemaker Implant without CC/MCC 
Cardiovascular, Cardiac Surgical 05 245: AICD Lead & Generator Procedures 
Cardiovascular, Cardiac Surgical 05 246: Perc Cardiovasc Proc with Drug-Eluting Stent with MCC or 4+ Vessels/Stents 
Cardiovascular, Cardiac Surgical 05 247: Perc Cardiovasc Proc with Drug-Eluting Stent without MCC 
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Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Cardiovascular, Cardiac Surgical 05 249: Perc Cardiovasc Proc with Non-Drug-Eluting Stent without MCC 
Cardiovascular, Cardiac Surgical 05 250: Perc Cardiovasc Proc without Coronary Artery Stent or Ami with MCC 
Cardiovascular, Cardiac Surgical 05 251: Perc Cardiovasc Proc without Coronary Artery Stent or Ami without MCC 
Cardiovascular, Cardiac Surgical 05 258: Cardiac Pacemaker Device Replacement with MCC 
Cardiovascular, Cardiac Surgical 05 259: Cardiac Pacemaker Device Replacement without MCC 
Cardiovascular, Cardiac Surgical 05 260: Cardiac Pacemaker Revision Except Device Replacement with MCC 
Cardiovascular, Cardiac Surgical 05 261: Cardiac Pacemaker Revision Except Device Replacement with CC 
Cardiovascular, General 05 286: Circulatory Disorders Except Ami, with Card Cath with MCC 
Cardiovascular, General 05 287: Circulatory Disorders Except Ami, with Card Cath without MCC 
Cardiovascular, General 05 302: Atherosclerosis with MCC 
Cardiovascular, General 05 303: Atherosclerosis without MCC 
Cardiovascular, General 05 304: Hypertension with MCC 
Cardiovascular, General 05 305: Hypertension without MCC 
Cardiovascular, General 05 311: Angina Pectoris 
Cardiovascular, General 05 312: Syncope & Collapse 
Cardiovascular, General 05 313: Chest Pain 
Cardiovascular, General 05 314: Other Circulatory System Diagnoses with MCC 
Cardiovascular, General 05 315: Other Circulatory System Diagnoses with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Cardiovascular, Vascular 
Medical 05 294: Deep Vein Thrombophlebitis with CC/MCC 
Cardiovascular, Vascular Medical 05 295: Deep Vein Thrombophlebitis without CC/MCC 
Cardiovascular, Vascular Medical 05 299: Peripheral Vascular Disorders with MCC 
Cardiovascular, Vascular Medical 05 300: Peripheral Vascular Disorders with CC 
Cardiovascular, Vascular Medical 05 301: Peripheral Vascular Disorders without CC/MCC 
Cardiovascular, Cardiac Medical 05 280: Acute Myocardial Infarction, Discharged Alive with MCC 
Cardiovascular, Cardiac Medical 05 281: Acute Myocardial Infarction, Discharged Alive with CC 
Cardiovascular, Cardiac Medical 05 282: Acute Myocardial Infarction, Discharged Alive without CC/MCC 
Cardiovascular, Cardiac Medical 05 288: Acute & Subacute Endocarditis with MCC 
Cardiovascular, Cardiac Medical 05 289: Acute & Subacute Endocarditis with CC 
Cardiovascular, Cardiac Medical 05 291: Heart Failure & Shock with MCC 
Cardiovascular, Cardiac Medical 05 292: Heart Failure & Shock with CC 
Cardiovascular, Cardiac Medical 05 293: Heart Failure & Shock without CC/MCC 
Cardiovascular, Cardiac Medical 05 296: Cardiac Arrest, Unexplained with MCC 
Cardiovascular, Cardiac Medical 05 306: Cardiac Congenital & Valvular Disorders with MCC 
Cardiovascular, Cardiac Medical 05 307: Cardiac Congenital & Valvular Disorders without MCC 
Cardiovascular, Cardiac Medical 05 308: Cardiac Arrhythmia & Conduction Disorders with MCC 
Cardiovascular, Cardiac Medical 05 309: Cardiac Arrhythmia & Conduction Disorders with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Orthopedic, Minor Surgical 08 463: Wnd Debrid & Skn Grft Exc Hand, for Musculo-Conn Tiss Dis with MCC 
Orthopedic, Minor Surgical 08 464: Wnd Debrid & Skn Grft Exc Hand, for Musculo-Conn Tiss Dis with CC 
Orthopedic, Minor Surgical 08 
465: Wnd Debrid & Skn Grft Exc Hand, for Musculo-Conn Tiss Dis without 
CC/MCC 
Orthopedic, Minor Surgical 08 477: Biopsies of Musculoskeletal System & Connective Tissue with MCC 
Orthopedic, Minor Surgical 08 478: Biopsies of Musculoskeletal System & Connective Tissue with CC 
Orthopedic, Minor Surgical 08 479: Biopsies of Musculoskeletal System & Connective Tissue without CC/MCC 
Orthopedic, Minor Surgical 08 480: Hip & Femur Procedures Except Major Joint with MCC 
Orthopedic, Minor Surgical 08 481: Hip & Femur Procedures Except Major Joint with CC 
Orthopedic, Minor Surgical 08 482: Hip & Femur Procedures Except Major Joint without CC/MCC 
Orthopedic, Minor Surgical 08 485: Knee Procedures with PDX of Infection with MCC 
Orthopedic, Minor Surgical 08 486: Knee Procedures with PDX of Infection with CC 
Orthopedic, Minor Surgical 08 487: Knee Procedures with PDX of Infection without CC/MCC 
Orthopedic, Minor Surgical 08 488: Knee Procedures without PDX of Infection with CC/MCC 
Orthopedic, Minor Surgical 08 489: Knee Procedures without PDX of Infection without CC/MCC 
Orthopedic, Minor Surgical 08 492: Lower Extrem & Humer Proc Except Hip, Foot, Femur with MCC 
Orthopedic, Minor Surgical 08 493: Lower Extrem & Humer Proc Except Hip, Foot, Femur with CC 
Orthopedic, Minor Surgical 08 494: Lower Extrem & Humer Proc Except Hip, Foot, Femur without CC/MCC 
Orthopedic, Minor Surgical 08 495: Local Excision & Removal Int Fix Devices Exc Hip & Femur with MCC 
Orthopedic, Minor Surgical 08 496: Local Excision & Removal Int Fix Devices Exc Hip & Femur with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Orthopedic, Minor Surgical 08 498: Local Excision & Removal Int Fix Devices of Hip & Femur with CC/MCC 
Orthopedic, Minor Surgical 08 499: Local Excision & Removal Int Fix Devices of Hip & Femur without CC/MCC 
Orthopedic, Minor Surgical 08 500: Soft Tissue Procedures with MCC 
Orthopedic, Minor Surgical 08 501: Soft Tissue Procedures with CC 
Orthopedic, Minor Surgical 08 502: Soft Tissue Procedures without CC/MCC 
Orthopedic, Minor Surgical 08 503: Foot Procedures with MCC 
Orthopedic, Minor Surgical 08 504: Foot Procedures with CC 
Orthopedic, Minor Surgical 08 505: Foot Procedures without CC/MCC 
Orthopedic, Minor Surgical 08 506: Major Thumb or Joint Procedures 
Orthopedic, Minor Surgical 08 510: Shoulder, Elbow or Forearm Proc, Exc Major Joint Proc with MCC 
Orthopedic, Minor Surgical 08 511: Shoulder, Elbow or Forearm Proc, Exc Major Joint Proc with CC 
Orthopedic, Minor Surgical 08 512: Shoulder, Elbow or Forearm Proc, Exc Major Joint Proc without CC/MCC 
Orthopedic, Minor Surgical 08 513: Hand or Wrist Proc, Except Major Thumb or Joint Proc with CC/MCC 
Orthopedic, Minor Surgical 08 515: Other Musculoskelet Sys & Conn Tiss O.R. Proc with MCC 
Orthopedic, Minor Surgical 08 516: Other Musculoskelet Sys & Conn Tiss O.R. Proc with CC 
Orthopedic, Minor Surgical 08 517: Other Musculoskelet Sys & Conn Tiss O.R. Proc without CC/MCC 
Orthopedic, Major Surgical 08 461: Bilateral or Multiple Major Joint Procs of Lower Extremity with MCC 
Orthopedic, Major Surgical 08 462: Bilateral or Multiple Major Joint Procs of Lower Extremity without MCC 
Orthopedic, Major Surgical 08 466: Revision of Hip or Knee Replacement with MCC 
Orthopedic, Major Surgical 08 467: Revision of Hip or Knee Replacement with CC 
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Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Orthopedic, Major Surgical 08 469: Major Joint Replacement or Reattachment of Lower Extremity with MCC 
Orthopedic, Major Surgical 08 470: Major Joint Replacement or Reattachment of Lower Extremity without MCC 
Orthopedic, Major Surgical 08 474: Amputation for Musculoskeletal Sys & Conn Tissue Dis with MCC 
Orthopedic, Major Surgical 08 475: Amputation for Musculoskeletal Sys & Conn Tissue Dis with CC 
Orthopedic, Major Surgical 08 476: Amputation for Musculoskeletal Sys & Conn Tissue Dis without CC/MCC 
Orthopedic, Major Surgical 08 483: Major Joint & Limb Reattachment Proc of Upper Extremity with CC/MCC 
Orthopedic, Major Surgical 08 484: Major Joint & Limb Reattachment Proc of Upper Extremity without CC/MCC 
Orthopedic, Major Surgical 08 507: Major Shoulder or Elbow Joint Procedures with CC/MCC 
Orthopedic, Major Surgical 08 508: Major Shoulder or Elbow Joint Procedures without CC/MCC 
Orthopedic, Major Surgical 24 956: Limb Reattachment, Hip & Femur Proc for Multiple Significant Trauma 
Orthopedic, Spinal 08 453: Combined Anterior/Posterior Spinal Fusion with MCC 
Orthopedic, Spinal 08 454: Combined Anterior/Posterior Spinal Fusion with CC 
Orthopedic, Spinal 08 455: Combined Anterior/Posterior Spinal Fusion without CC/MCC 
Orthopedic, Spinal 08 456: Spinal Fus Exc Cerv with Spinal Curv/Malig/Infec or 9+ Fus with MCC 
Orthopedic, Spinal 08 457: Spinal Fus Exc Cerv with Spinal Curv/Malig/Infec or 9+ Fus with CC 
Orthopedic, Spinal 08 458: Spinal Fus Exc Cerv with Spinal Curv/Malig/Infec or 9+ Fus without CC/MCC 
Orthopedic, Spinal 08 459: Spinal Fusion Except Cervical with MCC 
Orthopedic, Spinal 08 460: Spinal Fusion Except Cervical without MCC 
Orthopedic, Spinal 08 471: Cervical Spinal Fusion with MCC 
Orthopedic, Spinal 08 472: Cervical Spinal Fusion with CC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Orthopedic, Spinal 08 490: Back & Neck Proc Exc Spinal Fusion with CC/MCC or Disc Device/Neurostim 
Orthopedic, Spinal 08 491: Back & Neck Proc Exc Spinal Fusion without CC/MCC 
Orthopedic, Minor Medical 08 533: Fractures of Femur with MCC 
Orthopedic, Minor Medical 08 534: Fractures of Femur without MCC 
Orthopedic, Minor Medical 08 537: Sprains, Strains, & Dislocations of Hip, Pelvis & Thigh with CC/MCC 
Orthopedic, Minor Medical 08 538: Sprains, Strains, & Dislocations of Hip, Pelvis & Thigh without CC/MCC 
Orthopedic, Minor Medical 08 539: Osteomyelitis with MCC 
Orthopedic, Minor Medical 08 540: Osteomyelitis with CC 
Orthopedic, Minor Medical 08 545: Connective Tissue Disorders with MCC 
Orthopedic, Minor Medical 08 546: Connective Tissue Disorders with CC 
Orthopedic, Minor Medical 08 547: Connective Tissue Disorders without CC/MCC 
Orthopedic, Minor Medical 08 548: Septic Arthritis with MCC 
Orthopedic, Minor Medical 08 549: Septic Arthritis with CC 
Orthopedic, Minor Medical 08 551: Medical Back Problems with MCC 
Orthopedic, Minor Medical 08 552: Medical Back Problems without MCC 
Orthopedic, Minor Medical 08 553: Bone Diseases & Arthropathies with MCC 
Orthopedic, Minor Medical 08 554: Bone Diseases & Arthropathies without MCC 
Orthopedic, Minor Medical 08 555: Signs & Symptoms of Musculoskeletal System & Conn Tissue with MCC 
Orthopedic, Minor Medical 08 556: Signs & Symptoms of Musculoskeletal System & Conn Tissue without MCC 
Orthopedic, Minor Medical 08 557: Tendonitis, Myositis & Bursitis with MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Orthopedic, Minor Medical 08 559: Aftercare, Musculoskeletal System & Connective Tissue with MCC 
Orthopedic, Minor Medical 08 560: Aftercare, Musculoskeletal System & Connective Tissue with CC 
Orthopedic, Minor Medical 08 561: Aftercare, Musculoskeletal System & Connective Tissue without CC/MCC 
Orthopedic, Minor Medical 08 562: Fx, Sprn, Strn & Disl Except Femur, Hip, Pelvis & Thigh with MCC 
Orthopedic, Minor Medical 08 563: Fx, Sprn, Strn & Disl Except Femur, Hip, Pelvis & Thigh without MCC 
Orthopedic, Minor Medical 08 564: Other Musculoskeletal Sys & Connective Tissue Diagnoses with MCC 
Orthopedic, Minor Medical 08 565: Other Musculoskeletal Sys & Connective Tissue Diagnoses with CC 
Orthopedic, Minor Medical 08 566: Other Musculoskeletal Sys & Connective Tissue Diagnoses without CC/MCC 
Orthopedic, Major Medical 08 535: Fractures of Hip & Pelvis with MCC 
Orthopedic, Major Medical 08 536: Fractures of Hip & Pelvis without MCC 
Orthopedic, Major Medical 08 542: Pathological Fractures & Musculoskelet & Conn Tiss Malig with MCC 
Orthopedic, Major Medical 08 543: Pathological Fractures & Musculoskelet & Conn Tiss Malig with CC 
Orthopedic, Major Medical 08 544: Pathological Fractures & Musculoskelet & Conn Tiss Malig without CC/MCC 
Integumentary, Surgical 09 573: Skin Graft &/Or Debrid for Skn Ulcer or Cellulitis with MCC 
Integumentary, Surgical 09 574: Skin Graft &/Or Debrid for Skn Ulcer or Cellulitis with CC 
Integumentary, Surgical 09 575: Skin Graft &/Or Debrid for Skn Ulcer or Cellulitis without CC/MCC 
Integumentary, Surgical 09 576: Skin Graft &/Or Debrid Exc for Skin Ulcer or Cellulitis with MCC 
Integumentary, Surgical 09 577: Skin Graft &/Or Debrid Exc for Skin Ulcer or Cellulitis with CC 
Integumentary, Surgical 09 578: Skin Graft &/Or Debrid Exc for Skin Ulcer or Cellulitis without CC/MCC 
Integumentary, Surgical 09 579: Other Skin, Subcut Tiss & Breast Proc with MCC 
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Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Integumentary, Surgical 09 581: Other Skin, Subcut Tiss & Breast Proc without CC/MCC 
Integumentary, Surgical 09 582: Mastectomy for Malignancy with CC/MCC 
Integumentary, Surgical 09 583: Mastectomy for Malignancy without CC/MCC 
Integumentary, Surgical 09 584: Breast Biopsy, Local Excision & Other Breast Procedures with CC/MCC 
Integumentary, Surgical 09 585: Breast Biopsy, Local Excision & Other Breast Procedures without CC/MCC 
Integumentary, Medical 09 592: Skin Ulcers with MCC 
Integumentary, Medical 09 593: Skin Ulcers with CC 
Integumentary, Medical 09 594: Skin Ulcers without CC/MCC 
Integumentary, Medical 09 595: Major Skin Disorders with MCC 
Integumentary, Medical 09 596: Major Skin Disorders without MCC 
Integumentary, Medical 09 601: Non-Malignant Breast Disorders without CC/MCC 
Integumentary, Medical 09 602: Cellulitis with MCC 
Integumentary, Medical 09 603: Cellulitis without MCC 
Integumentary, Medical 09 604: Trauma To the Skin, Subcut Tiss & Breast with MCC 
Integumentary, Medical 09 605: Trauma To the Skin, Subcut Tiss & Breast without MCC 
Integumentary, Medical 09 606: Minor Skin Disorders with MCC 
Integumentary, Medical 09 607: Minor Skin Disorders without MCC 
Endocrine, Surgical 10 616: Amputat of Lower Limb for Endocrine, Nutrit,& Metabol Dis with MCC 
Endocrine, Surgical 10 617: Amputat of Lower Limb for Endocrine, Nutrit,& Metabol Dis with CC 
Endocrine, Surgical 10 619: O.R. Procedures for Obesity with MCC 
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Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Endocrine, Surgical 10 621: O.R. Procedures for Obesity without CC/MCC 
Endocrine, Surgical 10 622: Skin Grafts & Wound Debrid for Endoc, Nutrit & Metab Dis with MCC 
Endocrine, Surgical 10 623: Skin Grafts & Wound Debrid for Endoc, Nutrit & Metab Dis with CC 
Endocrine, Surgical 10 624: Skin Grafts & Wound Debrid for Endoc, Nutrit & Metab Dis without CC/MCC 
Endocrine, Surgical 10 625: Thyroid, Parathyroid & Thyroglossal Procedures with MCC 
Endocrine, Surgical 10 627: Thyroid, Parathyroid & Thyroglossal Procedures without CC/MCC 
Endocrine, Surgical 10 628: Other Endocrine, Nutrit & Metab O.R. Proc with MCC 
Endocrine, Surgical 10 629: Other Endocrine, Nutrit & Metab O.R. Proc with CC 
Endocrine, Surgical 10 630: Other Endocrine, Nutrit & Metab O.R. Proc without CC/MCC 
Endocrine, Medical 10 637: Diabetes with MCC 
Endocrine, Medical 10 638: Diabetes with CC 
Endocrine, Medical 10 639: Diabetes without CC/MCC 
Endocrine, Medical 10 640: Nutritional & Misc Metabolic Disorders with MCC 
Endocrine, Medical 10 641: Nutritional & Misc Metabolic Disorders without MCC 
Endocrine, Medical 10 642: Inborn Errors of Metabolism 
Endocrine, Medical 10 643: Endocrine Disorders with MCC 
Endocrine, Medical 10 644: Endocrine Disorders with CC 
Endocrine, Medical 10 645: Endocrine Disorders without CC/MCC 
Kidney & Urinary, Surgical 11 653: Major Bladder Procedures with MCC 
Kidney & Urinary, Surgical 11 654: Major Bladder Procedures with CC 
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Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Kidney & Urinary, Surgical 11 656: Kidney & Ureter Procedures for Neoplasm with MCC 
Kidney & Urinary, Surgical 11 657: Kidney & Ureter Procedures Forneoplasm with CC 
Kidney & Urinary, Surgical 11 658: Kidney & Ureter Procedures for Neoplasm without CC/MCC 
Kidney & Urinary, Surgical 11 659: Kidney & Ureter Procedures for Non-Neoplasm with MCC 
Kidney & Urinary, Surgical 11 660: Kidney & Ureter Procedures for Non-Neoplasm with CC 
Kidney & Urinary, Surgical 11 662: Minor Bladder Procedures with MCC 
Kidney & Urinary, Surgical 11 663: Minor Bladder Procedures with CC 
Kidney & Urinary, Surgical 11 665: Prostatectomy with MCC 
Kidney & Urinary, Surgical 11 666: Prostatectomy with CC 
Kidney & Urinary, Surgical 11 668: Transurethral Procedures with MCC 
Kidney & Urinary, Surgical 11 669: Transurethral Procedures with CC 
Kidney & Urinary, Surgical 11 670: Transurethral Procedures without CC/MCC 
Kidney & Urinary, Surgical 11 673: Other Kidney & Urinary Tract Procedures with MCC 
Kidney & Urinary, Surgical 11 674: Other Kidney & Urinary Tract Procedures with CC 
Kidney & Urinary, Medical 11 682: Renal Failure with MCC 
Kidney & Urinary, Medical 11 683: Renal Failure with CC 
Kidney & Urinary, Medical 11 684: Renal Failure without CC/MCC 
Kidney & Urinary, Medical 11 685: Admit for Renal Dialysis 
Kidney & Urinary, Medical 11 686: Kidney & Urinary Tract Neoplasms with MCC 
Kidney & Urinary, Medical 11 687: Kidney & Urinary Tract Neoplasms with CC 
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Major Diagnosis 
Category (MDC) MS-DRG 
Kidney & Urinary, Medical 11 690: Kidney & Urinary Tract Infections without MCC 
Kidney & Urinary, Medical 11 694: Urinary Stones without Esw Lithotripsy without MCC 
Kidney & Urinary, Medical 11 695: Kidney & Urinary Tract Signs & Symptoms with MCC 
Kidney & Urinary, Medical 11 696: Kidney & Urinary Tract Signs & Symptoms without MCC 
Kidney & Urinary, Medical 11 698: Other Kidney & Urinary Tract Diagnoses with MCC 
Kidney & Urinary, Medical 11 699: Other Kidney & Urinary Tract Diagnoses with CC 
Kidney & Urinary, Medical 11 700: Other Kidney & Urinary Tract Diagnoses without CC/MCC 
Infections, Surgical 18 853: Infectious & Parasitic Diseases with O.R. Procedure with MCC 
Infections, Surgical 18 854: Infectious & Parasitic Diseases with O.R. Procedure with CC 
Infections, Surgical 18 855: Infectious & Parasitic Diseases with O.R. Procedure without CC/MCC 
Infections, Surgical 18 856: Postoperative or Post-Traumatic Infections with O.R. Proc with MCC 
Infections, Surgical 18 857: Postoperative or Post-Traumatic Infections with O.R. Proc with CC 
Infections, Surgical 18 858: Postoperative or Post-Traumatic Infections with O.R. Proc without CC/MCC 
Infections, Medical 18 862: Postoperative & Post-Traumatic Infections with MCC 
Infections, Medical 18 863: Postoperative & Post-Traumatic Infections without MCC 
Infections, Medical 18 864: Fever of Unknown Origin 
Infections, Medical 18 865: Viral Illness with MCC 
Infections, Medical 18 866: Viral Illness without MCC 
Infections, Medical 18 867: Other Infectious & Parasitic Diseases Diagnoses with MCC 
Infections, Medical 18 868: Other Infectious & Parasitic Diseases Diagnoses with CC 
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Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Infections, Septicemia 18 870: Septicemia with MV 96+ Hours 
Infections, Septicemia 18 871: Septicemia without MV 96+ Hours with MCC 
Infections, Septicemia 18 872: Septicemia without MV 96+ Hours without MCC 
Transplant Pre 001: Heart Transplant or Implant of Heart Assist System with MCC 
Transplant Pre 005: Liver Transplant with MCC or Intestinal Transplant 
Transplant Pre 007: Lung Transplant 
Transplant Pre 009: Bone Marrow Transplant 
Transplant 11 652: Kidney Transplant 
GI & Hepatobiliary, Minor 
Surgical 06 335: Peritoneal Adhesiolysis with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 336: Peritoneal Adhesiolysis with CC 
GI & Hepatobiliary, Minor 
Surgical 06 337: Peritoneal Adhesiolysis without CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 06 338: Appendectomy with Complicated Principal Diag with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 339: Appendectomy with Complicated Principal Diag with CC 
GI & Hepatobiliary, Minor 
Surgical 06 340: Appendectomy with Complicated Principal Diag without CC/MCC 
GI & Hepatobiliary, Minor 
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Category (MDC) MS-DRG 
GI & Hepatobiliary, Minor 
Surgical 06 344: Minor Small & Large Bowel Procedures with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 345: Minor Small & Large Bowel Procedures with CC 
GI & Hepatobiliary, Minor 
Surgical 06 346: Minor Small & Large Bowel Procedures without CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 06 350: Inguinal & Femoral Hernia Procedures with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 351: Inguinal & Femoral Hernia Procedures with CC 
GI & Hepatobiliary, Minor 
Surgical 06 352: Inguinal & Femoral Hernia Procedures without CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 06 353: Hernia Procedures Except Inguinal & Femoral with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 354: Hernia Procedures Except Inguinal & Femoral with CC 
GI & Hepatobiliary, Minor 
Surgical 06 355: Hernia Procedures Except Inguinal & Femoral without CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 06 356: Other Digestive System O.R. Procedures with MCC 
GI & Hepatobiliary, Minor 
Surgical 06 357: Other Digestive System O.R. Procedures with CC 
GI & Hepatobiliary, Minor 
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GI & Hepatobiliary, Minor 
Surgical 07 408: Biliary Tract Proc Except Only Cholecyst with or without C.D.E. with MCC 
GI & Hepatobiliary, Minor 
Surgical 07 409: Biliary Tract Proc Except Only Cholecyst with or without C.D.E. with CC 
GI & Hepatobiliary, Minor 
Surgical 07 
410: Biliary Tract Proc Except Only Cholecyst with or without C.D.E. without 
CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 07 411: Cholecystectomy with C.D.E. with MCC 
GI & Hepatobiliary, Minor 
Surgical 07 412: Cholecystectomy with C.D.E. with CC 
GI & Hepatobiliary, Minor 
Surgical 07 414: Cholecystectomy Except by Laparoscope without C.D.E. with MCC 
GI & Hepatobiliary, Minor 
Surgical 07 415: Cholecystectomy Except by Laparoscope without C.D.E. with CC 
GI & Hepatobiliary, Minor 
Surgical 07 416: Cholecystectomy Except by Laparoscope without C.D.E. without CC/MCC 
GI & Hepatobiliary, Minor 
Surgical 07 417: Laparoscopic Cholecystectomy without C.D.E. with MCC 
GI & Hepatobiliary, Minor 
Surgical 07 418: Laparoscopic Cholecystectomy without C.D.E. with CC 
GI & Hepatobiliary, Minor 
Surgical 07 419: Laparoscopic Cholecystectomy without C.D.E. without CC/MCC 
GI & Hepatobiliary, Minor 
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GI & Hepatobiliary, Minor 
Surgical 07 421: Hepatobiliary Diagnostic Procedures with CC 
GI & Hepatobiliary, Minor 
Surgical 07 423: Other Hepatobiliary or Pancreas O.R. Procedures with MCC 
GI & Hepatobiliary, Minor 
Surgical 07 424: Other Hepatobiliary or Pancreas O.R. Procedures with CC 
GI & Hepatobiliary, Major 
Surgical 06 326: Stomach, Esophageal & Duodenal Proc with MCC 
GI & Hepatobiliary, Major 
Surgical 06 327: Stomach, Esophageal & Duodenal Proc with CC 
GI & Hepatobiliary, Major 
Surgical 06 328: Stomach, Esophageal & Duodenal Proc without CC/MCC 
GI & Hepatobiliary, Major 
Surgical 06 329: Major Small & Large Bowel Procedures with MCC 
GI & Hepatobiliary, Major 
Surgical 06 330: Major Small & Large Bowel Procedures with CC 
GI & Hepatobiliary, Major 
Surgical 06 331: Major Small & Large Bowel Procedures without CC/MCC 
GI & Hepatobiliary, Major 
Surgical 06 332: Rectal Resection with MCC 
GI & Hepatobiliary, Major 
Surgical 06 333: Rectal Resection with CC 
GI & Hepatobiliary, Major 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
GI & Hepatobiliary, Major 
Surgical 06 347: Anal & Stomal Procedures with MCC 
GI & Hepatobiliary, Major 
Surgical 06 348: Anal & Stomal Procedures with CC 
GI & Hepatobiliary, Major 
Surgical 06 349: Anal & Stomal Procedures without CC/MCC 
GI & Hepatobiliary, Major 
Surgical 07 405: Pancreas, Liver & Shunt Procedures with MCC 
GI & Hepatobiliary, Major 
Surgical 07 406: Pancreas, Liver & Shunt Procedures with CC 
GI & Hepatobiliary, Major 
Surgical 07 407: Pancreas, Liver & Shunt Procedures without CC/MCC 
GI & Hepatobiliary, Minor 
Medical 06 383: Uncomplicated Peptic Ulcer with MCC 
GI & Hepatobiliary, Minor 
Medical 06 384: Uncomplicated Peptic Ulcer without MCC 
GI & Hepatobiliary, Minor 
Medical 06 385: Inflammatory Bowel Disease with MCC 
GI & Hepatobiliary, Minor 
Medical 06 386: Inflammatory Bowel Disease with CC 
GI & Hepatobiliary, Minor 
Medical 06 387: Inflammatory Bowel Disease without CC/MCC 
GI & Hepatobiliary, Minor 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
GI & Hepatobiliary, Minor 
Medical 06 389: G.I. Obstruction with CC 
GI & Hepatobiliary, Minor 
Medical 06 390: G.I. Obstruction without CC/MCC 
GI & Hepatobiliary, Minor 
Medical 06 391: Esophagitis, Gastroent & Misc Digest Disorders with MCC 
GI & Hepatobiliary, Minor 
Medical 06 392: Esophagitis, Gastroent & Misc Digest Disorders without MCC 
GI & Hepatobiliary, Minor 
Medical 06 393: Other Digestive System Diagnoses with MCC 
GI & Hepatobiliary, Minor 
Medical 06 394: Other Digestive System Diagnoses with CC 
GI & Hepatobiliary, Minor 
Medical 06 395: Other Digestive System Diagnoses without CC/MCC 
GI & Hepatobiliary, Minor 
Medical 07 438: Disorders of Pancreas Except Malignancy with MCC 
GI & Hepatobiliary, Minor 
Medical 07 439: Disorders of Pancreas Except Malignancy with CC 
GI & Hepatobiliary, Minor 
Medical 07 440: Disorders of Pancreas Except Malignancy without CC/MCC 
GI & Hepatobiliary, Minor 
Medical 07 441: Disorders of Liver Except Malig, Cirr, Alc Hepa with MCC 
GI & Hepatobiliary, Minor 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
GI & Hepatobiliary, Minor 
Medical 07 443: Disorders of Liver Except Malig, Cirr, Alc Hepa without CC/MCC 
GI & Hepatobiliary, Minor 
Medical 07 444: Disorders of the Biliary Tract with MCC 
GI & Hepatobiliary, Minor 
Medical 07 445: Disorders of the Biliary Tract with CC 
GI & Hepatobiliary, Minor 
Medical 07 446: Disorders of the Biliary Tract without CC/MCC 
GI & Hepatobiliary, Major 
Medical 06 368: Major Esophageal Disorders with MCC 
GI & Hepatobiliary, Major 
Medical 06 369: Major Esophageal Disorders with CC 
GI & Hepatobiliary, Major 
Medical 06 370: Major Esophageal Disorders without CC/MCC 
GI & Hepatobiliary, Major 
Medical 06 371: Major Gastrointestinal Disorders & Peritoneal Infections with MCC 
GI & Hepatobiliary, Major 
Medical 06 372: Major Gastrointestinal Disorders & Peritoneal Infections with CC 
GI & Hepatobiliary, Major 
Medical 06 373: Major Gastrointestinal Disorders & Peritoneal Infections without CC/MCC 
GI & Hepatobiliary, Major 
Medical 06 374: Digestive Malignancy with MCC 
GI & Hepatobiliary, Major 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
GI & Hepatobiliary, Major 
Medical 06 377: G.I. Hemorrhage with MCC 
GI & Hepatobiliary, Major 
Medical 06 378: G.I. Hemorrhage with CC 
GI & Hepatobiliary, Major 
Medical 06 379: G.I. Hemorrhage without CC/MCC 
GI & Hepatobiliary, Major 
Medical 06 380: Complicated Peptic Ulcer with MCC 
GI & Hepatobiliary, Major 
Medical 06 381: Complicated Peptic Ulcer with CC 
GI & Hepatobiliary, Major 
Medical 07 432: Cirrhosis & Alcoholic Hepatitis with MCC 
GI & Hepatobiliary, Major 
Medical 07 433: Cirrhosis & Alcoholic Hepatitis with CC 
GI & Hepatobiliary, Major 
Medical 07 435: Malignancy of Hepatobiliary System or Pancreas with MCC 
GI & Hepatobiliary, Major 
Medical 07 436: Malignancy of Hepatobiliary System or Pancreas with CC 
Hematologic, Surgical 16 799: Splenectomy with MCC 
Hematologic, Surgical 16 800: Splenectomy with CC 
Hematologic, Surgical 16 802: Other O.R. Proc of the Blood & Blood Forming Organs with MCC 
Hematologic, Surgical 16 803: Other O.R. Proc of the Blood & Blood Forming Organs with CC 
Hematologic, Surgical 17 820: Lymphoma & Leukemia with Major O.R. Procedure with MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Hematologic, Surgical 17 823: Lymphoma & Non-Acute Leukemia with Other O.R. Proc with MCC 
Hematologic, Surgical 17 824: Lymphoma & Non-Acute Leukemia with Other O.R. Proc with CC 
Hematologic, Surgical 17 825: Lymphoma & Non-Acute Leukemia with Other O.R. Proc without CC/MCC 
Hematologic, Surgical 17 827: Myeloprolif Disord or Poorly Diff Neopl with Maj O.R. Proc with CC 
Hematologic, Medical 16 808: Major Hematol/Immun Diag Exc Sickle Cell Crisis & Coagul with MCC 
Hematologic, Medical 16 809: Major Hematol/Immun Diag Exc Sickle Cell Crisis & Coagul with CC 
Hematologic, Medical 16 810: Major Hematol/Immun Diag Exc Sickle Cell Crisis & Coagul without CC/MCC 
Hematologic, Medical 16 811: Red Blood Cell Disorders with MCC 
Hematologic, Medical 16 812: Red Blood Cell Disorders without MCC 
Hematologic, Medical 16 813: Coagulation Disorders 
Hematologic, Medical 16 814: Reticuloendothelial & Immunity Disorders with MCC 
Hematologic, Medical 16 815: Reticuloendothelial & Immunity Disorders with CC 
Hematologic, Medical 16 816: Reticuloendothelial & Immunity Disorders without CC/MCC 
Hematologic, Medical 17 834: Acute Leukemia without Major O.R. Procedure with MCC 
Hematologic, Medical 17 836: Acute Leukemia without Major O.R. Procedure without CC/MCC 
Hematologic, Medical 17 839: Chemo with Acute Leukemia As Sdx without CC/MCC 
Hematologic, Medical 17 840: Lymphoma & Non-Acute Leukemia with MCC 
Hematologic, Medical 17 841: Lymphoma & Non-Acute Leukemia with CC 
Hematologic, Medical 17 842: Lymphoma & Non-Acute Leukemia without CC/MCC 
Hematologic, Medical 17 843: Other Myeloprolif Dis or Poorly Diff Neopl Diag with MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Hematologic, Medical 17 846: Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC 
Hematologic, Medical 17 847: Chemotherapy without Acute Leukemia as Secondary Diagnosis with CC 
Hematologic, Medical 17 849: Radiotherapy 
Other, Surgical All 981: Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC 
Other, Surgical All 982: Extensive O.R. Procedure Unrelated to Principal Diagnosis with CC 
Other, Surgical All 983: Extensive O.R. Procedure Unrelated to Principal Diagnosis without CC/MCC 
Other, Surgical All 984: Prostatic O.R. Procedure Unrelated to Principal Diagnosis with MCC 
Other, Surgical All 986: Prostatic O.R. Procedure Unrelated to Principal Diagnosis without CC/MCC 
Other, Surgical All 987: Non-extensive O.R. Proc Unrelated to Principal Diagnosis with MCC 
Other, Surgical All 988: Non-extensive O.R. Proc Unrelated to Principal Diagnosis with CC 
Other, Surgical All 989: Non-extensive O.R. Proc Unrelated to Principal Diagnosis without CC/MCC 
Other, Surgical 02 113: Orbital Procedures with CC/MCC 
Other, Surgical 03 129: Major Head & Neck Procedures with CC/MCC or Major Device 
Other, Surgical 03 130: Major Head & Neck Procedures without CC/MCC 
Other, Surgical 03 131: Cranial/Facial Procedures with CC/MCC 
Other, Surgical 03 133: Other Ear, Nose, Mouth & Throat O.R. Procedures with CC/MCC 
Other, Surgical 03 136: Sinus & Mastoid Procedures without CC/MCC 
Other, Surgical 03 137: Mouth Procedures with CC/MCC 
Other, Surgical 03 139: Salivary Gland Procedures 
Other, Surgical 05 265 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Other, Surgical 12 711: Testes Procedures with CC/MCC 
Other, Surgical 12 713: Transurethral Prostatectomy with CC/MCC 
Other, Surgical 12 714: Transurethral Prostatectomy without CC/MCC 
Other, Surgical 12 715: Other Male Reproductive System O.R. Proc for Malignancy with CC/MCC 
Other, Surgical 13 734: Pelvic Evisceration, Rad Hysterectomy & Rad Vulvectomy with CC/MCC 
Other, Surgical 13 735: Pelvic Evisceration, Rad Hysterectomy & Rad Vulvectomy without CC/MCC 
Other, Surgical 13 737: Uterine & Adnexa Proc for Ovarian or Adnexal Malignancy with CC 
Other, Surgical 13 739: Uterine, Adnexa Proc for Non-ovarian/Adnexal Malig with MCC 
Other, Surgical 13 740: Uterine, Adnexa Proc for Non-ovarian/Adnexal Malig with CC 
Other, Surgical 13 741: Uterine, Adnexa Proc for Non-ovarian/Adnexal Malig without CC/MCC 
Other, Surgical 13 742: Uterine & Adnexa Proc for Non-malignancy with CC/MCC 
Other, Surgical 13 743: Uterine & Adnexa Proc for Non-malignancy without CC/MCC 
Other, Surgical 13 744: D & C, Conization, Laparoscopy & Tubal Interruption with CC/MCC 
Other, Surgical 13 746: Vagina, Cervix & Vulva Procedures with CC/MCC 
Other, Surgical 13 747: Vagina, Cervix & Vulva Procedures without CC/MCC 
Other, Surgical 13 748: Female Reproductive System Reconstructive Procedures 
Other, Surgical 21 901: Wound Debridements for Injuries with MCC 
Other, Surgical 21 902: Wound Debridements for Injuries with CC 
Other, Surgical 21 903: Wound Debridements for Injuries without CC/MCC 
Other, Surgical 21 904: Skin Grafts for Injuries with CC/MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Other, Surgical 21 908: Other O.R. Procedures for Injuries with CC 
Other, Surgical 21 909: Other O.R. Procedures for Injuries without CC/MCC 
Other, Surgical 22 927: Extensive Burns or Full Thickness Burns with MV 96+ Hrs with Skin Graft 
Other, Surgical 22 928: Full Thickness Burn with Skin Graft or Inhal Inj with CC/MCC 
Other, Surgical 23 939: O.R. Proc with Diagnoses of Other Contact with Health Services with MCC 
Other, Surgical 23 940: O.R. Proc with Diagnoses of Other Contact with Health Services with CC 
Other, Surgical 23 
941: O.R. Proc with Diagnoses of Other Contact with Health Services without 
CC/MCC 
Other, Surgical 24 957: Other O.R. Procedures for Multiple Significant Trauma with MCC 
Other, Surgical 24 958: Other O.R. Procedures for Multiple Significant Trauma with CC 
Other, Medical 02 121: Acute Major Eye Infections with CC/MCC 
Other, Medical 02 123: Neurological Eye Disorders 
Other, Medical 02 125: Other Disorders of the Eye without MCC 
Other, Medical 03 147: Ear, Nose, Mouth & Throat Malignancy with CC 
Other, Medical 03 148: Ear, Nose, Mouth & Throat Malignancy without CC/MCC 
Other, Medical 03 149: Dysequilibrium 
Other, Medical 03 150: Epistaxis with MCC 
Other, Medical 03 151: Epistaxis without MCC 
Other, Medical 03 152: Otitis Media & Uri with MCC 
Other, Medical 03 153: Otitis Media & Uri without MCC 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Other, Medical 03 155: Nasal Trauma & Deformity with CC 
Other, Medical 03 156: Nasal Trauma & Deformity without CC/MCC 
Other, Medical 03 157: Dental & Oral Diseases with MCC 
Other, Medical 03 158: Dental & Oral Diseases with CC 
Other, Medical 03 159: Dental & Oral Diseases without CC/MCC 
Other, Medical 12 722: Malignancy, Male Reproductive System with MCC 
Other, Medical 12 723: Malignancy, Male Reproductive System with CC 
Other, Medical 12 725: Benign Prostatic Hypertrophy with MCC 
Other, Medical 12 726: Benign Prostatic Hypertrophy without MCC 
Other, Medical 12 727: Inflammation of the Male Reproductive System with MCC 
Other, Medical 12 728: Inflammation of the Male Reproductive System without MCC 
Other, Medical 12 729: Other Male Reproductive System Diagnoses with CC/MCC 
Other, Medical 13 754: Malignancy, Female Reproductive System with MCC 
Other, Medical 13 755: Malignancy, Female Reproductive System with CC 
Other, Medical 13 760: Menstrual & Other Female Reproductive System Disorders with CC/MCC 
Other, Medical 14 776: Postpartum & Post Abortion Diagnoses without O.R. Procedure 
Other, Medical 19 880: Acute Adjustment Reaction & Psychosocial Dysfunction 
Other, Medical 19 881: Depressive Neuroses 
Other, Medical 19 882: Neuroses Except Depressive 
Other, Medical 19 883: Disorders of Personality & Impulse Control 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Other, Medical 19 885: Psychoses 
Other, Medical 20 895: Alcohol/Drug Abuse or Dependence with Rehabilitation Therapy 
Other, Medical 20 896: Alcohol/Drug Abuse or Dependence without Rehabilitation Therapy with MCC 
Other, Medical 20 
897: Alcohol/Drug Abuse or Dependence without Rehabilitation Therapy without 
MCC 
Other, Medical 21 913: Traumatic Injury with MCC 
Other, Medical 21 914: Traumatic Injury without MCC 
Other, Medical 21 915: Allergic Reactions with MCC 
Other, Medical 21 917: Poisoning & Toxic Effects of Drugs with MCC 
Other, Medical 21 918: Poisoning & Toxic Effects of Drugs without MCC 
Other, Medical 21 919: Complications of Treatment with MCC 
Other, Medical 21 920: Complications of Treatment with CC 
Other, Medical 21 921: Complications of Treatment without CC/MCC 
Other, Medical 21 922: Other Injury, Poisoning & Toxic Effect Diag with MCC 
Other, Medical 21 923: Other Injury, Poisoning & Toxic Effect Diag without MCC 
Other, Medical 23 945: Rehabilitation with CC/MCC 
Other, Medical 23 947: Signs & Symptoms with MCC 
Other, Medical 23 948: Signs & Symptoms without MCC 
Other, Medical 23 949: Aftercare with CC/MCC 
Other, Medical 23 951: Other Factors Influencing Health Status 






Table 5-1 (continued) 
Classification for defining primary reason for treatment or “condition groups” 
 
Primary Diagnosis Group 
Major Diagnosis 
Category (MDC) MS-DRG 
Other, Medical 24 964: Other Multiple Significant Trauma with CC 
Other, Medical 24 965: Other Multiple Significant Trauma without CC/MCC 
Other, Medical 25 974: HIV with Major Related Condition with MCC 
Other, Medical 25 975: HIV with Major Related Condition with CC 
Other, Medical 25 976: HIV with Major Related Condition without CC/MCC 







Comorbidities crosswalk of groupings to component Hierarchical Condition Categories1 
Comorbidity Groups Condition Category 
Cellulitis (HCC120,164) 120: Major Eye Infections/Inflammations 
Cellulitis (HCC120,164) 164: Cellulitis, Local Skin Infection 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 106: Atherosclerosis of the Extremities with Ulceration or Gangrene 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 107: Vascular Disease with Complications 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 108: Vascular Disease 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 84: Cardio-Respiratory Failure and Shock 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 86: Acute Myocardial Infarction 
Shock, Ischemic HD, Vascular (HCC84,86,87,106,107,108) 87: Unstable Angina and Other Acute Ischemic Heart Disease 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 17: Diabetes with Acute Complications 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 18: Diabetes with Chronic Complications 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 19: Diabetes without Complication 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 20: Type I Diabetes Mellitus 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 21: Protein-Calorie Malnutrition 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 23: Other Significant Endocrine and Metabolic Disorders 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 24: Disorders of Fluid/Electrolyte/Acid-Base Balance 
Metabolic, Diabetes, Other Endocrine (HCC21,23,24,17, 18,19,20,26) 26: Other Endocrine/Metabolic/Nutritional Disorders 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 27: End-Stage Liver Disease 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 28: Cirrhosis of Liver 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 29: Chronic Hepatitis 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 30: Acute Liver Failure/Disease 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 31: Other Hepatitis and Liver Disease 






Table 5-2 (continued) 
Comorbidities crosswalk of groupings to component Hierarchical Condition Categories1 
Comorbidity Groups Condition Category 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 33: Intestinal Obstruction/Perforation 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 34: Chronic Pancreatitis 
Liver, Other GI (HCC27,28, 30,29, 31,32,33,34,35) 35: Inflammatory Bowel Disease 
Head and Spine Injury (HCC166,167,70,71,72) 166: Severe Head Injury 
Head and Spine Injury (HCC166,167,70,71,72) 167: Major Head Injury 
Head and Spine Injury (HCC166,167,70,71,72) 70: Quadriplegia 
Head and Spine Injury (HCC166,167,70,71,72) 71: Paraplegia 
Head and Spine Injury (HCC166,167,70,71,72) 72: Spinal Cord Disorders/Injuries 
Morbid Obesity (HCC22) 22: Morbid Obesity 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
189: Amputation Status, Lower Limb/Amputation Complications 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
39: Bone/Joint/Muscle Infections/Necrosis 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
40: Rheumatoid Arthritis and Inflammatory Connective Tissue 
Disease 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
41: Disorders of the Vertebrae and Spinal Discs 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 






Table 5-2 (continued) 
Comorbidities crosswalk of groupings to component Hierarchical Condition Categories1 
Comorbidity Groups Condition Category 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
43: Osteoporosis and Other Bone/Cartilage Disorders 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
44: Congenital/Developmental Skeletal and Connective Tissue 
Disorders 
Ortho—Bone/Joint/Muscle Infections, Rheumatoid Arthritis, Severe 
Skeletal, Musculoskeletal, Amputation (HCC39,40,41,42, 
43,44,45,189) 
45: Other Musculoskeletal and Connective Tissue Disorders 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 73: Amyotrophic Lateral Sclerosis and Other Motor Neuron Disease 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 74: Cerebral Palsy 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 75: Polyneuropathy 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 76: Muscular Dystrophy 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 77: Multiple Sclerosis 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 78: Parkinson’s and Huntington’s Diseases 
Polyneuropathy, Seizure, Other Neuro (HCC75,79,73,74,76, 77,78) 79: Seizure Disorders and Convulsions 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
54: Drug/Alcohol Psychosis 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
55: Drug/Alcohol Dependence 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
56: Drug/Alcohol Abuse, Without Dependence 








Table 5-2 (continued) 
Comorbidities crosswalk of groupings to component Hierarchical Condition Categories1 
Comorbidity Groups Condition Category 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
58: Major Depressive, Bipolar, and Paranoid Disorders 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
59: Reactive and Unspecified Psychosis 
Severe Psychiatric, Drug Alcohol Abuse w Dependence 
(HCC54,55,57,58,59,60) 
60: Personality Disorders 
Renal Failure, Kidney Disease (HCC135,136,137,138) 135: Acute Renal Failure 
Renal Failure, Kidney Disease (HCC135,136,137,138) 136: Chronic Kidney Disease, Stage 5 
Renal Failure, Kidney Disease (HCC135,136,137,138) 137: Chronic Kidney Disease, Severe (Stage 4) 
Renal Failure, Kidney Disease (HCC135,136,137,138) 138: Chronic Kidney Disease, Moderate (Stage 3) 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
110: Cystic Fibrosis 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
111: Chronic Obstructive Pulmonary Disease 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
112: Fibrosis of Lung and Other Chronic Lung Disorders 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
114: Aspiration and Specified Bacterial Pneumonias 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
115: Pneumococcal Pneumonia, Empyema, Lung Abscess 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
116: Viral and Unspecified Pneumonia, Pleurisy 
Pneumonia, Pleural Effusion and Other Respiratory (CF, COPD, 
Fibrosis) (HCC110,111,112,114,115,116,117) 
117: Pleural Effusion/Pneumothorax 






Table 5-2 (continued) 
Comorbidities crosswalk of groupings to component Hierarchical Condition Categories1 
Comorbidity Groups Condition Category 
Stroke (HCC99,100,101,102,103,104) 101: Precerebral Arterial Occlusion and Transient Cerebral Ischemia 
Stroke (HCC99,100,101,102,103,104) 102: Cerebrovascular Atherosclerosis, Aneurysm, and Other Disease 
Stroke (HCC99,100,101,102,103,104) 103: Hemiplegia/Hemiparesis 
Stroke (HCC99,100,101,102,103,104) 104: Monoplegia, Other Paralytic Syndromes 
Stroke (HCC99,100,101,102,103,104) 99: Cerebral Hemorrhage 
UTI (HCC141,144) 141: Nephritis 
UTI (HCC141,144) 144: Urinary Tract Infection 
1 Version 21. 
NOTE:  Not all available HCCs were included in the condition groupings used in current modeling. Categories excluded were those 
that were very common and nonspecific in the PAC population, conditions captured by other items on the CARE tool, or rare 





Motor scale:  Raw score to Rasch measure equivalent 
Raw score Rasch measure SE (Rasch measure) 
25 0.40 (estimate) 15.92 (estimate) 
26 10.37 8.43 
27 15.76 5.82 
28 18.81 4.71 
29 20.95 4.07 
30 22.61 3.65 
31 23.98 3.35 
32 25.16 3.13 
33 26.19 2.95 
34 27.12 2.80 
35 27.96 2.68 
36 28.73 2.58 
37 29.45 2.49 
38 30.12 2.41 
39 30.76 2.34 
40 31.36 2.28 
41 31.93 2.23 
42 32.47 2.18 
43 33.00 2.14 
44 33.50 2.10 
45 33.99 2.07 
46 34.46 2.04 
47 34.92 2.01 
48 35.37 1.98 
49 35.80 1.96 
50 36.23 1.94 
51 36.65 1.92 
52 37.06 1.90 
53 37.46 1.89 
54 37.85 1.87 
55 38.24 1.86 
56 38.63 1.85 
57 39.01 1.84 
58 39.39 1.83 





Table 5-3 (continued) 
Motor scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
60 40.13 1.81 
61 40.50 1.80 
62 40.86 1.80 
63 41.22 1.79 
64 41.58 1.79 
65 41.94 1.78 
66 42.29 1.78 
67 42.65 1.77 
68 43.00 1.77 
69 43.35 1.77 
70 43.70 1.76 
71 44.05 1.76 
72 44.39 1.76 
73 44.74 1.76 
74 45.09 1.75 
75 45.43 1.75 
76 45.78 1.75 
77 46.12 1.75 
78 46.46 1.75 
79 46.80 1.74 
80 47.14 1.74 
81 47.48 1.74 
82 47.83 1.74 
83 48.16 1.74 
84 48.50 1.74 
85 48.84 1.74 
86 49.18 1.74 
87 49.52 1.74 
88 49.86 1.74 
89 50.20 1.74 
90 50.54 1.74 
91 50.87 1.74 
92 51.21 1.74 
93 51.55 1.74 
94 51.89 1.74 





Table 5-3 (continued) 
Motor scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
96 52.57 1.74 
97 52.91 1.74 
98 53.25 1.75 
99 53.60 1.75 
100 53.94 1.75 
101 54.29 1.76 
102 54.63 1.76 
103 54.98 1.77 
104 55.34 1.77 
105 55.69 1.78 
106 56.04 1.79 
107 56.40 1.79 
108 56.77 1.80 
109 57.13 1.81 
110 57.50 1.82 
111 57.88 1.83 
112 58.25 1.84 
113 58.64 1.85 
114 59.02 1.87 
115 59.42 1.88 
116 59.82 1.90 
117 60.23 1.92 
118 60.64 1.93 
119 61.07 1.95 
120 61.50 1.98 
121 61.94 2.00 
122 62.40 2.02 
123 62.86 2.05 
124 63.34 2.08 
125 63.83 2.11 
126 64.34 2.15 
127 64.87 2.18 
128 65.41 2.23 
129 65.98 2.27 
130 66.57 2.32 





Table 5-3 (continued) 
Motor scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
132 67.83 2.43 
133 68.51 2.49 
134 69.23 2.57 
135 69.99 2.65 
136 70.80 2.74 
137 71.68 2.84 
138 72.62 2.97 
139 73.66 3.11 
140 74.81 3.29 
141 76.10 3.51 
142 77.60 3.81 
143 79.40 4.22 
144 81.68 4.84 
145 84.87 5.93 
146 90.39 8.49 
147 100.41 (estimate) 15.93 (estimate) 





Self-care scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
8 7.64 (estimate) 15.33 (estimate) 
9 16.72 8.03 
10 21.72 5.70 
11 24.75 4.79 
12 27.04 4.29 
13 28.94 3.96 
14 30.60 3.73 
15 32.08 3.55 
16 33.44 3.40 
17 34.69 3.28 
18 35.86 3.18 
19 36.96 3.10 
20 38.01 3.03 
21 39.02 2.97 
22 40.00 2.92 
23 40.94 2.89 
24 41.87 2.86 
25 42.78 2.84 
26 43.69 2.83 
27 44.59 2.83 
28 45.49 2.84 
29 46.39 2.85 
30 47.31 2.87 
31 48.25 2.90 
32 49.20 2.94 
33 50.18 2.98 
34 51.20 3.03 
35 52.24 3.08 
36 53.33 3.15 
37 54.47 3.22 
38 55.65 3.29 
39 56.90 3.38 
40 58.23 3.49 
41 59.65 3.62 
42 61.19 3.79 
43 62.90 4.03 
44 64.86 4.37 
45 67.26 4.91 
46 70.48 5.90 
47 75.87 8.35 
48 85.57 15.71 





Mobility scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
17 5.79 15.91 
18 15.75 8.43 
19 21.14 5.82 
20 24.18 4.71 
21 26.33 4.07 
22 28.00 3.66 
23 29.38 3.37 
24 30.57 3.15 
25 31.62 2.99 
26 32.58 2.86 
27 33.46 2.75 
28 34.29 2.67 
29 35.06 2.60 
30 35.80 2.54 
31 36.51 2.49 
32 37.20 2.45 
33 37.86 2.42 
34 38.51 2.39 
35 39.14 2.37 
36 39.77 2.35 
37 40.38 2.33 
38 40.99 2.32 
39 41.59 2.30 
40 42.18 2.29 
41 42.76 2.28 
42 43.34 2.27 
43 43.92 2.26 
44 44.49 2.25 
45 45.05 2.24 
46 45.61 2.23 
47 46.16 2.21 
48 46.71 2.20 
49 47.25 2.19 
50 47.78 2.18 
51 48.31 2.17 





Table 5-5 (continued) 
Mobility scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
53 49.36 2.14 
54 49.87 2.13 
55 50.38 2.12 
56 50.88 2.12 
57 51.38 2.11 
58 51.88 2.10 
59 52.37 2.10 
60 52.86 2.09 
61 53.35 2.09 
62 53.84 2.09 
63 54.33 2.09 
64 54.82 2.09 
65 55.31 2.09 
66 55.80 2.10 
67 56.30 2.10 
68 56.80 2.11 
69 57.30 2.12 
70 57.81 2.13 
71 58.32 2.15 
72 58.84 2.16 
73 59.37 2.18 
74 59.91 2.20 
75 60.45 2.22 
76 61.01 2.25 
77 61.59 2.27 
78 62.17 2.30 
79 62.78 2.34 
80 63.40 2.37 
81 64.04 2.42 
82 64.71 2.46 
83 65.40 2.51 
84 66.13 2.57 
85 66.88 2.63 
86 67.68 2.69 
87 68.51 2.77 





Table 5-5 (continued) 
Mobility scale:  Raw score to Rasch measure equivalent 
Score Measure SE (Measure) 
89 70.35 2.95 
90 71.36 3.07 
91 72.47 3.21 
92 73.68 3.37 
93 75.03 3.58 
94 76.58 3.86 
95 78.42 4.25 
96 80.72 4.85 
97 83.90 5.90 
98 89.34 8.41 
99 99.20 (estimate) 15.83 (estimate) 



























   Overall (n = 12,065) 46.68 15.89 9.79 28.91 39.98 46.39 53.33 64.87 78.97 
HHA (n = 3,190) 59.58 15.82 35.83 41.86 49.20 58.23 70.50 85.58 85.58 
IRF (n = 4,158) 43.64 9.65 27.01 33.41 39.98 44.58 49.20 53.33 55.65 
LTCH (n = 1,968) 33.94 18.66 7.60 7.60 16.68 36.94 46.85 54.46 59.70 
SNF (n = 2,749) 45.44 10.16 28.91 34.66 40.93 46.39 51.19 55.65 59.65 
Mobility  
Overall (n = 12,080) 45.11 15.67 12.24 27.81 37.39 44.61 52.75 63.70 71.85 
HHA (n = 3,186) 58.91 15.37 35.24 41.90 50.52 57.86 66.90 79.18 88.90 
IRF (n = 4,161) 41.21 9.83 20.89 31.38 37.06 41.84 47.17 51.65 54.61 
LTCH (n = 1,986) 33.53 16.90 8.92 9.66 19.57 34.07 45.06 52.40 58.49 
SNF (n = 2,747) 43.40 10.47 27.98 32.97 38.69 43.24 48.43 54.61 58.63 
Motor  
Overall (n = 12,093) 45.13 15.30 17.63 29.37 38.32 44.95 52.40 62.15 69.33 
HHA (n = 3,191) 58.20 14.63 36.23 42.18 50.19 57.55 65.31 74.58 84.52 
IRF (n = 4,161) 42.02 8.82 27.85 32.89 38.04 42.73 47.48 51.21 53.89 
LTCH (n = 1,991) 32.55 18.24 2.10 2.86 20.85 35.03 44.81 52.51 57.68 
SNF (n = 2,750) 43.79 9.70 29.44 34.35 39.32 44.09 48.74 53.62 57.20 
IADL  
Overall (n = 10,863) 40.90 18.63 2.22 18.00 29.23 41.22 52.71 62.39 69.59 
HHA (n = 2,816) 51.27 19.70 11.77 23.25 42.38 53.65 62.49 72.05 78.70 
IRF (n = 3,980) 38.97 15.03 2.50 19.02 29.83 40.07 49.21 56.26 60.18 
LTCH (n = 1,560) 26.84 19.75 1.83 1.83 2.44 26.71 38.12 52.71 58.77 
SNF (n = 2,507) 41.06 14.75 17.85 23.28 33.45 40.74 52.71 56.77 63.58 



























   Overall (n = 12,065) 59.08 19.48 24.72 35.83 47.30 58.23 75.91 85.58 85.58 
HHA (n = 3,190) 69.57 17.26 37.99 45.48 58.23 75.91 85.58 85.58 85.58 
IRF (n = 4,158) 59.11 15.80 36.30 41.86 49.19 55.65 70.50 85.58 85.58 
LTCH (n = 1,968) 43.79 22.43 7.60 7.89 28.91 43.67 58.23 78.97 85.58 
SNF (n = 2,749) 57.82 16.92 32.05 39.00 47.30 56.90 70.50 85.58 85.58 
Mobility  
Overall (n = 12,080) 59.70 19.83 26.98 35.24 48.12 59.26 71.79 87.25 96.36 
HHA (n = 3,186) 71.00 18.79 39.40 48.52 59.20 70.79 83.49 96.36 98.74 
IRF (n = 4,161) 57.91 14.80 35.24 41.19 49.27 57.25 66.43 76.06 83.49 
LTCH (n = 1,986) 44.97 21.99 9.59 12.07 30.93 43.34 58.02 74.81 87.25 
SNF (n = 2,747) 59.95 18.16 32.80 38.40 48.34 59.11 70.63 83.49 96.36 
Motor  
Overall (n = 12,093) 58.90 19.94 27.07 35.32 47.62 58.20 70.27 84.54 96.58 
HHA (n = 3,191) 70.73 19.21 38.83 47.33 58.49 70.05 84.54 98.06 100.01 
IRF (n = 4,161) 57.50 14.20 36.12 41.54 49.17 56.38 66.16 74.81 81.30 
LTCH (n = 1,991) 43.67 22.89 2.56 6.74 29.82 42.74 57.39 71.20 84.54 
SNF (n = 2,750) 58.31 17.42 32.02 38.82 47.97 57.63 68.44 79.00 90.02 
IADL  
Overall (n = 10,863) 53.67 23.25 2.76 23.49 39.73 54.99 68.80 83.01 95.48 
HHA (n = 2,816) 62.69 24.84 11.79 27.45 48.18 65.43 77.95 97.86 99.53 
IRF (n = 3,980) 53.69 18.95 22.38 30.71 42.38 54.27 65.29 78.70 85.13 
LTCH (n = 1,560) 37.60 25.16 1.83 2.00 18.37 35.35 55.67 72.93 82.23 
SNF (n = 2,507) 53.52 20.82 18.66 27.84 40.07 52.97 66.67 82.23 90.72 
SOURCE: RTI analysis of Phase 1 CARE assessments (CARE_CS370). 
 









FACTORS ASSOCIATED WITH FIRST SITES OF POST-ACUTE CARE 
One of the key goals in this payment reform demonstration (PRD) is to better understand 
the types of patients treated in each of the four post-acute care (PAC) settings, including long-
term care hospitals (LTCH), inpatient rehabilitation facilities (IRF), skilled nursing facilities 
(SNF), and home health agencies (HHA).  The use of a standardized assessment tool allows 
examination of the populations admitted to each setting in greater detail than possible using 
claims data.  It also allows populations to be compared across settings to identify factors that 
distinguish admissions to each setting as well as identify overlapping characteristics that may be 
useful for understanding whether the same patient is treated in more than one setting.  This 
section will examine how patient complexity (medical, functional, and cognitive) factors are 
associated with hospital discharge home or to a PAC setting.  The focus is on the use of a 
Medicare-covered PAC service during the first 30 days from acute discharge, and, if there was 
use, on the factors associated with the type of first PAC site used.  It is important to note that 
these analyses are based on current practice patterns and do not necessarily reflect an “ideal” 
system of care or PAC decision.   
The analyses presented in this chapter are important for understanding whether the types 
of patients treated in each setting overlap or are distinguishable.  These issues are important 
because Medicare uses a different payment system with different payment units, case-mix 
groups, and payment amounts for each type of provider.  Hence, Medicare may be paying 
different amounts for similar types of patients who may be treated in more than one setting.  
Furthermore, outcomes may differ depending on the type of PAC setting used.  Understanding 
differences in the complexity of post-acute patients admitted to each type of setting and the 
outcomes associated with their treatment will be important for considering future payment 
reform.  These issues are complicated by variations in the availability of the more specialized 
PAC settings, such as IRFs and LTCHs, compared with the widely available SNFs and HHAs.  
Understanding whether similar populations can effectively be treated in more than one setting, 
and the availability of those services, is important for ensuring that Medicare beneficiaries have 
access to appropriate care.  
This analysis builds on much of our past work using Medicare claims to predict the 
discharge destinations of acute hospital patients.  The claims data are useful as a first stage in 
measuring medical complexity, but they fail to measure more specific areas of medical, 
functional, and cognitive health status complexity.  The standardized Continuity Assessment 
Record and Evaluation (CARE) items provide additional detailed information on these areas.   
6.1 Literature Review 
In examining the issue of discharge destination, there may be a number of different ways 
to consider factors associated with PAC use.  Most prior analyses have been limited by data 
availability and rely on the patient factors available in the claims data, or, if studying one setting 
of care, the assessment data such as the Minimum Data Set (MDS), IRF-Patient Assessment 
Index (PAI), or Outcome and Assessment Information Set (OASIS) data associated with that 
type of setting (Gage et al., 2008;  Wolfe and Meadow, 2008; Gage et al., 2005; Gage, 1999; Liu, 




Pettigrew, 1985).  The studies have varied in whether they looked specifically at the use of 
certain types of PAC, such as the choice of HHA use vs. discharge home without services 
(Kenney and Moon, 1994) or whether they looked across the range of PAC providers either in 
comparisons of dyads (SNF vs. IRF choice) or more generically (PAC service vs. no PAC 
service) or in multisetting models (predicting no service use vs. SNF use vs. IRF use (Gage et al., 
2009, McCall et al., 2001, Lee et al., 1997).   
Many studies have examined service use for specific types of cases, such as those with 
congestive heart failure (Li et al., 2004), joint replacements (DeJong et al., 2008), stroke (Sandel 
et al., 2009), or other types of populations commonly admitted to PAC (Morley et al., 2010).  
While the exact factors associated with the type of PAC used or length of stay may vary, most 
studies have found certain factors to be consistently important: age, gender, dual eligibility under 
Medicare and Medicaid, as well as precipitating medical conditions and comorbidities.  
Functional status is another important factor in considering PAC use.  Nguyen et al. 
(2007) found that stroke patients with relatively low functional status (empirically defined by a 
functional independence measure (FIM®) score of 75 or lower) were significantly more likely to 
be discharged to a SNF after acute hospitalization than home.  Within the low functional status 
group, the likelihood of nursing home referral was relatively lower among those who were 
married.  However, marital status did not influence the discharge to nursing home or home for 
patients with FIM® scores higher than 75.  Ilett et al. (2010) also found functional status—here 
measured by Mobility Scale scores—to significantly predict discharge to home, IRF, or SNF 
after acute stroke treatment.  History of falls and cognitive status also have been found to be 
important predictors of discharge setting.  Bentler et al (2009) found that hip or knee replacement 
patients with falls or a secondary diagnosis of dementia were more likely to be discharged to a 
SNF than to inpatient rehabilitation.  However, in general, patients with replacement surgeries 
were more likely to be discharged home than to a SNF after hospital discharge. 
In addition to the patient’s demographic and clinical factors, the availability of services is 
one of the most important predictors for determining actual service use (Gage et al., 2009; 
Beeuwkes-Buntin et al., 2005; Gage, 1999; Lee et al., 1997).  After controlling for demographic 
factors, primary diagnoses, and comorbidities, the availability of a PAC bed or the affiliation 
with a hospital were both associated with a higher likelihood of using a respective PAC service 
(Gage et al., 2005).   
Understanding which factors are associated with the choice of discharge destination is 
important for examining the mix of patients seen in a particular type of facility.  Presumably, if 
there is strong differentiation in the types of patients referred to a particular type of setting, then 
the populations in those different settings will differ in their characteristics at admission and the 
degree of population overlap will be limited.  While the argument has been made that patients 
treated in different PAC settings vary in terms of their acuity, little empirical evidence exists to 
support the hypothesis.  The absence of consistent severity measures in the PAC assessment 
tools has contributed to the difficulties in examining severity as it relates to site of care choices, 
treatment intensity, and outcomes (Gage and Green, 2006).  Adequately controlling for case-mix 
severity is key to understanding the differences in populations using each post-acute provider.  




providers may be providing substitute services while receiving substantially different payments 
for those services (MedPAC, 2004). 
6.2 Sample and Methods 
This analysis presents four different approaches to examining factors associated with 
PAC use after discharge from an acute hospital stay.  Each of these models controls for medical, 
functional, and cognitive status as well as certain market characteristics, such as the availability 
of PAC options.  First, a logistic regression is used to predict the probability of any post-acute 
use within 30 days of hospital discharge (ANYPAC).  Post-acute use in this model is broadly 
defined as receiving services in one of the four PAC settings examined in this project (LTCH, 
IRF, SNF, or HHA), any Part B therapy, or subsequent hospitalizations.  The contrast is 
discharge home with no services in the 30-day window.  Second, a multinomial logistic 
regression (FIRSTPAC) is presented to compare the relative odds of being discharged home 
without Medicare-covered inpatient or home health services to being discharged to (1) home 
health care or (2) a SNF (3) an IRF or (4) a LTCH.1  Third, two additional logistic regressions 
examine the relative characteristics differentiating between hospital discharges to (1) SNFs 
versus IRFs (SNF/IRF) and (2) SNFs versus HHAs (SNF/HHA).   
6.2.1 Sample  
The sample for these analyses is based on 13,554 cases with a CARE assessment at the 
time of transfer from the inpatient prospective payment system to the PAC setting (Table 6-1).  
CARE at time of transfer could originate from two sources:  (1) the CARE assessment for 
patients at the time of discharge from acute hospitals (n = 4,412) or (2) the CARE assessment at 
the time of admission to the PAC setting (n = 9,142).  The PAC admission sample was restricted 
to admissions occurring within 2 days of hospital discharge date.  
The providers included in the sample were chosen on the basis of the purpose of 
examining Medicare PAC populations.  Hospital units included in this study were selected on the 
basis of their likelihood of treating Medicare populations with the types of diagnosis that 
frequently are discharged to PAC (e.g., stroke, cardiac, chronic obstructive pulmonary disease 
[COPD]).  As noted in Section 4, the acute care sample represents a higher proportion of PAC 
users than the national sample but it allows for a robust analysis of cases that had the potential to 
use PAC.  This approach reflects the analytic focus on addressing payment equities across PAC 
systems.  As a result of this sampling approach, the analyses presented here are useful for 
understanding the types of cases treated in each setting or going home without services, but they 
do not reflect the entire Medicare population likely to go home without PAC.  Second, the 
markets were selected for having higher or lower options for PAC.  The high-PAC markets have 
IRFs or LTCHs in addition to SNFs and HHAs, whereas the low-PAC markets reflect the 
absence of these more specialized services.  These factors, and other market-level referral pattern 
variations, may influence discharge destinations.   
                                                 
1  The FIRSTPAC model excludes claims from the “other” settings, including Part B therapy, Federal hospitals, 




Excluded from the 4,412 hospital assessments in this section were 208 CARE 
assessments completed on step-down units because these cases continued into subsequent 
medical/surgical units and were not true hospital discharges.  The second assessment for these 
cases was used to identify patient complexity at time of hospital discharge.  Also excluded were 
the small number of hospital transfer cases (i.e., discharges to another short-stay acute hospital), 
as transfer populations are assumed not to be equivalent to the populations ready for discharge 
from the acute hospital.  Similarly, 496 discharges to other acute hospital inpatient settings, such 
as Federal hospitals, inpatient psychiatric hospitals, outpatient services, and hospice, were 
excluded from the models.  Acute hospital stays in these analyses could be either the start of care 
or a readmission later in the episode.  Among the cases from the acute hospital sample, 93 were 
discharged to LTCH, 248 to IRF, 1,071 to SNF, and 821 to HHA; 1,719 were discharged home 
without PAC services in the subsequent 30 days.  
The sample derived from PAC admissions within 2 days of hospital discharge consisted 
of 9,142 cases, including 1,476 LTCH cases, 3,515 IRF cases, 2,786 SNF cases, and 1,365 HHA 
cases.  This part of the sample contributes no “no PAC” cases, by definition.2  The two samples 
were combined to increase sample size for the analysis, on the theory that assessments done at 
the time of transfer would be roughly equivalent.  At the same time, the unique nature of the 
sample means that care needs to be taken to interpret the models correctly.   
6.2.2 Methods 
6.2.2.1  Dependent Variable Definitions 
Several dependent variables are tested in the four models in this section.  All of the 
outcomes are measuring the odds of admission to another service within 30 days of discharge 
from the acute hospital.  If more than one service is used during that window, only the 
chronologically first type of service is considered the discharge destination.  Service use is based 
on the first Medicare claim within 30 days of discharge from the short-stay acute hospital.  We 
tested several different discharge destinations as the dependent variables.  
• Any PAC Model: This outcome was defined as a yes/no indicator of whether the 
beneficiary had a Medicare claim (LTCH, IRF, SNF, HHA, Part B therapy, 
hospitalization) within 30 days after discharge from the hospital.  Note that cases with 
a zero day transfer from an acute hospital to another acute hospital, as noted above, 
were excluded from the analysis. 
• First PAC Model:  This outcome was defined as one of five outcomes on the basis of 
the first site of PAC used within 30 days after discharge.  The multinomial model 
predicts the odds of using one of the following settings relative to not having a claim 
for any of the following services.  Cases discharged to “other” were excluded from 
this analysis.  The settings were defined as follows: 
                                                 
2  While the acute-based sample offers a 30-day window to be assigned to “no PAC” or any of the four PAC 
settings on the basis of claims identification, the subset of PAC cases included in the sample had to have started 




– Long-term care hospital (LTCH)  
– Inpatient rehabilitation facility or hospital unit (IRF) 
– Skilled nursing facility (SNF/transitional care unit)  
– Home health agency (HHA) 
• IRF/SNF Outcomes: This outcome selects only IRF and SNF admissions to examine 
more closely the factors associated with discharge to either of these services.  This 
outcome was defined as having either a SNF or an IRF claim within 30 days after 
discharge from the hospital.  The SNF group was the referent category. 
• SNF/HHA Outcomes: This outcome selects only SNF and HHA admissions to 
examine more closely the factors associated with discharge to either of these services.  
This outcome was defined as having either a SNF or an HHA claim within 30 days 
after discharge from the hospital.  The SNF group was the referent category. 
The last two models both use SNF as the reference group.  Together these models are 
useful for identifying the characteristics of patients treated in each setting, allowing comparison 
of both the similarities and differences associated with those using IRF or HHA relative to the 
odds of using SNF. 
The models are designed to examine the characteristics of beneficiaries discharged to 
each setting.  They have not been weighted for relative proportions in the Medicare population 
since the weights would reduce the ability to determine the factors related to discharge to IRFs 
and LTCHs because of the relatively low frequency of such stays in the national population.  The 
goal of these analyses is to understand the medical, functional, and cognitive characteristics of 
beneficiaries treated in each setting.  These models provide important information on the 
presence or absence of a characteristic and the relative direction of the associations.  This is 
helpful for understanding whether a patient with “factor x” is more or less likely to be discharged 
to a certain setting, particularly relative to the reference group (non-PAC admissions, or in the 
last two models, SNF admissions), holding the other variables in the model constant.  
6.2.2.2 Independent Variable Definitions 
The analysis of discharge destination is primarily focused on examining the medical, 
functional, and cognitive factors associated with Medicare service use after hospital discharge.  
The independent variables used in this analysis include demographic, medical, and functional 
characteristics; mood and cognition; and indicators of premorbid functional status and premorbid 
living arrangements as noted in the classification schema presented in Section 5.  While 
additional variables also were tested, some were omitted due to collinearity with others retained 
in the models.  Others were kept in the models despite small numbers because of their expected 
contribution.  The reference group for each health status factor is the “healthiest” characteristic, 




This model included some variables unique to this examination and not included in the 
other sections of this report.  Because of the importance of local patterns of referrals and the 
availability of services on discharge decisions, market identifiers were included in these models.   
6.3 Discharge Destination Results 
This section consists of two principal parts.  First, the final discharge destination analysis 
sample is described with respect to the case-mix characteristics used in the models.  These 
factors are displayed by discharge destination setting and can be used for each set of models.   
• Any-PAC Model: For the descriptive statistics associated with this model, refer to 
the “home no services” compared with the combination of the other columns. 
• First PAC Model: Refer to the LTCH, SNF, IRF, and HHA columns for sample 
description associated with those services used.  The reference category is represented 
by the “home no services.”  “Other services” are excluded from the models. 
• SNF/IRF Model: Refer to the SNF and the IRF columns for sample descriptions 
associated with this model.   
• SNF/HHA Model: Refer to the SNF and the HHA columns for sample descriptions 
associated with this model. 
6.3.1 Discharge Destination Sample Description 
This section presents the descriptive statistics characterizing the distribution of patients in 
this discharge destination sample.  Tables 6-2 through 6-11 contain descriptive information 
about the overall sample of beneficiaries included in this discharge destination analysis and how 
their characteristics vary by discharge setting. 
6.3.1.1 Demographics by Setting 
Table 6-2 shows basic demographic information about the sample at time of admission.   
Age.  Over all settings, patients were distributed across the four age groups, with the 
smallest numbers in the groups “under 65” and “over 85” years of age.  The largest groups of 
patients in our overall sample were 65-74 years (29 percent) or 75-84 years (36 percent).  
Differences were seen across the discharge destination sites.  Those who went home without 
additional services tended to have a high proportion of the under 65 years (26 percent) or the 
65-74 years (31 percent), while those who were discharged to SNFs had a larger share of the 
oldest populations (33 percent were 85 years or older).  Home health users were distributed 
across the four age groups, while IRF admissions tended to be in the middle two age groups 
(65-74 and 75-84 years old).  LTCHs tended to have a relatively high proportion of cases in the 
under 65 years old (20 percent) compared with other types of PAC users in our sample.  
Race.  About 8 percent of the cases were Black/African American.  A slightly higher 
proportion of Blacks were treated by HHAs (9 percent), IRFs (9 percent), and LTCHs 




Gender.  Overall, like the Medicare population in general, the sample had a higher 
proportion of females (58 percent).  This held true in all settings except LTCHs (48 percent), 
although the proportion varied across settings, with SNFs having the highest proportion 
(67 percent).  
Medicaid as Secondary Payer.  About 11 percent of the sample had Medicaid as a 
secondary payer.  The greatest proportions of dually eligible were among those who went home 
with no services (18 percent) and those discharged to LTCHs (15 percent) or “other services” 
(27 percent).   
6.3.1.2 Medical Status by Setting 
Table 6-3 shows the distribution in our sample of the primary condition in the acute 
hospital stay associated with each discharge destination.  Medicaid Severity Diagnosis-Related 
Groups (MS-DRGs) have been aggregated as discussed in Section 5 (Table 5-1).  The four 
largest groups of cases in this sample include orthopedic (28 percent of all cases), respiratory (17 
percent), cardiovascular (15 percent), and neurologic (14 percent).  Medical cases ranged from 
gastrointestinal (GI) and hepatobiliary (8 percent) to kidney and urinary (4 percent) to infections 
(4 percent), followed by integumentary (2 percent), endocrine (2 percent), and hematologic (1 
percent) cases. 
Differences are seen in the proportions using PAC and the type of PAC used.  The groups 
with the largest proportions going home without services were the respiratory (20 percent) and 
the GI/hepatobiliary (20 percent) cases.  However, within those groups there was wide variation.  
Table 6-4 disaggregates these cases into subcategories distinguishing between medical and 
surgical cases and some of the more likely “crossover” cases, or cases that may be treated in 
more than one setting.  Among the respiratory cases, four subgroups—those with ventilators or 
tracheostomies; those hospitalized for surgical respiratory issues, such as major chest procedures 
or other surgical procedures; those with medical respiratory issues, such as respiratory infections; 
and those with COPD—were not in any of the other 3 groups.  The ventilator cases were largely 
associated with LTCH use (74 percent of these cases) and they constituted 42 percent of the 
LTCH admissions, whereas those who went home without services tended to have been 
hospitalized for medical respiratory issues, such as respiratory infections (12 percent of those 
who went home without services).  If they used PAC, the medical respiratory cases were likely to 
go home with home health (8 percent of the HHA cases) or SNF (7 percent of the SNF cases).  In 
addition to the medical respiratory cases, COPD cases also were a larger share of the respiratory 
cases going home without services (6 percent of their cases); others were transferred  to HHA (4 
percent of HHA cases) or to LTCHs (4 percent of their cases).   
Over all cases, the orthopedic/musculoskeletal cases constitute the largest group in this 
sample (3,707 cases).  These cases included two surgical groups: minor and major.  Minor 
includes hip and femur procedures except major joints; knee procedures with and without 
primary diagnosis of infections; lower extremity and humerus procedures except hip, foot, 
femur; local incisions; soft tissue procedures; and shoulder, elbow, and other musculoskeletal 
procedures.  Major includes bilateral or multiple major joint procedures, hip/knee revisions, 
major joint replacements and reattachments, amputations for musculoskeletal systems, major 
shoulder or elbow joint procedures, and limb reattachments.  The third group of orthopedic cases 




other than spinal fusions.  The final two groups of orthopedic cases are major and minor medical 
cases.  Minor medical orthopedic cases included fractures, sprains, medical back problems, 
septic arthritis, tendonitis, and aftercare of musculoskeletal system and connective tissue.  Major 
medical orthopedic included hip and pelvis fractures and pathological fractures (see Section 5, 
Table 5-1, for complete descriptions of the groups).   
The two largest orthopedic groups were the surgical cases, particularly the major surgical 
cases such as those with multiple joint procedures, hip/knee revisions, and other joint 
replacement and revision cases.  The major surgical cases were frequently found in all three 
settings, including HHA (16 percent of HHA cases), IRF (15 percent of IRF cases) and SNF 
(20 percent of SNF cases).  The minor surgical cases accounted for a larger share of the IRF and 
SNF cases in our sample (10 percent and 9 percent, respectively).  
Cardiovascular cases are the third largest group in the sample.  These include two 
surgical groups (vascular surgical and cardiac surgical) as well as general circulatory disorders 
and vascular medical conditions, such as acute myocardial infarction cases.  The relative 
distributions across PAC settings vary.  Cases transferred to the SNFs and HHAs tended to be 
either post-surgical or medical in nature, while IRFs had more of the post-surgical cases. 
The fourth largest group in the sample is the neurological cases.  These include cases 
admitted to the acute hospital for a stroke; other neurological surgical issues, such as intracranial 
procedures or ventricular shunt procedures; or neurological medical issues, such as a range of 
nervous system disorders, multiple sclerosis, and related conditions.  The majority of cases in all 
three groups in our sample are discharged to IRF.  However, the first site of PAC was clearly 
differentiated, with IRFs admitting the highest proportion of cases that had been hospitalized for 
a stroke, while SNF neurological admissions were as likely to have been neurological/medical 
cases as stroke cases in the prior hospital stay.  
Comorbidities.  Comorbidities are another important factor in predicting discharge 
destination.  Table 6-5 shows the sample distribution of comorbid conditions by PAC setting.  
The two most common types of comorbidities in our sample are orthopedic/musculoskeletal 
(found in 49 percent of the cases in this sample) and metabolic/endocrine (48 percent of the 
sample).  Liver patients follow closely behind, with 40 percent of the patients having comorbid 
liver conditions.   
The presence of a comorbidity in patients transferred to different PAC settings varied.  
Comorbidities of liver disease are quite common in this sample, especially in the LTCH patient 
population (50 percent) and at a slightly lower percentage across home health (41 percent), IRF 
(36 percent), and SNF (41 percent).  Metabolic/endocrine comorbidities are also common among 
these cases, found in 74 percent of the LTCH sample, as well as noticeably present in the SNF 
and IRF settings at 50 percent and 48 percent, respectively.   
Cardiovascular is another common comorbidity in the LTCH patients (74 percent), 
compared with only about 25 percent in the other PAC settings and 15 percent of those going 
home without services.  Respiratory comorbid conditions were also quite common in the PAC 
population, especially in the LTCH group (73 percent) although also frequently found in the 




In contrast, having a comorbidity of an orthopedic/musculoskeletal condition, such as 
orthopedic infections, rheumatoid arthritis, and amputation, was more commonly associated with 
discharge to a SNF (63 percent), IRF (59 percent), or HHA (49 percent) in our sample.   
Comorbidities that were commonly treated in settings other than LTCH and SNF include 
diabetes (35 percent in home health), other neurological (19 percent in IRF), stroke (34 percent 
in IRF), and head and spine (10 percent in IRF).  Thus, while LTCH admissions tended to have 
the most comorbidities, IRFs hold the next highest number of comorbidity groups.   
Major Treatments at Discharge.  Another factor affecting medical status was whether the 
patient was being transferred with particular treatment needs that may require higher levels of 
nursing or other specialized treatment, such as respiratory therapy (Table 6-6).  One factor was 
whether the patient required hemodialysis at discharge or at any time during the stay.  These 
patients require additional resources in settings that do not commonly have hemodialysis 
equipment, such as SNFs.  In our sample, these cases were most common in LTCHs (10 percent 
of LTCH cases compared with 4 percent overall).  Being discharged with a ventilator was 
another intensive treatment examined.  Most of these cases were found in the LTCH sample 
(30 percent), although small numbers were found in the other settings, as well.  Total parenteral 
nutrition (TPN) was a third resource-intensive treatment at discharge, again primarily found in 
those discharged to the LTCHs (8 percent).  
Length of stay in the intensive care unit (ICU) during the acute hospital stay is associated 
with case complexity.  In this sample, LTCH admissions were most likely to have had an ICU 
stay of at least 7 days (15 percent).    
Skin Integrity.  Skin integrity is another major factor associated with different treatment 
needs.  Included in this analysis is a measure of having a severe pressure ulcer (stage 3, 4, 
unstageable or a stage 2 present for more than 1 month).  In this sample, the severe pressure 
ulcers tended to be found in the LTCH (15 percent of these cases).  
6.3.1.3 Cognitive Status by Setting 
Depression.  About 22 percent of the sample population had a symptom of depression 
(Table 6-7).  Depression was most frequently associated with cases discharged to IRFs and 
SNFs (26 percent of patients in each setting).  About 20 percent of the LTCH cases also reported 
signs of depression.  It appears that these patients were distributed fairly evenly across settings, 
but generally were less likely to go home, either with no services (14 percent) or with home 
health (19 percent).   
Temporal Orientation.  While the majority of patients had no or minimal/borderline 
impairment in terms of temporal orientation (70 percent), 16 percent suffered from moderate 
impairment and 15 percent from severe impairment.  Among patients discharged home with no 
services, 50 percent were categorized as least impaired, while 46 percent may have moderate 
impairments.  Those discharged home with home health had a higher proportion in the healthiest 
group (79 percent), while those discharged to LTCHs were the most impaired (41 percent in the 






Impairments.  Table 6-8 shows patient functional impairment at the time of discharge 
from acute care.  Forty-two percent of the patient sample had a history of falls, and these patients 
were common in discharge to both the SNF setting, at 52 percent, and the IRF setting, at 
46 percent.  Bladder incontinent patients were notably higher in proportion in the LTCH 
(69 percent) than in comparable settings.  This is also true of patients with an indwelling bowel 
device, with a 16 percent LTCH representation in comparison with 2-7 percent in other settings.  
While 45 percent of the LTCH patients had swallowing impairments that required no oral intake 
(NPO) at transfer, only 6 percent of the LTCH cases had swallowing difficulties such as 
coughing or choking; patients at this level of impairment were most commonly seen in an IRF 
(11 percent).  This difference in impairment level highlights the differences seen across settings.  
When comparing communication, respiratory status, and sitting/mobility endurance, the 
most severely impaired patients in all three categories were most likely to appear in the LTCH 
setting (29 percent, 60 percent, and 80 percent, respectively).  Furthermore, having oxygen at 
discharge was more frequently associated with a higher proportion of cases in the LTCH group 
than in any other setting (14 percent).  Again, this highlights the more complicated nature of 
patients found in LTCHs.  
Functional Status.  Table 6-9 illustrates functional status in terms of self-care, mobility, 
and motor Rasch scores by setting.  Self-care, mobility, and motor status, over all cases, have 
similar means, at 44.78, 44.71, and 44.81, and medians of 45.06, 44.02, and 44.57, respectively.  
Patients who went home without services after acute care consistently score the highest means at 
time of transfer across the three functional statuses.  These patients also have some of the highest 
scores across the 95th percentile.  Similarly, patients who were discharged to home health have 
higher mean and median functional scores at admission compared to patients discharged to other 
settings.   
While patients discharged to the IRF settings have the lowest scores at admission in the 
95th percentile across settings, patients in the LTCHs have the lowest overall mean and median 
scores, with means ranging from 28.06 (self care) to 29.69 (mobility), and medians ranging from 
29.31 (self care) to 30.59 (mobility).  LTCH cases also have the lowest motor Rasch 5th 
percentile score across settings, at just 1.77.  Comparatively, 5th percentile functional scores for 
other settings span from 15.13 (mobility; SNF) to 35.72 (motor; home health).  This illustrates 
the range of patients admitted to each setting.  On an unadjusted basis, functional scores in IRFs 
and SNFs are similar, although IRF patients are slightly lower.  LTCH patients clearly have the 
lowest average functional scores at transfer; those who are discharged home, either with services 
or without, have the highest functional scores.  
6.3.2 Multivariate Results 
Four sets of multivariate models were examined to consider the relative contributions of 
different factors in predicting the probability of using any service within 30 days (Any PAC) 
compared with receiving no services; the relative odds of being discharged to each of the four 
PAC settings compared with the odds of being discharged home without a PAC services; and the 





The three bivariate models predicting (Any PAC model, IRF/SNF model, and SNF/HHA 
model) are based on logistic regression models to predict the probability of use within 30 days of 
an acute discharge.  The fourth model in this analysis, the First PAC model, is a multinomial 
logistic regression predicting the relative odds of discharge to each type of PAC service 
compared with no inpatient PAC or HHA services.  
We used the SAS command PROC SURVEYLOGISTIC, which fits linear logistic 
regression models for data on the basis of complex sample design using pseudomaximum 
likelihood methods and incorporates the sample design into the analysis.  Because patients in the 
same facility or receiving services from the same provider are likely to be more similar and 
receive more similar services than patients receiving services from different providers, the 
analyses took into account clustering at the provider level.   
The samples differed in each of the models.  The first logistic model predicting 
ANYPAC contrasted those discharged home without services to those using any of the four PAC 
services or those listed in the “other” category.  The multinomial model excluded the “other” 
cases and used the rest of the patients in our sample.  The two setting-specific comparisons were 
based on cases discharged to one of the two relevant settings.   
Model results are reported below as odds ratios (OR), which are the ratio of the odds of 
PAC use for patients with a characteristic over the ratio of the odds of PAC use for patients with 
the referent characteristic.  ORs have been interpreted here as risk.  An OR greater than 1.00 for 
a particular characteristic is associated with a greater likelihood and an odds ratio of less than 
1.00 is associated with a lesser likelihood of using the service.   
Pseudo R-squares are presented as model fit statistics to help explain the proportion of 
the variance explained by the model.  The scales range from 0 to 1, with higher numbers 
indicating more explanatory power.  Table 6-12 shows the pseudo-R-squares for the four 
models.  Notably, the ANYPAC model explains 34 percent of the variation in predicting whether 
PAC services are used.  The multinomial model predicting which, if any, PAC services are used 
explained the most variation (47 percent).  The other two models, which examined the factors 
associated with IRF or HHA use relative to SNF use, explained almost as much variation 
(38 percent and 40 percent, respectively). 
6.3.2.1 Multivariate Results Associated With the Any PAC Model  
Table 6-13 shows the results from the two models analyzing the odds of PAC use 
(ANYPAC) and the odds of using each type of PAC relative to no PAC at discharge 
(FIRSTPAC).  The first two columns show findings related to the Any PAC model, which 
predicts the probability of PAC use (LTCH, IRF, SNF, HHA, or other service) relative to not 
using one of those services within 30 days for all patients.  About 34 percent of the variation in 
Any-PAC models was explained by the variables included in the models.3  
                                                 
3  Note that for the purposes of the discussion of the Any PAC model, the phrase “any PAC” may refer to services 




Demographics/Insurance Status.  Three demographic factors were tested for their 
association with the use of any PAC relative to not receiving services within 30 days after 
discharge.  The odds of using PAC or other services increased with age after 75 years of age but 
were relatively lower for the younger-than-65 population.  No significant differences were found 
between Black/African Americans and others in their odds of using PAC.  Similarly, no gender 
differences were significant in the odds of using PAC.  Having Medicaid as a secondary payer 
was associated with lower odds of using PAC (OR: 0.50, p < 0.0001). 
Medical Status.  The odds of using PAC also varied by several medical status factors.  
Each of the 11 primary diagnosis groups in the model was significantly less likely to use PAC 
than the referral category of orthopedic/musculoskeletal cases, with the exception of 
cardiovascular and transplant cases, which were not significantly different from orthopedic 
cases.  In other words, the odds of a cardiovascular or transplant case using PAC was similar to 
the odds of an orthopedic case.  Having had a surgery in the hospital before discharge was 
associated with significantly lower odds of using PAC (OR: 0.44, p < 0.0001).  This may be due 
to healthier patients undergoing surgery, all else equal.  
Comorbid conditions, as noted by the hierarchical condition category (HCC) groups, 
were also largely significant.  Having one of the specified comorbid conditions was generally 
associated with much higher odds of being discharged to PAC than someone without this 
comorbid condition.   
Those discharged from the acute hospital on a ventilator had significantly higher odds of 
using PAC.  
Mood/Cognitive Status.  Mood/cognitive status factors were included in the models.  
Having signs or symptoms of depression as noted by the Patient Health Questionnaire (PHQ-2) 
items on sadness or the presence of a comorbid diagnosis of depression was associated with 
higher odds of using PAC.  
Functional Status and Impairments.  The model also controls for numerous impairments 
in considering the odds of discharge to each PAC setting.  NPO status was associated with 
somewhat high odds of using PAC.  Having a moderate communication problem, in either 
expression or understanding verbal content, was associated with almost 2 times greater odds of 
being discharged to PAC.   
Premorbid Status: Lived Alone in Community Before Illness. Living alone in the 
community before this hospital admission was also associated with higher odds of being 
discharged to PAC.  
Provider Market.  The last section of the model controlled for each of the market areas to 
examine whether market “richness” and variations in referral patterns had an effect after 
controlling for patient characteristics.  The reference market was Boston, which has a high level 
of availability for types of PAC.  The results show that after controlling for patient 
characteristics, the market area was not significantly associated with whether to use any PAC.4 
                                                 




This may reflect the availability of some PAC in each market, although the types of PAC 
services varied across markets.  
6.3.2.2 Multivariate Results Associated With the First PAC Model  
Table 13 also shows the results from the multinomial model that separately examines the 
odds of being admitted to HHA, SNF, IRF, or LTCH within 30 days after leaving the hospital 
compared with the reference group of being discharged without a referral to one of these four 
services.  About 47 percent of the variation in the FirstPAC model was explained by the 
variables included in the model. 
The odds ratios presented in the tables show the odds of a patient with that characteristic 
being discharged to a given setting relative to going home with no services, holding all other 
variables in the model constant.  While the odds are expressed in comparison to no services, the 
relative odds between the PAC settings can be examined by first noting whether a factor was 
significantly associated with that setting and, if so, examining the direction and relative 
magnitude of the factor compared with other settings.    
In examining the results associated with the First PAC model, it is important to keep in 
mind that these factors are indicative of the types of cases discharged (or admitted) to each 
setting within our sample.  They are not conclusive, but they highlight similarities and 
differences among the populations admitted to each setting after acute hospital discharge.  Most 
notably, many of the factors are significantly associated with more than one setting.  This 
suggests that the types of cases treated in each setting are not mutually exclusive.  The odds of a 
patient being admitted with a particular characteristic may differ by setting but where significant, 
the factor is associated with that setting.  
Demographics/Insurance Status.  Three demographic factors were tested for their 
association with using each type of PAC relative to going home without services.  As found in 
the model predicting ANYPAC, older patients have higher odds of using HHA, SNF, and IRF 
services, but there was no significant difference in age across the LTCH admissions relative to 
the non-PAC users in this sample.  This likely reflects the two groups’ both having higher 
numbers of the youngest and oldest populations in addition to the two middle age groups.  
No significant differences were associated with being Black/African American relative to 
others in their odds of using each type of PAC.  Males were more likely than females to be 
discharged to an IRF or an LTCH than go home without services (OR: 1.52, p < 0.0001, (OR: 
1.37, p < 0.01, respectively).  Having Medicaid as a secondary payer was associated with lower 
odds of using any of the four settings.  
Medical Status.  The odds of using each type of PAC also varied by several medical 
status factors.  The odds of using each type of service for each condition relative to the 
orthopedic/musculoskeletal cases’ odds differed across primary conditions.  Neurologic cases 
were less likely than orthopedic cases to use HHA and SNF services, although the odds of using 
IRFs and LTCHs were not significantly different from the orthopedic cases.  Respiratory cases 
had odds that were over 3 times greater for using LTCHs and significantly lower for using the 
other three services.  Cases with a primary diagnosis of infections also had much higher odds of 




p < 0.001, respectively.)  Having had a surgery in the hospital before discharge was also 
associated with significantly lower odds of using any of the PAC settings.  This may be due to 
healthier patients undergoing surgery, after controlling for all the other patient characteristics.  
Comorbid conditions, as noted by the HCC groups, were also largely significant.  Having 
one of the specified comorbid conditions was generally associated with almost 2 times (or 
higher) greater odds of being discharged to any one of the PAC settings than someone without 
this comorbid condition.  Interesting to note is the difference in the relative odds of using each 
service given a specific comorbidity.  While people with comorbid liver conditions had odds that 
were over 2 times greater for their use of HHA (OR: 2.48, p < 0.0001), SNF (OR: 2.85, 
p < 0.0001), or IRF services (OR: 2.89, p < 0.0001), the odds were nearly double that to be 
discharged to LTCHs (OR: 4.50, p < 0.0001).   
The comorbid conditions with the highest odds of being discharged to HHA were 
diabetes (OR: 2.74, p < 0.0001), orthopedic (OR: 4.27, p < 0.0001), and stroke (OR: 3.89, 
p < 0.0001).  Those with the highest odds of being discharged to SNF include the orthopedic 
comorbidities (OR: 6.98, p < 0.0001), stroke (OR: 4.54, p < 0.0001), and cellulitis (OR: 3.89, 
p < 0.0001).  Among the IRF admissions, the comorbid conditions with the highest odds of use 
included orthopedic (OR: 6.61, p < 0.0001), stroke (OR: 11.33, p < 0.0001), head and spine 
conditions (OR: 5.35, p < 0.0001), and cellulitis (OR: 4.90, p < 0.0001).  For those discharged to 
the LTCH, the odds were higher than the odds for other PAC settings for most types of 
comorbidities in the list.  The exceptions were for those with orthopedic comorbidities, where the 
odds were comparable to HHA (OR: 4.18, p <0.0001) but lower than SNF or IRF and other 
neurological comorbidities (OR: 1.70, p < 0.01), which was lower than the odds of using any of 
the other PAC settings.  Comorbidities of stroke were slightly higher odds for LTCH (OR: 4.20, 
p < 0.0001) than HHAs (OR: 3.89, p < 0.0001), equivalent to SNF (OR: 4.54, p < 0.0001) but 
much lower than the odds of being discharged to IRF (OR: 11.33, p < 0.0001).  Patients with a 
comorbidity of psychiatric conditions had higher odds of being discharged to SNFs (OR: 2.14, 
p < 0.0001) or LTCHs (OR: 2.64, p < 0.0001). 
Having certain types of high-intensity treatments during the acute hospital stay was also 
associated with higher odds of using the various types of PAC compared with no services.  
Those discharged from the acute hospital on a ventilator had significantly higher odds of LTCH 
use (OR: 11.67, p < 0.002).  Being on TPN at time of transfer was significant only in the odds of 
discharge to LTCHs (OR: 8.09, p < 0.01).  Having been in the ICU for at least 7 days during the 
hospital stay was associated with lower odds of being discharged to IRF: (OR: 0.26, p < 0.03).  
However, it had no significant association with the odds of being discharged to an LTCH after 
controlling for other patient characteristics.  
Severe pressure ulcers also were associated with higher odds of using certain services.  
Those who had a stage 3 or stage 4 pressure ulcer, or a stage 2 pressure ulcer that was over a 
month old, had odds that were 3 times greater of using LTCHs than going home without 
services.  No significant differences showed across the other settings after controlling for the 
factors in the model.  
Mood/Cognitive Status.  Mood/cognitive status factors were included in the components 




on sadness or the comorbid diagnosis of depression was associated with about 2 times the odds 
of discharge to SNF, IRF, and LTCH, although the odds of using HHA were slightly lower (OR: 
1.59, p <.0001).   
Temporal orientation was also included in the models to test the association between 
knowing the month and year during the hospital stay.  Those with a moderate impairment were 
significantly less likely to use each of the four PAC settings than those without impairments.   
Functional Status and Impairments.  Having a history of falls is associated with 
increasing the odds of discharge to SNF (OR: 1.60, p < 0.001).  Two functional status subscales 
were also included in the model.  Because of nonlinearity, the scales were entered both in their 
natural form and squared.  The first scale on self-care was positively associated with discharges 
to both SNFs and IRFs and somewhat negatively associated in the squared term, highlighting the 
nonlinear but significant effect on discharge to these two settings.  The second scale was 
mobility, and it also had a positive relationship with HHA and IRF, as well as a significant but 
minor effect on the squared term associated with these two settings.  This suggests that after 
controlling for the other patient characteristics, self-care at hospital discharge and mobility at 
discharge are significantly associated with the odds of using these types of PAC.   
The model also controls for numerous impairments in considering the odds of discharge 
to each PAC setting.  Bladder and bowel impairments were positively associated with discharge 
to LTCHs.  The use of an indwelling bowel catheter was associated with 3 times greater odds of 
being discharged to an LTCH (OR: 3.24, p < 0.0001) and nearly as high an odds of going to IRF 
(OR: 2.41, p < 0.01).  Bladder incontinence was associated with slightly higher odds of being 
discharged to an LTCH. 
Not taking food by mouth (NPO) at time of transfer was associated with discharge to a 
SNF or IRF, with odds 2 times greater for those with this impairment (OR: 2.007, p < 0.01 and 
OR: 2.42, p < 0.01, respectively) and over 6 times greater for discharge to an LTCH (OR: 6.44, 
p < 0.0001). 
Having a moderate communication problem, in either expressing or understanding verbal 
content, was associated with almost 2 times greater odds of being discharged to the HHA, IRF, 
and LTCH settings, although it was slightly lower but still positive odds for discharge to SNF.  
Relatively speaking, these types of cases had the highest odds of being discharged to an IRF 
(OR: 2.68 p < 0.0001). 
Respiratory status was also significant in predicting PAC use.  A moderate impairment 
was associated with a 3 times higher odds of using HHA (OR: 3.14, p < 0.0001), while severe 
impairment status was not significantly different in predicting HHA discharge compared with no 
services.  In contrast, for LTCHs, patients with moderate levels of respiratory impairment were 
only half as likely to use LTCH (OR: 0.44, p < 0.01).  However, being severely impaired was 
associated with higher odds of being discharged to an LTCH (OR: 1.62, p < 0.04), even after 
controlling for primary medical diagnosis and comorbid conditions.   
Sitting and mobility endurance were also examined as factors associated with discharge 




without support or walk or wheel 50 feet.  Having no endurance at time of transfer was 
associated with higher odds of using LTCH (OR: 3.32, p < 0.0001).  Having some endurance 
limitations was associated with HHA use after controlling for the other factors in the model (OR: 
1.89, p < 0.0001). 
Premorbid Function.  Two measures of self-reported prior functioning were included in 
the models.  Those with severe limitations before this spell of illness had higher odds of using 
HHA, while having some limitations was associated with slightly lower but positive odds of 
using HHA (OR: 2.22,p < 0.0001, and OR: 1.55, p < 0.0001, respectively.)  The severe prior 
functional limitations cases had lower relative odds of being discharged to IRFs and LTCHs.  
Having some limitations was associated with SNF use (OR: 1.56, p < 0.0076), but severe 
limitations were not significant in this population.   
Premorbid Status: Lived Alone in Community Before Illness.  Living alone in the 
community before this hospital admission was also associated with higher odds of using SNF 
and IRF (OR: 1.70, p < 0.0001, and OR: 1.70, p < 0.0001, respectively).   
Provider Market.  The last section of the model controlled for each of the market areas to 
examine whether market “richness” and other market factors had an effect after controlling for 
patient characteristics.  We will not interpret the coefficients in Table 6-13 because they are 
market level effects capturing many differences between the markets including availability of 
providers of each type in the sample, referral patterns, and the characteristics of the specific 
providers. 
6.3.2.3 Patient Characteristics Associated With IRF Use and HHA Use Relative to SNF 
Table 6-14 shows the results of two logistic regressions related to the SNF/IRF model 
and SNF/HHA model.  The models are useful for identifying the patient characteristics that may 
be disproportionately associated with one setting or the other.  For example, the population of 
patients with moderate impairment in communication is treated and “common” in both IRFs 
(35 percent) and SNFs (26 percent).  At the same time, while these types of patients are treated in 
both settings, after controlling for the other variables in the model, a patient with this status is 
statistically more likely to be treated in an IRF than a SNF.  The same medical, functional, 
cognitive, and supply factors are included in these two models as in the earlier models.  As in all 
regression models, the coefficient associated with each variable represents the impact of that 
factor, holding all other factors constant.   
The first model (SNF/IRF) predicts whether a patient having each characteristic has 
significantly different odds of using IRF (coded as 1) than using SNF (coded as 0).  This model 
had a pseudo R-square of 0.37, explaining 37 percent of the variation in this model.  The second 
model predicts whether a patient having each characteristic has a significantly different odds of 
using HHA (coded as 1) than using SNF (coded as 0).  This model had a pseudo R-square of 
0.40, explaining 40 percent of the variation in this model.  The analysis focuses on the first site 
of care within 30 days after hospital discharge.  Discharge patterns associated with community 
entrant or PAC-to-PAC transfers were not examined. 
Demographics/Insurance Status.  Age showed significant differences in the odds of being 




likely than the 65- to 74-year-old population to be discharged to the IRF than to the SNF (OR: 
1.43, p < 0.01).  However, the older populations (75-84 and 85 years and above) were 
significantly less likely to be discharged to either an IRF or HHA than to a SNF (OR: 0.66, 
p < 0.0001, OR: 0.44, p < 0.0001).  Males were more likely than females to be discharged to an 
IRF instead of a SNF (OR: 1.48, p < 0.0001), although there were no significant differences in 
their relative probability of being discharged to a HHA rather than a SNF.  Similarly, no 
significant differences in discharge to a SNF versus IRF or HHA were found for patients with 
Medicaid as a secondary payer source.  
Medical Status.  The relative probability of being discharged to an IRF compared with a 
SNF varied somewhat by primary diagnosis group.  In general, the only patients with a higher 
probability of being discharged to an IRF than the reference orthopedic group were those with a 
primary diagnosis in the acute hospital of a neurologic condition (OR: 2.61, p < 0.0001).  The 
rest of the condition groups were less likely than orthopedic groups to go to an IRF than a SNF, 
all else equal.  This includes cases that had been hospitalized with integumentary conditions 
(OR: 0.33, p < 0.01), kidney and urinary conditions (OR: 0.31, p < 0.0001), infections (OR: 0.51, 
p < 0.01), GI and hepatobiliary conditions (OR: 0.38, p < 0.0001), and hematologic conditions 
(OR: 0.43, p < 0.07).  This highlights the differences in the types of cases discharged to SNFs 
compared with IRFs, with the former being more medical in nature.  No significant differences 
in the odds of use between IRF and SNF appeared for the cardiovascular populations.   
In contrast, many of the primary conditions showed no significant difference between 
being discharged to a HHA rather than a SNF.  The exceptions were those with respiratory 
conditions (OR: 1.49, p < 0.033), transplant cases (OR: 8.65, p < 0.02), GI and hepatobiliary 
diagnoses (OR: 1.67, p < 0.01), and other types of cases not otherwise categorized that had 
higher odds of being discharged to a HHA than a SNF.   
Surgery in the prior hospital stay did not differentiate a significant difference in the 
probability of being discharged to either IRF or HHA relative to SNF.   
Interestingly, certain comorbid conditions were associated either positively or negatively 
with the use of SNF relative to IRF or HHA.  Most comorbid conditions that were positively 
associated with IRF use relative to SNF use were also negatively related to HHA use relative to 
SNF use, suggesting a hierarchy in the likelihood with which these settings may be treating cases 
with certain comorbid conditions, after controlling for primary conditions.  The one case where 
this did not hold was in comorbid liver conditions.  These patients were less likely to use HHA 
than SNF (OR: 0.81, p < 0.0255), but there were no significant differences in their probability of 
being discharged to an IRF compared with a SNF.  Diabetes had no significant effect on the 
probability of using either the IRF relative to the SNF or the HHA relative to the SNF, although 
other endocrine comorbidities were associated with a higher probability of being discharged to 
IRF (OR: 1.18, p < 0.0246) and a lower probability of being discharged to HHA (OR: 0.68, 
p < 0.0001) than to SNF.  Having comorbid orthopedic or musculoskeletal conditions was 
associated with a lower probability of using HHA than SNF (OR: 0.69, p < 0.0009) but had no 
effect on the relative use of IRF to SNF.   
Cases with a comorbidity of other neurological conditions had a higher probability of 




of stroke were almost 2.5 times more likely to be discharged to an IRF than a SNF (OR: 2.41, 
p < 0.0001).  Similarly, cases with a comorbidity of cardiovascular conditions were more likely 
to be discharged to an IRF than a SNF (OR: 1.45, p < 0.0001) and less likely to be discharged to 
a HHA rather than a SNF (OR: 0.76, p < 0.0045).  Those with a comorbidity of cellulitis were 
also less likely to be discharged to HHA relative to SNF (OR: 0.57, p < 0.01).  Comorbidities of 
head and spine conditions were also associated with a higher probability of being discharged to 
an IRF than a SNF (OR: 3.26, p < 0.0001), and those with comorbid psychiatric conditions were 
significantly less likely to be discharged to HHA than SNF (OR: 0.78, p < 0.05). 
Patients varied in the odds of their being discharged to SNFs relative to IRFs and HHAs 
if they were discharged with certain major treatment needs.  Receiving hemodialysis treatments 
was associated with a lower odds of HHA use (OR: 0.33, p < 0.0057) but had no significant 
effect on the relative use of IRF and SNF care.  Ventilator use (weaning or nonweaning) at 
transfer also had no effect on the difference between IRF and SNF, but patients with these needs 
were much more likely to be discharged to HHA than SNF, although the significance level was 
marginal (OR: 3.2, p = 0.08). 
Cognitive Status. No significant differences were observable in the odds of being 
discharged to an IRF relative to a SNF for patients who had signs or symptoms of depression.  
However, patients with these symptoms were significantly less likely to be discharged to a HHA 
(OR: 0.65, p < 0.000). 
Temporal orientation also had an effect in some cases.  Knowing the month and year was 
a distinguishing factor in predicting discharge destination.  Those with any impairment 
(moderate or severe) were significantly less likely to be discharged to an IRF than a SNF (OR: 
0.31, p < 0.0057, OR: 0.604, p < 0.0357, respectively).  However, those with moderate 
impairments were much more likely to be discharged to HHA than to SNF (OR: 3.72, 
p < 0.0298), although the severely impaired were significantly less likely to be discharged to 
HHA than SNF (OR: 0.70, p < 0.05). 
Functional Status and Impairments. As noted in the earlier models, patients with a 
history of falls were significantly more likely to be discharged to a SNF than to other settings.  
These cases had lower odds of being discharged to an IRF (OR: 0.73, p < 0.02) or to HHA (OR: 
0.61, p < 0.0001) than to SNF, all else equal. 
Because of greater likelihood of functional limitations in both self-care and mobility in 
the more impaired rehabilitation patients, a motor scale was used to test the difference between 
SNF and IRF patients.  The motor scale and the squared term on the motor scale were both 
significant.  The results suggest that those with a higher motor scale are more likely to be 
discharged to an IRF and that effect is mildly curvilinear, suggesting it may change at different 
levels of impairment.  Comparisons of HHA to SNF patients show that patients with higher self-
care scores are less likely to be discharged to HHA (OR: 0.90, p < 0.0001) and that those with 
higher mobility scores are more likely to be discharged to HHA than SNF (OR: 1.08, 
p < 0.0035). 
The effect of impairments varied across the two models.  Having an indwelling bowel 




2.42, p < 0.01) but had no effect on the odds of being discharged to HHA relative to SNF.  
Similarly, having signs of difficulty swallowing was associated with a somewhat higher odds of 
being discharged to an IRF than to a SNF (OR: 1.41, p < 0.0616) but was not significant between 
HHA and SNF use.  Having a moderate communication impairment was also associated with a 
higher odds of being discharged to an IRF than a SNF (OR: 1.64, p < 0.01), but severe 
impairment was not significant.  Neither level of communication impairment was significant in 
being discharged to HHA rather than SNF. 
Respiratory status impairments varied in whether they affected the odds of discharge to 
IRF or HHA relative to SNF.  Those with a moderate respiratory impairment had a much higher 
odds of being discharged to HHA than SNF (OR: 3.27, p < 0.0001) and were moderately 
significant for severe impairment (OR: 1.31, p < 0.07).  In the IRF/SNF model, moderate 
respiratory impairment was not a statistically significant predictor, but the severe respiratory 
impairment population had higher odds of being discharged to an IRF than a SNF (OR: 1.54, 
p < 0.001).   
Endurance also had differing effects.  Those with the greatest impairments (no 
endurance) had lower odds of being discharged to an IRF than a SNF (OR: 0.70, p < 0.03), 
although there was no significant difference in the odds of their being discharged to an HHA 
relative to SNF.  Those who could sit with support or walk 50 feet with rest had higher odds of 
being discharged to a HHA than a SNF (OR: 1.46, p < 0.02) and no significant difference in their 
odds of being discharged to IRF relative to SNF.  Again, these factors suggest overlaps in the 
populations using these services although the groups that overlap between the IRF and the SNF 
may be different from those that overlap between the HHA and the SNF. 
Premorbid Function.  The results suggest that patients with severe premorbid limitations 
had lower odds of being discharged to an IRF than to a SNF (OR: 0.21; p < 0.0001) and higher 
odds of being discharged to HHA than to a SNF (OR: 1.75, p < 0.000).  Those with some 
limitations before this admission had lower odds of being discharged to an IRF than to a SNF 
(OR: 0.57, p < 0.01). 
Premorbid Status: Lived Alone in Community Before Illness.  Those who lived alone in 
the community before their admission for this illness were less likely to be discharged to HHA 
than to SNF (OR: 0.57, p < 0.0001) than those who did not live alone in the community before 
this illness. 
Provider Market. Market area had few effects on the odds of using IRF or HHA relative 
to SNF after controlling for patient characteristics.  The two exceptions were in the Dallas 
market where, all else equal, patients were almost 19 times more likely to be discharged to an 
IRF than a SNF (OR: 18.96, p < 0.01) and seven times more likely to use HHA than a SNF 
(OR: 7.76, p < 0.01).  There were differences in the Columbia market as well between the odds 
of IRF and SNF use, with IRF use being not observed because there were no IRFs in the 
Columbia market sample. The only other market-level difference after controlling for patient 
characteristics was in Wilmington, North Carolina, where patients had a higher odds of being 
discharged to HHA than SNF, all else equal, although the significance level is marginal on this 





These results provided important information on the types of cases being treated in each 
PAC setting or going home without PAC.  As shown in earlier work (Gage et al., 2009), the 
majority of hospital discharges go home without PAC (65 percent of admissions).  However, 
among those who are transferred to PAC, it has been difficult to compare the cases because of 
limited information on primary diagnoses and comorbidities.  Earlier work has suggested that the 
medical complexity (or in the case of rehabilitation patients, the functional/medical complexity) 
of cases admitted to each setting differs, but data allowing empirical analysis of these issues 
across settings have been missing.  While the results of this study reflect the oversampling of the 
PAC populations, particularly the types of cases treated in LTCHs and IRFs, the information 
about the relative significance of each factor, and the direction of the impact as increasing or 
decreasing the odds of using each service, are important findings.  
These analyses do not answer the question of where patients should go, but instead 
examine the existing patterns of care given the regulations and incentives currently in the 
marketplace.  The models showed the types of patients treated at each setting.  On average, after 
controlling for receiving services in a high or low PAC area, the types of patients treated in each 
of the four settings had areas of overlap in their characteristics.  Notably, the results showed that 
medical cases were more likely to be discharged to HHA, SNF, and LTCH while postsurgical 
cases typically needing physical rehabilitation tended to be discharged to IRFs, SNFs, and 
HHAs.  While the complexity of patients using each PAC setting tended to differ across settings, 
the results suggest that the populations using PAC also appeared to overlap in the types of 
conditions and impairments being treated.  Medical factors, such as primary diagnosis in the 
acute hospital, were important but not sufficient for predicting subsequent PAC use.  
Comorbidities played an important role in identifying the difference in the potential complexity 
of cases treated in each setting.  For example, the odds were greatest for the LTCH setting when 
more medical comorbidities were present.  However, when the comorbidities were the type that 
required therapy services, such as orthopedic/musculoskeletal conditions and the neurological 
conditions, patients had higher odds of IRF use or SNF use.  Patients with a comorbidity of 
stroke had significantly higher odds of going to PAC than going home without services at 
discharge, and substantially higher odds of being transferred to an IRF than to any of the other 
PAC settings.  Similarly, cases with higher medical resource needs—such as being discharged on 
a ventilator, requiring hemodialysis, or being discharged with TPN—were all associated with 
greater odds of being discharged to an LTCH.  Interestingly, after controlling for the other 
factors in the model, having had an intensive care unit stay longer than 7 days did not increase 
the odds of going to an LTCH.  This suggests that these better measures of medical complexity 
may be useful in replacing resource use in the models.   
Most importantly, each of the PAC settings had a higher probability of admitting most of 
these cases than having them be discharged home without further services.  This underscores the 
importance of examining treatment outcomes and resource intensity associated with treating 
these cases in the different PAC settings.   
Functional status was also an important factor in explaining site of care.  While IRF 
patients frequently have falls problems, the models suggest that after controlling for the other 




discharged to an IRF.  However, falls history is significantly associated with higher odds of 
being discharged to a SNF, all other patient characteristics equal.  This is consistent with the self-
care and mobility score results being curvilinear in nature.  In other words, while the SNF and 
IRF have significantly higher odds of taking patients with higher self-care scales, the scale is 
curvilinear and negative, suggesting that patients have a lower likelihood of being discharged to 
these settings once the self-care score is too high.  Similar results are shown with mobility 
scores, although the two settings with the higher odds of accepting patients with higher scores at 
admission are HHA and IRF—but again, these scales reach a point where the patient is 
significantly less likely to be admitted to these settings as the mobility scale increases.  And as 
with the medical characteristics, these factors are significant in more than one setting, 
underscoring the overlap in patients admitted to the different sites of care. 
Cognitive impairments were also significantly associated with PAC use.  Depression was 
associated with higher odds of using all four PAC settings, although HHA to a lesser degree.  
The last two comparisons allowed better drilling down of the characteristics associated 
with treatment at each setting.  It was notable that IRF patients had significantly different 
primary diagnosis and comorbidities but similar odds for receiving a patient with the more 
complicated medical resource needs.  However, the models also showed that many of the 
primary diagnoses may not be significantly different, either being absent in both, or overlapping 
between the IRF and SNF.  Similarly, SNF-to-HHA comparisons showed the opposite, with 
HHA patients having lower odds than SNF patients for having patients with many of the more 
medical complex factors, although this is a relative finding and not suggestive that these cases 
are not also treated in HHAs.  Functional status clearly differed as well after controlling for all 
other factors.  These results were consistent with those in the multinomial FirstPAC results.   
The role of HHA in treating some of the more chronic populations was also notable.  
After controlling for primary diagnosis and comorbidities, the cases with severe respiratory 
status impairments and those with limited endurance (could endure with support or rest) had 
higher odds of being discharged to HHA than SNF.  However, cases with a history of falls had 
higher odds of being discharged to a SNF than HHA, supporting the concern over patient safety 
when discharging them to the home environment.   
Together, these results present a picture of the constellation of factors affecting patients 
in these settings.  Medicare patients are complex.  Unlike the younger, nondisabled populations, 
Medicare beneficiaries tend to have multiple factors affecting their general health status.  These 
analyses were useful for identifying some of the overlapping characteristics and beginning to 





Data source for discharge destination sample 
 First Destination Setting Total IPPS Discharge Sample PAC Admission Sample1 
Total 13,554 4,412 9,142 
LTCH 1,569 93 1,476 
IRF 3,763 248 3,515 
SNF 3,857 1,071 2,786 
HHA 2,186 821 1,365 
Home/No PAC2 1,719 1,719 N/A 
NOTE: N = 13,432. 
1  Cases in the PAC Admission Sample were restricted to cases admitted within 2 days of the 
Acute discharge.  
2 Home/No PAC= absence of LTCH, IRF, SNF, or HHA within 30 days discharge from 
hospital.  May include other services such as Part B therapy or Hospital readmissions. 










































64 years and under 1,803 13 449 26 285 13 382 10 304 20 278 7 105 21 
65-74 years  3,885 29 526 31 708 33 1,191 32 542 35 811 21 107 22 
75-84 years  4,774 36 472 28 761 35 1425 38 501 32 1,470 39 145 29 
85 years and above  2,970 22 251 15 414 19 702 19 208 13 1,256 33 139 28 
Total 13,432 100 1,698 100 2,168 100 3,700 100 1,555 100 3,815 100 496 100 
Race/ethnicity 
Non Black or African 
American 12,310 92 1,577 93 1,977 91 3,363 91 1,372 88 3,548 93 473 95 
Black or African 
American 1,122 8 121 7 191 9 337 9 183 12 267 7 23 5 
Gender 
Female  7,810 58 898 53 1,239 57 2,093 57 752 48 2,541 67 287 58 
Male 5,622 42 800 47 929 43 1,607 43 803 52 1,274 33 209 42 
Medicaid as secondary 
payer (FFS or HMO) 
No 11,975 89 1,384 82 1,989 92 3,392 92 1,320 85 3,526 92 364 73 
Yes 1,457 11 314 18 179 8 308 8 235 15 289 8 132 27 
NOTE: N = 13,432 
Age at acute hospital admission: this variable was coded into four groups (younger than 65 years, 65-74 years, 75-84 years, 85 years or older).  The reference group was 65-74 
years.  
Race:  this variable was coded into two groups (Black, not Black).  The latter was the reference group. 
Gender: this variable was coded into two groups (Male, Female).  The latter was the reference group. 
Medicaid as a secondary payer at Admission: this variable identifies whether the beneficiary had secondary insurance coverage under either Medicaid fee-for-service or managed 
care as specified during admission (yes/no).  The latter was the reference group. 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
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Neurologic 1,925 14 146 9 143 7 1,193 32 102 7 309 8 32 6 
Respiratory 2,259 17 338 20 318 15 249 7 810 52 417 11 127 26 
Cardiovascular 1,991 15 219 13 548 25 463 13 168 11 523 14 70 14 
Orthopedic 3,707 28 209 12 511 24 1,353 37 94 6 1,500 39 40 8 
Integumentary 284 2 53 3 61 3 24 1 40 3 98 3 † 0 
Endocrine 282 2 59 3 52 2 33 1 20 1 100 3 18 4 
Kidney & Urinary 543 4 105 6 84 4 59 2 21 1 233 6 41 8 
Infections 560 4 66 4 80 4 71 2 124 8 169 4 50 10 
Transplant 34 0 15 1 † 0 † 0 † 0 † 0 † 0 
GI & Hepatobiliary 1,114 8 346 20 226 10 94 3 110 7 270 7 68 14 
Hematologic 147 1 36 2 35 2 16 0 † 1 38 1 13 3 
Other 586 4 106 6 101 5 141 4 54 3 157 4 27 5 
† Indicates sample size of less than 11. 
NOTE: N = 13,432 
Primary Diagnosis Group: this variable was defined as the MS-DRG from the acute care claim corresponding to the CARE acute discharge assessment.  For cases included 
because of a PAC CARE assessment within 2 days of discharge from acute, the MS-DRG was derived from the claim for the acute hospital stay immediately before PAC 
admission.  (See Section 5, Table 5-1, for specific details on the PDG (Primary Diagnosis Groups). 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
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Primary Diagnosis Group 
(35 Groups) 
Neurologic, Stroke 992 7 32 2 49 2 736 20 48 3 113 3 14 3 
Neurologic, Surgical 344 3 29 2 17 1 227 6 35 2 32 1 † 1 
Neurologic, Medical 589 4 85 5 77 4 230 6 19 1 164 4 14 3 
Respiratory, Ventilator 
and Tracheostomy 884 7 23 1 27 1 109 3 656 42 51 1 18 4 
Respiratory, Surgical 121 1 11 1 29 1 30 1 19 1 27 1 † 1 
Respiratory, Medical 896 7 203 12 182 8 80 2 80 5 264 7 87 18 
Respiratory, COPD 358 3 101 6 80 4 30 1 55 4 75 2 17 3 
Cardiovascular, Vascular 
Surgical 304 2 30 2 61 3 93 3 41 3 72 2 † 1 
Cardiovascular, Cardiac 
Surgical 828 6 49 3 264 12 266 7 73 5 168 4 † 2 
Cardiovascular, General 256 2 57 3 63 3 30 1 11 1 72 2 23 5 
Cardiovascular, Vascular 
Medical 63 0 15 1 16 1 † 0 † 0 19 0 † 1 
Cardiovascular, Cardiac 
Medical 540 4 68 4 144 7 66 2 42 3 192 5 28 6 
Orthopedic, Minor 
Surgical 898 7 49 3 66 3 362 10 48 3 361 9 12 2 
Orthopedic, Major 
Surgical 1,783 13 67 4 344 16 553 15 22 1 778 20 19 4 
Orthopedic, Spinal 475 4 36 2 36 2 283 8 10 1 109 3 † 0 
Orthopedic, Minor 
Medical 395 3 52 3 50 2 104 3 † 1 172 5 † 2 
Orthopedic, Major 
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Integumentary, Surgical 74 1 † 0 26 1 † 0 14 1 16 0 † 1 
Integumentary, Medical 210 2 46 3 35 2 17 0 26 2 82 2 † 1 
Endocrine, Surgical 35 0 † 0 † 0 † 0 11 1 † 0 † 1 
Endocrine, Medical 247 2 55 3 49 2 27 1 † 1 92 2 15 3 
Kidney & Urinary, 
Surgical 69 1 17 1 14 1 † 0 † 0 22 1 † 1 
Kidney & Urinary, 
Medical 474 4 88 5 70 3 54 1 15 1 211 6 36 7 
Infections, Surgical 162 1 14 1 23 1 26 1 57 4 29 1 13 3 
Infections, Medical 43 0 11 1 12 1 † 0 † 0 12 0 † 0 
Infections, Septicemia 355 3 41 2 45 2 43 1 63 4 128 3 35 7 
Transplant 34 0 15 1 † 0 † 0 † 0 † 0 † 0 
GI & Hepatobiliary, 
Minor Surgical 174 1 32 2 39 2 27 1 18 1 52 1 † 1 
GI & Hepatobiliary, 
Major Surgical 255 2 44 3 50 2 33 1 62 4 64 2 † 0 
GI & Hepatobiliary, 
Minor Medical 390 3 167 10 78 4 18 0 20 1 83 2 24 5 
GI & Hepatobiliary, 
Major Medical 295 2 103 6 59 3 16 0 10 1 71 2 36 7 
Hematologic, Surgical 30 0 † 0 † 0 † 0 † 0 † 0 — — 
Hematologic, Medical 117 1 31 2 27 1 † 0 † 1 30 1 13 3 
Other, Surgical 248 2 23 1 49 2 83 2 39 3 49 1 † 1 
Other, Medical 338 3 83 5 52 2 58 2 15 1 108 3 22 4 
† Indicates sample size of less than 11. 
NOTE: N = 13,432 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
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No 8,123 60 1,147 68 1,269 59 2,366 64 777 50 2,255 59 309 62 
Yes 5,309 40 551 32 899 41 1,334 36 778 50 1,560 41 187 38 
HCC: Diabetes 
No 9,733 72 1,380 81 1,417 65 2,665 72 1,134 73 2,766 73 371 75 
Yes 3,699 28 318 19 751 35 1,035 28 421 27 1,049 27 125 25 
HCC: Other EndoMet 
No 7,012 52 1,190 70 1,347 62 1,924 52 409 26 1,901 50 241 49 
Yes 6,420 48 508 30 821 38 1,776 48 1,146 74 1,914 50 255 51 
HCC: Ortho 
No 6,913 51 1,349 79 1,109 51 1,525 41 1,175 76 1,409 37 346 70 
Yes 6,519 49 349 21 1,059 49 2,175 59 380 24 2,406 63 150 30 
HCC: Other Neuro 
No 11,716 87 1,592 94 1,941 90 2,989 81 1,367 88 3,384 89 443 89 
Yes 1,716 13 106 6 227 10 711 19 188 12 431 11 53 11 
HCC: Cardiovascular 
No 9,336 70 1,445 85 1,575 73 2,647 72 410 26 2,896 76 363 73 
Yes 4,096 30 253 15 593 27 1,053 28 1,145 74 919 24 133 27 
HCC: Stroke 
No 11,118 83 1,612 95 1,972 91 2,428 66 1,295 83 3,373 88 438 88 
Yes 2,314 17 86 5 196 9 1,272 34 260 17 442 12 58 12 
HCC: Respiratory 
No 8,318 62 1,256 74 1,333 61 2,514 68 420 27 2,517 66 278 56 
Yes 5,114 38 442 26 835 39 1,186 32 1,135 73 1,298 34 218 44 
HCC: Acute/chronic renal 
No 10,397 77 1,432 84 1,768 82 3,040 82 816 52 2,985 78 356 72 
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HCC: Morbid Obesity 
No 12,805 95 1,655 97 2,068 95 3,521 95 1,426 92 3,651 96 484 98 
Yes 627 5 43 3 100 5 179 5 129 8 164 4 12 2 
HCC: UTI 
No 10,369 77 1,544 91 1,889 87 2,565 69 1,054 68 2,940 77 377 76 
Yes 3,063 23 154 9 279 13 1,135 31 501 32 875 23 119 24 
HCC: Cellulitis 
No 12,709 95 1,648 97 2,062 95 3,533 95 1,374 88 3,615 95 477 96 
Yes 723 5 50 3 106 5 167 5 181 12 200 5 19 4 
HCC: Head and Spine 
No 12,766 95 1,669 98 2,125 98 3,331 90 1,449 93 3,714 97 478 96 
Yes 666 5 29 2 43 2 369 10 106 7 101 3 18 4 
HCC: Psych 
No 11,856 88 1,515 89 1,943 90 3,228 87 1,337 86 3,384 89 449 91 
Yes 1,576 12 183 11 225 10 472 13 218 14 431 11 47 9 
NOTE: N = 13,432  
Comorbidities: this includes a set of comorbidity indicator variables based on the secondary hospital diagnoses and the PAC diagnoses on the associated claims.  ICD-9s were 
grouped into modified hierarchical condition categories: Examples include Liver, Diabetes, other endometrial, orthopedic, stroke, other neuro, cardiovascular, respiratory, 
cellulitis, morbid obesity, head and spine, psychiatric, renal, and urinary tract infections.  (See Section 5, Table 5-2 for an explanation of the modified HCC groupings). 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
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Major Treatments at 
Transfer  
Any Hemodialysis 
No Hemodialysis 12,918 96 1,590 94 2,133 98 3,625 98 1,403 90 3,703 97 464 94 
Hemodialysis, Stay/ 
Discharge 514 4 108 6 35 2 75 2 152 10 112 3 32 6 
Any vent (wean or 
nonwean) at transfer 
No 12,928 96 1,690 100 2,163 100 3,692 100 1,090 70 3,807 100 486 98 
Yes 504 4 † 0 † 0 † 0 465 30 † 0 10 2 
TPN at transfer 
No 13,258 99 1,690 100 2,164 100 3,682 100 1,432 92 3,800 100 490 99 
Yes 174 1 † 0 † 0 18 0 123 8 15 0 † 1 
IPPS ICU Days >= 7 /<7 
days 
No 12,808 95 1,645 97 2,032 94 3,658 99 1,322 85 3,701 97 450 91 
Yes 624 5 53 3 136 6 42 1 233 15 114 3 46 9 
Other Acute Claim within 
Past 2 Months 
No 12,310 92 1,437 85 2,002 92 3,603 97 1,498 96 3,473 91 297 60 




Table 6-6 (continued)  


































Pressure Ulcers  
Severe Pressure Ulcer 
No 12,913 96 1,673 99 2,139 99 3,639 98 1,315 85 3,699 97 448 90 
Yes 519 4 25 1 29 1 61 2 240 15 116 3 48 10 
† Indicates sample size of less than 11. 
NOTE: N = 13,432 
Major Treatments: Indicates whether the patient had certain major treatments at discharge from the hospital or within two days of discharge from the hospital.  The specific 
treatments included hemodialysis (this also included those who received hemodialysis at any time during the stay), ventilator use (weaning or nonweaning), or TPN.  
ICU Days Greater Than 7 Days: Indicates whether the patient had an ICU stay of at least 8 days during the hospital stay. 
Other Acute Claim within Past 2 Months: this variable identifies whether the patient was in an acute hospital (other than the hospital stay being studied) in the prior two month 
window.  This measure was based on Medicare claims examinations. 
Pressure Ulcer: Indicates whether the patient had a severe (stage 3/4/unstageable) pressure ulcer or a stage 2 ulcer that was known to be present for more than 1 month at the time 
of discharge from the hospital or admission to the PAC setting. 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 









































No 10,466 78 1,468 86 1,757 81 2,752 74 1,246 80 2,831 74 412 83 
Yes 2,966 22 230 14 411 19 948 26 309 20 984 26 84 17 
Temporal Orientation 
Intact/Borderline Impairment 9,342 70 848 50 1,723 79 3,029 82 862 55 2,748 72 132 27 
Moderate 2,111 16 773 46 321 15 143 4 59 4 512 13 303 61 
Severely Impaired 1,979 15 77 5 124 6 528 14 634 41 555 15 61 12 
NOTE: N = 13,432 
Depression diagnosis: Indicates whether the patient was depressed during the discharge assessment window.  Depressed was defined as having scored any of the following on the 
discharge assessment: 1) little interest or pleasure in doing things more than half of the days (7-11 days) or nearly every day (12 -14 days) in the last two weeks, or 2) feeling 
down, depressed or hopeless more than half of the days (7-11 days) or nearly every day (12 -14 days) in the last two weeks, or having a comorbid diagnosis on the associated 
acute or PAC claim.  This indicator variable is coded yes/no; the latter is the reference group.  
Temporal Orientation: this three level variable indicates whether the patient had difficulty knowing the month or year at discharge from the hospital or admission to the PAC stay.  
It is a composite variable based on a combination of the Brief Interview for Mental Status (BIMS) items year and month, or if not answered, the observation of patient 
knowing a subset of the following: season, room location, staff names/faces, or that they are in a hospital, nursing home, or home.  The codes are:  
Intact or borderline: both month and year were answered correctly (year is correct; month is accurate within 5 day) or observation showed at least 3 items were correct 
Severely impaired: missed two years or more or missed month by more than one month or couldn’t answer (and did not have a communication deficit) or were observed to 
only know one or fewer of the observation items 
Moderately impaired: not missing and not in either of the above groups 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 








































History of Falls 
No 7,810 58 1,229 72 1,559 72 1,990 54 887 57 1,831 48 314 63 
Yes 5,622 42 469 28 609 28 1,710 46 668 43 1,984 52 182 37 
Bladder Incontinence 
Frequency 
No 8,429 63 1,364 80 1,682 78 2,201 59 481 31 2,441 64 260 52 
Yes 5,003 37 334 20 486 22 1,499 41 1,074 69 1,374 36 236 48 
Indwelling Bowel catheter 
No 12,778 95 1,664 98 2,127 98 3,512 95 1,305 84 3,711 97 459 93 
Yes 654 5 34 2 41 2 188 5 250 16 104 3 37 7 
Swallowing: NPO 
No 12,370 92 1,657 98 2,143 99 3,571 97 848 55 3,721 98 430 87 
Yes 1,062 8 41 2 25 1 129 3 707 45 94 2 66 13 
Swallowing: sign/symptoms   
No 12,507 93 1,640 97 2,093 97 3,286 89 1,463 94 3,583 94 442 89 
Yes 925 7 58 3 75 3 414 11 92 6 232 6 54 11 
Communication 
No Impairment 8,903 66 1,411 83 1,673 77 2,199 59 670 43 2,650 69 300 60 
Moderately Impaired 3,514 26 225 13 458 21 1,305 35 438 28 977 26 111 22 
Severely Impaired 1,015 8 62 4 37 2 196 5 447 29 188 5 85 17 
Respiratory Status 
Severe 3,207 24 307 18 459 21 658 18 938 60 712 19 133 27 
Moderate 990 7 105 6 395 18 211 6 33 2 211 6 35 7 
Healthy 9,235 69 1,286 76 1,314 61 2,831 77 584 38 2,892 76 328 66 
Oxygen at Discharge 
No 13,126 98 1,685 99 2,158 100 3,678 99 1,334 86 3,788 99 483 97 





Table 6-8 (continued)  


































Sitting/Mobility Endurance  
No Endurance 5,444 41 302 18 431 20 1,534 41 1,251 80 1,706 45 220 44 
Endurance with 
support/rest 3,493 26 388 23 874 40 951 26 169 11 992 26 119 24 
Endurance w/out 
support/rest 4,400 33 975 57 851 39 1,199 32 132 8 1,097 29 146 29 
NOTE: N = 13,432 
History of falls: Indicates whether the patient has had two or more falls in the past year or any fall with injury in the past year (yes or no/unable to assess).  The latter is the 
reference group. 
Bladder incontinence frequency: This is a three level variable indicating level of incontinence.  The first two are examined in the model; the third level includes those who are 
neither continent nor incontinent. 
0= continent or stress incontinence 
1= incontinent daily or always incontinent 
Bowel device:  The patient used an external or indwelling device for bowel care (yes/no).  The reference group is the latter.  
Swallowing NPO: The patient had no intake by mouth at discharge or within 2 days of discharge (yes/no).  The reference group is the latter. 
Swallowing- other signs of difficulty: The patient had signs or symptoms of a possible swallowing disorder including coughing or choking during meals or when swallowing 
medications, or holding food in mouth/cheeks or residual food in mouth after meals, or loss of liquids/solids from mouth when eating or drinking (yes/no).  The reference 
group is the latter. 
Communication:  This set of variables is a composite variable based on the patient’s ability to understand verbal content and express ideas and wants.  The three indicator variables 
are:  
not impaired: if both understanding and expression are coded as “4” (clear comprehension without cues or repetitions and expresses complex messages without difficulty and 
with speech that is clear and easy to understand)           
severely impaired: if  either item is coded “8” (unable to assess) or “9” (unknown) 






Table 6-8 (continued)  
Functional impairments for discharge destination sample 
Respiratory status: This set of variables is a composite variable based on the patient’s respiratory status with supplemental oxygen and without supplemental oxygen.  The three 
indicator variables are:  
Healthy respiratory status reflected  patients who were only short of breath when climbing stairs without oxygen or never short of  breath on oxygen.    
Moderate  respiratory status reflected patients who with oxygen, had shortness of breath climbing stairs AND without oxygen were either never out of breath (coded “0”) or 
only when climbing stairs (coded “1”) or with moderate exertion (coded “2”).  Others in this category used no oxygen but had shortness of breath with moderate exertion 
(coded “2”) or were missing data. 
Severe respiratory status reflected patients who were not on oxygen but were coded “3” (shortness of breath with minimal exertion), “4” (shortness of breath at rest), or “5” 
(severely struggling to breathe at rest).  
With oxygen, shortness of breath on stairs (coded “1”) AND without oxygen, shortness of breath with minimal exertion (coded “3) or mild shortness of breath at rest (coded 
“4”), or severely struggling to breathe at rest, or 
With oxygen, shortness of breath with moderate exertion (coded “2”) AND without oxygen, shortness of breath with minimal exertion (coded “3) or mild shortness of breath 
at rest (coded “4”), or severely struggling to breathe at rest, or  
With oxygen, any difficulty with minimal exertion or at rest (coded as “3”, “4” , or “5”), regardless of rating without oxygen, or  
With oxygen, coded as not assessed or not applicable but without oxygen, coded as any difficulty with minimal exertion or at rest (coded as “3”, “4” , or “5”). 
Sitting/Mobility endurance: This variable is a composite of the two endurance impairment variables – sitting for 15 minutes with/without support and walk/wheel 50 feet 
with/without rest.  Having a code in either sitting or mobility will lead to an equal code for the combined variable.  This variable is coded as follows:  
No endurance: if either mobility OR sitting endurance were coded as “0” (could not do) or “8” (not assessed due to medical restriction) 
Endurance with support/rest: if mobility OR sitting endurance were coded as “1” could do with support/rest and neither were coded as “0” or “8” 
Endurance without support/rest: if mobility AND sitting endurance were coded as “2” could do with support/rest 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
SOURCE: RTI analysis of CARE assessments and Medicare claims 
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Table 6-9  
Functional status for discharge destination sample 




Health  SNF IRF LTCH 
Self Care Rasch  
Mean 44.78 57.51 56.05 42.41 41.81 28.06 
Median 45.06 58.22 54.28 43.52 42.26 29.31 
5th percentile 6.76 20.51 34.55 15.54 23.51 6.49 
95th percentile 77.75 81.93 84.53 58.30 54.28 55.54 
Mobility Rasch  
Mean 44.71 59.61 57.01 41.27 40.48 29.69 
Median 44.02 60.13 55.69 41.63 41.49 30.59 
5th percentile 10.09 15.34 34.59 15.13 19.49 8.38 
95th percentile 79.36 85.27 86.58 58.51 53.72 54.68 
Motor Rasch  
Mean 44.81 59.69 56.25 41.87 41.3 28.19 
Median 44.57 57.72 55.49 42.78 42.36 30.20 
5th percentile 6.84 22.39 35.72 22.21 26.49 1.77 
95th percentile 81.19 84.29 83.98 57.07 52.98 53.78 
NOTE: N = 13,432 








































Severe Limitations 1,996 15 177 10 333 15 266 7 290 19 755 20 175 35 
Some Limitations 5,308 40 650 38 837 39 1,292 35 637 41 1,689 44 203 41 
Independence 6,128 46 871 51 998 46 2,142 58 628 40 1,371 36 118 24 
Lived alone before 
admission 
No 9,387 70 1,281 75 1,567 72 2,493 67 1,188 76 2,463 65 395 80 
Yes 4,045 30 417 25 601 28 1,207 33 367 24 1,352 35 101 20 
Lived in community before 
admission 
Yes with Assistance 6,091 45 758 45 1,187 55 1,378 37 698 45 1,800 47 270 54 
Yes without Assistance 6,458 48 792 47 955 44 2,293 62 727 47 1,598 42 93 19 
No 883 7 148 9 26 1 29 1 130 8 417 11 133 27 
NOTE: N = 13,432 
Prior function: Based on a composite of the five interview items on the patient’s usual ability with everyday activities before this current illness, exacerbation, or injury.  The five 
items include the following and each was scored on a 5-point scale:  3) independent, 2) needed some help, 1) dependent, 8) not applicable, or 9) unknown.  The items were 
used to create a 3-level scale of prior functioning: 
Severe limitations: If self-care OR wheelchair mobility OR stairs ambulation were coded “1” (dependent) 
Some limitations: those who were not completely dependent in one area or completely independent across both self-care and mobility items. 
Independence:  If self-care AND wheelchair mobility AND stairs ambulation were coded “3” (independent) 
Lived alone in community before admission: This indicator variable identifies beneficiaries who lived in the community before this admission AND who lived alone (yes).  Those 
who did not live in the community or who lived with others were the reference group (no).   
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 




Table 6-11  


































PAC Provider Market 
Boston, MA 1,281 10 98 6 146 7 222 6 370 24 407 11 38 8 
Rochester, NY 501 4 126 7 149 7 28 1 0 0 186 5 12 2 
Tampa, FL 1,007 7 39 2 359 17 306 8 159 10 137 4 † 1 
Louisville, KY 1,308 10 87 5 116 5 461 12 100 6 535 14 † 2 
Chicago, IL 1,646 12 89 5 152 7 715 19 302 19 369 10 19 4 
Dallas, TX 1,125 8 74 4 152 7 595 16 229 15 60 2 15 3 
Lincoln, NE 898 7 161 9 153 7 147 4 48 3 335 9 54 11 
Seattle, WA 308 2 0 0 68 3 32 1 44 3 164 4 0 0 
San Francisco, CA 772 6 87 5 59 3 233 6 0 0 386 10 † 1 
Columbia, MO 281 2 † 0 152 7 0 0 0 0 115 3 10 2 
Wilmington, NC 871 6 173 10 299 14 215 6 † 0 158 4 25 5 
Non-high PAC (Region 5 
Supp) 592 4 212 12 81 4 18 0 † 1 190 5 82 17 
High PAC (Region 1-4,6,9 
Supp) 2,842 21 548 32 282 13 728 20 293 19 773 20 218 44 
† Indicates sample size of less than 11. 
NOTE: N = 13,432 
Provider Market:  This set of covariates identifies the market in which the data were collected.  Each market was selected in the first phase as representing a high or low PAC 
market on the basis of whether they had an IRF or LTCH available within a 2 hour radius (High PAC) or did not and were reliant on SNFs and HHAs for PAC services within 
a 2 hour radius.  (See Section 4, Table 4-1). 
Home with no services= absence of any of these services within 30 days discharge from hospital. 
Other= rehospitalization to an acute care hospital, psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language 
pathology services within 30 days of discharge from hospital. 
* 'No services' is defined as no Medicare claim for LTCH, IRF, SNF, HHA, Part B therapy, or hospitalization within 30 days of hospital discharge.  
SOURCE: RTI analysis of CARE assessments and Medicare claims 




Pseudo R-square for discharge destination models 
Model Pseudo R-Square 
Any PAC 0.34 
FirstPAC 0.47 
SNF/IRF 0.38 
SNF/HHA  0.40 
NOTE: N = 13,432 
SNF= Skilled Nursing Facility 
IRF= Inpatient Rehabilitation Facility 
HHA= Home Health 





Table 6-13  
Discharge destination models: AnyPAC and FirstPAC 
Variable 




PAC vs. no 
PAC  



































64 years and under 0.71 <0.01 0.66 <0.01 0.60 0.01 0.75 0.17 1.25 0.31 
65-74 years (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
75-84 years  1.30 <0.01 1.33 <0.01 2.02 <.0001 1.28 0.01 1.11 0.43 
85 years and above  1.48 <.0001 1.70 <.0001 3.03 <.0001 1.31 0.09 0.93 0.70 
Race/ethnicity  
Non Black or African 
American (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Black or African American 1.07 0.86 1.16 0.65 1.16 0.72 0.86 0.74 1.06 0.91 
Gender  
Female  1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Male 1.11 0.11 0.99 0.94 1.01 0.93 1.52 <.0001 1.37 <0.01 
Medicaid as secondary payer 
(FFS or HMO) 
Yes 0.50 <.0001 0.54 <0.01 0.43 <.0001 0.57 0.02 0.62 0.09 
Other acute claim within past 2 
months  
Yes 0.44 <.0001 0.69 0.03 1.00 1.00 0.44 <0.01 0.20 <.0001 
Medical status  
Primary diagnosis group  
Neurologic 0.57 0.03 0.38 <0.01 0.34 <0.01 0.84 0.60 1.70 0.20 
Respiratory 0.41 <.0001 0.49 0.01 0.43 <0.01 0.33 <0.01 3.13 <0.01 
Cardiovascular 0.64 0.05 0.88 0.66 0.74 0.27 0.61 0.20 1.77 0.19 
Orthopedic (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Integumentary 0.57 0.05 0.71 0.27 0.56 0.11 0.18 <.0001 2.17 0.12 
Endocrine 0.34 <.0001 0.42 0.01 0.39 0.01 0.21 <0.01 0.99 0.98 
Kidney & Urinary 0.28 <.0001 0.32 <0.01 0.37 <0.01 0.11 <.0001 0.18 <0.01 
Infections 0.47 <0.01 0.68 0.27 0.65 0.19 0.31 <0.01 3.10 <0.01 
Transplant 0.49 0.11 0.65 0.46 0.14 0.05 0.79 0.82 1.98 0.53 
GI & Hepatobiliary 0.21 <.0001 0.26 <.0001 0.19 <.0001 0.07 <.0001 0.46 0.01 
Hematologic 0.55 0.05 0.83 0.50 0.73 0.48 0.32 0.02 2.76 0.11 






Table 6-13 (continued) 
Discharge destination models: AnyPAC and FirstPAC 
Variable 




PAC vs. no 
PAC  































Pr >  
ChiSq 
Surgical indicator  
Yes 0.44 <.0001 0.35 <.0001 0.35 <.0001 0.31 <.0001 0.24 <.0001 
HCC: Liver  
Yes 2.41 <.0001 2.48 <.0001 2.85 <.0001 2.89 <.0001 4.50 <.0001 
HCC: Diabetes  
Yes 2.37 <.0001 2.74 <.0001 2.54 <.0001 2.32 <.0001 3.16 <.0001 
HCC: Other EndoMet  
Yes 2.08 <.0001 1.82 <.0001 2.75 <.0001 3.25 <.0001 5.41 <.0001 
HCC: Ortho  
Yes 4.19 <.0001 4.27 <.0001 6.98 <.0001 6.61 <.0001 4.18 <.0001 
HCC: Other neuro  
Yes 2.16 <.0001 2.33 <.0001 2.24 <.0001 3.94 <.0001 1.70 0.01 
HCC: Cardiovascular  
Yes 2.09 <.0001 1.62 <0.01 2.17 <.0001 3.11 <.0001 4.38 <.0001 
HCC: Stroke  
Yes 3.32 <.0001 3.89 <.0001 4.54 <.0001 11.33 <.0001 4.20 <.0001 
HCC: Respiratory  
Yes 2.30 <.0001 2.30 <.0001 2.77 <.0001 2.97 <.0001 4.25 <.0001 
HCC: Acute/chronic renal 
Yes 1.88 <.0001 1.98 <.0001 2.18 <.0001 2.20 <.0001 4.21 <.0001 
HCC: UTI 
Yes 1.96 <.0001 1.63 <0.01 2.26 <.0001 4.22 <.0001 4.05 <.0001 
HCC: Cellulitis  
Yes 2.94 <.0001 2.36 <0.01 3.89 <.0001 4.90 <.0001 11.15 <.0001 
HCC: Head and Spine  
Yes 2.29 <0.01 1.85 0.08 1.55 0.22 5.35 <.0001 1.95 0.09 
HCC: Psych  






Table 6-13 (continued) 
Discharge destination models: AnyPAC and FirstPAC 
Variable 




PAC vs. no 
PAC  































Pr >  
ChiSq 
Treatments  
Any hemodialysis  
No Hemodialysis 
(referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Hemodialysis, 
Stay/Discharge 0.59 0.01 0.27 <.0001 0.69 0.20 0.53 0.07 1.48 0.31 
Any vent (wean or 
nonwean) at discharge  
Yes 2.94 0.04 2.94 0.10 1.17 0.85 1.18 0.87 11.67 <0.01 
TPN at discharge  
Yes 1.56 0.21 0.55 0.55 0.97 0.97 1.14 0.87 8.09 0.01 
IPPS ICU Days >= 7 /<7 
days  
Yes 0.77 0.35 1.07 0.87 1.02 0.98 0.26 0.03 1.63 0.50 
Severe pressure ulcer  
Yes 0.72 0.05 1.10 0.76 1.17 0.58 0.72 0.31 3.05 <0.01 
Cognitive status  
Depression diagnosis  
Yes 1.77 <.0001 1.59 <.0001 2.23 <.0001 2.20 <.0001 2.00 <0.01 
Temporal orientation  
Intact/Borderline 
Impairment (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Moderate 0.07 <.0001 0.22 <0.01 0.06 <.0001 0.02 <.0001 0.01 <.0001 
Severely impaired 0.79 0.13 0.70 0.14 0.99 0.96 0.62 0.12 0.77 0.36 
Functional status  
History of falls  
Yes 1.19 0.07 0.90 0.37 1.60 <0.01 1.21 0.24 1.03 0.88 
Self care Rasch  1.05 <.0001 0.99 0.58 1.08 <.0001 1.13 <.0001 1.04 0.14 
Self care Rasch squared 1.00 <.0001 1.00 0.56 1.00 <.0001 1.00 <.0001 1.00 0.02 
Mobility Rasch  1.01 0.34 1.09 <.0001 1.01 0.44 1.05 0.07 0.98 0.43 






Table 6-13 (continued) 
Discharge destination models: AnyPAC and FirstPAC 
Variable 




PAC vs. no 
PAC  































Pr >  
ChiSq 
Motor Rasch  na — — — — — — — — — 
Motor Rasch squared na — — — — — — — — — 
Bladder incontinence frequency  
Yes 1.15 0.20 1.21 0.22 1.02 0.91 1.15 0.40 1.35 0.08 
Bowel device  
Yes 1.28 0.21 1.38 0.36 1.03 0.92 2.41 0.01 3.24 <0.01 
Swallowing: NPO  
Yes 1.38 0.06 1.40 0.37 2.01 0.01 2.42 0.01 6.44 <.0001 
Swallowing: sign/symptoms b-d 
Yes 1.06 0.69 0.97 0.88 1.05 0.81 1.41 0.10 1.34 0.40 
Communication  
No Impairment (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Moderately Impaired 1.95 <.0001 2.26 <.0001 1.67 <0.01 2.68 <.0001 2.43 <.0001 
Severely Impaired 1.36 0.12 1.53 0.16 1.25 0.50 1.80 0.12 2.08 0.06 
Respiratory status  
Healthy (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Moderate 1.82 <0.01 3.14 <.0001 0.88 0.60 1.26 0.40 0.44 0.01 
Severe 1.17 0.25 1.33 0.08 0.91 0.59 1.38 0.10 1.62 0.04 
Sitting/mobility endurance  
Endurance w/out 
support/rest (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
No Endurance  1.44 0.03 1.45 0.08 1.29 0.22 0.88 0.60 3.32 <.0001 
Endurance with support/rest 1.42 0.06 1.89 <0.01 1.25 0.32 0.88 0.64 1.20 0.57 
Premorbid/social factors  
Prior functioning  
Independence (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Severe Limitations 0.85 0.17 2.22 <.0001 1.29 0.16 0.29 <.0001 0.59 0.04 






Table 6-13 (continued) 
Discharge destination models: AnyPAC and FirstPAC 
 Variable 




PAC vs. no 
PAC  































Pr >  
ChiSq 
Lived alone in community 
before illness  
Yes 1.26 <0.01 0.97 0.76 1.70 <.0001 1.70 <.0001 1.25 0.10 
PAC provider market  
Boston, MA (referent) 1.00 — 1.00 — 1.00 — 1.00 — 1.00 — 
Rochester, NY 0.68 0.70 0.77 0.79 0.57 0.60 0.16 0.25 <0.01 <.0001 
Tampa, FL 2.92 0.28 4.00 0.14 0.73 0.76 3.30 0.42 0.22 0.33 
Louisville, KY 1.10 0.92 0.72 0.76 1.15 0.91 1.64 0.75 0.06 0.07 
Chicago, IL 1.20 0.86 0.86 0.88 0.66 0.71 2.66 0.51 0.08 0.07 
Dallas, TX 0.99 0.99 1.03 0.97 0.12 0.01 2.44 0.51 0.38 0.50 
Lincoln, NE 0.42 0.19 0.56 0.33 0.39 0.26 0.35 0.43 0.04 0.02 
Seattle, WA >999.999 <.0001 >999.999 <.0001 >999.999 <.0001 >999.999 <.0001 >999.999 <.0001 
San Francisco, CA 0.82 0.83 0.45 0.38 0.80 0.83 0.61 0.74 <0.01 <.0001 
Columbia, MO 4.17 0.29 21.12 0.01 6.52 0.20 <0.01 <.0001 <0.01 <.0001 
Wilmington, NC 0.65 0.61 1.17 0.85 0.28 0.20 0.71 0.81 <0.01 <.0001 
Non-high PAC (Region 5 
Supp) 1.81 0.29 0.96 0.95 1.74 0.44 3.40 0.29 0.20 0.14 
High PAC (Region 1-
4,6,9 Supp) 1.69 0.40 1.18 0.78 1.99 0.41 0.60 0.72 0.05 0.01 
NOTE: PAC vs. no PAC N = 13432; Pseudo R-Square Any PAC= .34; N FirstPAC= 12936; Pseudo R-Square Which PAC= .47 
Any PAC Model: this outcome was defined as a yes/no indicator of whether the beneficiary had a Medicare claim (LTCH, IRF, SNF, HHA, Part B therapy, hospitalization) within 
30 days after discharge from the hospital.  Note that cases with a zero day transfer from an acute hospital to another acute hospital, as defined above, were excluded from the 
analysis. 
No PAC Care (reference category) this category is defined as not having one of the above services types.  This group may include patients with no services within 30 days (other 
than physician services) or it may include patients who received services within 30 days including re-hospitalizations, hospice, long-term nursing facility, psychiatric hospital, 
federal hospitals, and Part B therapy services, including physical, occupational, or speech and language pathology services 
Other types of medical services including psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language pathology 
services were excluded from all models except ANYPAC where they were included in the PAC group.  These services each had small numbers; however, each type of service 
in this category reflects a continued medical need that is different from no service use. 







Discharge destination models: IRF/SNF and HHA/SNF 
Variable 
IRF vs. SNF 
Odds ratio 
estimate 
IRF vs. SNF 
Pr> chi sq 
HHA vs. SNF  
Odds ratio 
estimate 
HHA vs. SNF  
Pr> chi sq 
Demographics  
Age  
64 years and under 1.43 0.01 1.11 0.48 
65-74 years (referent) 1.00 — 1.00 — 
75-84 years  0.66 <.0001 0.64 <.0001 
85 years and above  0.44 <.0001 0.54 <.0001 
Race/ethnicity  
Non Black or African American (referent) 1.00 — 1.00 — 
Black or African American 0.76 0.31 0.98 0.94 
Gender  
Female  1.00 — 1.00 — 
Male 1.48 <.0001 0.94 0.40 
Medicaid as secondary payer (FFS or HMO) 
Yes 1.31 0.19 1.20 0.44 
Other acute claim within past 2 months  
Yes 0.44 <.0001 0.73 0.06 
Medical status  
Primary diagnosis group  
Neurologic 2.61 <.0001 1.27 0.32 
Respiratory 0.71 0.15 1.49 0.03 
Cardiovascular 0.80 0.44 1.24 0.35 
Orthopedic (referent) 1.00 — 1.00 — 
Integumentary 0.33 <0.01 1.43 0.27 
Endocrine 0.57 0.08 1.19 0.52 
Kidney & Urinary 0.31 <.0001 0.99 0.95 
Infections 0.51 0.01 1.12 0.69 
Transplant 4.63 0.13 8.65 0.02 
GI & Hepatobiliary 0.38 <.0001 1.67 0.01 
Hematologic 0.43 0.07 1.15 0.76 






Table 6-14 (continued) 
Discharge destination models: IRF/SNF and HHA/SNF 
Variable 
IRF vs. SNF 
Odds ratio 
estimate 
IRF vs. SNF 
Pr> chi sq 
HHA vs. SNF  
Odds ratio 
estimate 
HHA vs. SNF  
Pr> chi sq 
Surgical indicator  
Yes 0.86 0.24 0.99 0.92 
HCC: Liver  
Yes 1.01 0.86 0.81 0.03 
HCC: Diabetes  
Yes 0.91 0.23 1.15 0.12 
HCC: Other EndoMet  
Yes 1.18 0.02 0.68 <.0001 
HCC: Ortho  
Yes 0.92 0.42 0.69 <0.01 
HCC: Other neuro  
Yes 1.70 <.0001 1.13 0.32 
HCC: Cardiovascular  
Yes 1.45 <0.01 0.76 0.01 
HCC: Stroke  
Yes 2.41 <.0001 0.93 0.60 
HCC: Respiratory  
Yes 1.08 0.31 0.82 0.03 
HCC: Acute/chronic renal 
Yes 1.00 0.96 0.95 0.66 
HCC: UTI 
Yes 1.81 <.0001 0.75 <0.01 
HCC: Cellulitis  
Yes 1.24 0.17 0.57 0.01 
HCC: Head and Spine  
Yes 3.26 <.0001 1.21 0.52 
HCC: Psych  






Table 6-14 (continued) 
Discharge destination models: IRF/SNFand HHA/SNF 
Variable 
IRF vs. SNF 
Odds ratio 
estimate 
IRF vs. SNF 
Pr> chi sq 
HHA vs. SNF  
Odds ratio 
estimate 
HHA vs. SNF  
Pr> chi sq 
Treatments  
Any hemodialysis  
No Hemodialysis (referent) 1.00 — 1.00 — 
Hemodialysis, Stay/Discharge 0.69 0.14 0.33 0.01 
Any vent (wean or nonwean) at discharge  
Yes 1.19 0.84 3.20 0.08 
TPN at discharge  
Yes 0.97 0.95 0.22 0.11 
IPPS ICU Days >= 7 /<7 days  
Yes 0.20 0.11 0.82 0.71 
Severe pressure ulcer  
Yes 0.68 0.11 0.85 0.50 
Cognitive status  
Depression diagnosis  
Yes 0.96 0.77 0.65 <0.01 
Temporal orientation  
Intact/Borderline Impairment (referent) 1.00 — 1.00 — 
Moderate 0.31 0.01 3.72 0.03 
Severely impaired 0.60 0.04 0.70 0.05 
Functional status  
History of falls  
Yes 0.73 0.02 0.61 <.0001 
Self care Rasch  na — 0.90 <.0001 
Self care Rasch squared na — 1.00 <.0001 
Mobility Rasch  na — 1.09 <0.01 
Mobility Rasch squared na — 1.00 — 
Motor Rasch  1.08 <0.01 na — 






Table 6-14 (continued) 
Discharge destination models: IRF/SNF and HHA/SNF 
Variable 
IRF vs. SNF 
Odds ratio 
estimate 
IRF vs. SNF 
Pr> chi sq 
HHA vs. SNF  
Odds ratio 
estimate 
HHA vs. SNF  
Pr> chi sq 
Bladder incontinence frequency  
Yes 1.15 0.26 1.03 0.82 
Bowel device  
Yes 2.42 <0.01 1.17 0.73 
Swallowing: NPO  
Yes 1.27 0.33 0.67 0.12 
Swallowing: sign/symptoms b-d 
Yes 1.41 0.06 0.97 0.88 
Communication  
No Impairment (referent) 1.00 — 1.00 — 
Moderately Impaired 1.64 <0.01 1.24 0.18 
Severely Impaired 1.32 0.29 1.10 0.77 
Respiratory status  
Healthy (referent) 1.00 — 1.00 — 
Moderate 1.49 0.11 3.27 <.0001 
Severe 1.54 <0.01 1.31 0.07 
Sitting/mobility endurance  
Endurance w/out support/rest (referent) 1.00 — 1.00 — 
No Endurance  0.70 0.03 1.14 0.44 
Endurance with support/rest 0.71 0.11 1.46 0.02 
Premorbid/social factors  
Prior functioning  
Independence (referent) 1.00 — 1.00 — 
Severe Limitations 0.21 <.0001 1.75 <0.01 
Some Limitations 0.57 0.01 0.94 0.66 
Lived alone in community before illness  






Table 6-14 (continued) 
Discharge destination models: IRF/SNFand HHA/SNF 
Variable 
IRF vs. SNF 
Odds ratio 
estimate 
IRF vs. SNF 
Pr> chi sq 
HHA vs. SNF  
Odds ratio 
estimate 
HHA vs. SNF  
Pr> chi sq 
PAC provider market  
Boston, MA (referent) 1.00 — 1.00 — 
Rochester, NY 0.21 0.25 1.18 0.84 
Tampa, FL 4.26 0.26 3.98 0.12 
Louisville, KY 1.23 0.84 0.55 0.48 
Chicago, IL 3.41 0.22 1.03 0.97 
Dallas, TX 18.96 <0.01 7.76 0.01 
Lincoln, NE 0.72 0.78 1.23 0.78 
Seattle, WA 0.16 0.16 0.73 0.79 
San Francisco, CA 0.65 0.68 0.46 0.38 
Columbia, MO <0.01 <.0001 2.82 0.33 
Wilmington, NC 2.40 0.42 3.76 0.09 
Non-high PAC (Region 5 Supp) 1.61 0.60 0.48 0.38 
High PAC (Region 1-4,6,9 Supp) 0.28 0.31 0.57 0.46 
NOTE: SNF/IRF N = 7515; Pseudo R-Square SNF/IRF= .38; SNF/HHA N = 5983; Pseudo R-Square SNF/HHA= .40 
IRF/SNF outcomes: this outcome selects only IRF and SNF admissions to examine more closely the factors associated with discharge to either of these services.  This outcome 
was defined having either a SNF or an IRF claim within 30 days after discharge from the hospital.  The SNF group was the referent category. 
SNF/HHA outcomes: this outcome selects only SNF and HHA admissions to examine more closely the factors associated with discharge to either of these services.  This outcome 
was defined having either a SNF or an HHA claim within 30 days after discharge from the hospital.  The SNF group was the referent category. 
Other types of medical services including psychiatric hospital, federal hospitals, and Part B therapy services, including physical, occupational, or speech and language pathology 
services were excluded from all models except ANYPAC where they were included in the PAC group.  These services each had small numbers; however, each type of service 
in this category reflects a continued medical need that is different from no service use. 
SOURCE: RTI analysis of CARE assessments and Medicare claims; PACPRD_JD055_DD_Model3_4Diag_SNFvIRF1.xls; 
PACPRD_JD056_DD_Model4_4Diag_SNFvHHA1.xls 
126
 
